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Abstract 
According to the concept of perinatal programming environmental factors 
during fetal development and early postnatal life can influence phenotype 
in later life by modifying organ and tissue development and the epigenetic 
information of specific genes which, in turn, induce alteration in gene 
expression. Global nutrient restriction is a well-established intervention to 
study fetal programming but choline, a micronutrient essential for tissue 
growth and development, has not been extensively studied.  
The aim of this thesis is to investigate long term effects of modifications in 
PDWHUQDOPDFURDQGPLFURQXWULHQWLQWDNHRQWKHRIIVSULQJV¶DSSHWLWH
regulation and metabolic health. 
Twin-pregnant sheep were fed to requirements until 110 days of gestation 
and then randomised to stay on the same diet (R) or be restricted to 60% 
of caloric requirements (N) until term (~145 days). Offspring were 
subsequently subject either to a standard early postnatal growth rate as 
both twins remained with the mother (S) or to an accelerated growth rate 
resulting when only one twin remained to be mother fed (A). After 
weaning, offspring were reared in either a lean (L) or an obesogenic 
environment (O) until 17 months of age. These interventions gave rise to 4 
groups: RAO, NAO, NSO and NSL. There were no differences in body 
weight, composition or adipocyte size with perinatal nutrient restriction but 
insulin response to a glucose tolerance test was increased in offspring born 
to N mothers. Measurement of hypothalamic gene expression in the latter 
offspring suggested a more orexigenic and cortisol-sensitive regulatory 
phenotype. 
ii 
 
During lactation, rats were fed a diet that was either choline-devoid (D), or 
contained a standard amount of choline either as bitartrate (C) or as 
phosphatidylcholine (PC). After weaning, female offspring were maintained 
on a standard choline diet until 11 weeks of age. D mothers had a 
substantial decrease in food intake and offspring were smaller at weaning 
EXWKDGVLPLODUJOXFRVHWROHUDQFH$GXOWRIIVSULQJV¶EUDLQSKRVSKROLSLG
concentrations were reduced, which may suggest changes in brain 
development, but food intake and hypothalamic protein expression were 
unchanged. Intake of different forms of choline, i.e. bitartrate versus PC, 
during lactation had no long term effects on offspring. 
Both maternal dietary interventions had long term effects on offspring. 
Sheep developed the most adverse metabolic phenotype when the 
offspring were subjected to slow growth in late gestation followed by rapid 
growth and obesity, with the onset of insulin resistance mediated through 
changes in peripheral tissues. Maternal choline intake during lactation is 
essential for the health of the offspring as it alters brain composition.  
In conclusion, both studies produced results which are consistent with the 
concept of perinatal programming as adult metabolic health was affected in 
the sheep study and organ development was affected in a long term 
manner in the rat study. 
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1. Introduction 
1.1. General study overview 
My thesis presents two models for investigating long term outcomes in 
appetite regulation and metabolic health after perinatal interventions of 
maternal food intake. In the first study, carried out at the University of 
Nottingham, sheep were subjected to global nutrient restriction during late 
pregnancy and growth rate manipulation in early postnatal life. Outcomes 
assessed from this study were growth pattern, metabolic and endocrine 
characteristics into young adult life, including assessment of glucose 
tolerance and appetite regulation, and post mortem analysis of the 
hypothalamus to gain further insights into regulatory effects of the 
interventions. The second study was carried out at the University of 
Alberta in Canada, for which the influence of maternal dietary intake of 
choline, an essential micronutrient, during lactation was investigated. 
Maternal and offspring development, body composition, appetite regulation 
DQGWKHRIIVSULQJV¶JOXFRVHWROHUDQFHZHUHDVVHVVHGLQWKLVPRGHO 
In this Chapter, I will summarise and discuss current knowledge on the 
interactions of obesity, insulin sensitivity and appetite regulations together 
with the epidemiological and animal research studies underlying the 
concepts of perinatal programming of long term health outcomes.  
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1.2. Obesity 
1.2.1. Definition and incidence  
Obesity is defined as excessive storage of triglycerides in adipose tissues 
and is one part of a cluster of metabolic risk factors, the metabolic 
syndrome, which are associated with increased risk of Type 2 diabetes 
mellitus (T2DM) and cardiovascular disease [1, 2]. To assess obesity in 
DGXOWVDQLQGLYLGXDO¶VKHLJKWDQGZHLJKWDUH used to calculate their body 
mass index (BMI): 
ܤܯܫ ൌ ݓ݄݁݅݃ݐሺ݇݃ሻ݄݄݁݅݃ݐሺ݉ଶሻ 
Even though the BMI is only an approximate measure of adiposity as it 
does not distinguish between lean and fat mass, it is a standard measure 
in epidemiological studies and is often used in combination with other 
measures of obesity including waist circumference, waist-to-hip-ratio and 
body composition measurements. Internationally used cutoff points for 
RYHUZHLJKWLVD%0,DQGIRUREHVLW\D%0, 
In England in 2010, 26% of both adult men and women were estimated to 
EHREHVHDVGHILQHGE\D%0,DQGDQDGGLWLRQDODQGRI
adult men and women, respectively, were overweight with BMIs between 
25 and 30 [3]. This was a slight increase from 24% obese and 41% and 
32% overweight in 2007 [4]. This trend is consistent with the worldwide 
development of obesity with 1.5 billion, i.e. about 25% of the world 
population being overweight and, of these, 200 million men and 300 
million women were obese in 2008 [5].  
In childhood, the BMI is not a valid method to determine obesity without 
an adjustment for age. Instead, children are compared to the World Health 
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2UJDQLVDWLRQ¶V:+2JURZWKVWDQGDUGPHGLDQV7ZR standard deviations 
(SD) over the median is considered overweight and 3 SD over the median 
is considered to represent obesity [6]. Worldwide, 6.7% of preschool 
children were estimated to be overweight in 2010 and 9.1% of preschool 
children are expected to be overweight in 2020 [6]. For the UK, the 
1DWLRQDO+HDOWK6HUYLFH¶V1DWLRQDO&KLOG0HDVXUHPHQW3URJUDPPHGHILQHG
childhood obesity as a BMI over the 95th percentile on the British growth 
reference from 1990 [7]. For 4 year old children, obesity prevalence was 
10.1% in boys and 8.8% in girls in 2010/2011 and, in 10 year old children, 
the prevalence is considerably higher with 20.6% in boys and 17.4% in 
girls, which are increasing annually [8].  
1.2.2. White and brown adipose tissue 
Although adipose tissue exists both as white (WAT) and brown adipose 
tissue (BAT) in mammals, only WAT increases significantly with obesity 
whilst BAT decreases [9]. Both tissues are made up of adipocytes but also 
immune cells and endothelial cells from blood vessels. WAT adipocytes 
mainly consist of triglycerides in a lipid droplet and the nucleus, whilst in a 
brown adipocyte lipids take up less space and cells have more 
mitochondria. Whilst WAT is mainly storing energy, BAT releases energy 
from glucose and free fatty acids as heat by activating its unique protein, 
uncoupling protein 1 (UCP1) [10], and plays an important role in the 
survival of the newborn. Recent findings showed that brown adipocytes do 
not exclusively turn into white adipocytes soon after birth, as had been 
assumed. Adult humans still have a small depot of brown adipocytes in the 
supraclavicular region and UCP1-positive cells are interspersed in WAT as 
well [10-12]. Sheep have a similar region of high UCP1-expressing adipose 
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tissue [13]. In contrast to humans and sheep, however, rodents have long 
been known to have a distinct interscapular depot of BAT. UCP1 is, at least 
in rodents, activated by leptin [14] and the sympathetic nervous system 
[15] and is reduced in energy-scarce situations like starvation [16] and 
lactation [17].  
1.2.3. Endocrine functions of white adipose tissue 
Whilst BAT has no known significant endocrine function, WAT expresses 
and secretes into circulation several hormones, including leptin [18]. The 
plasma concentration of leptin is positively correlated with obesity and 
body fat mass [19] whilst adiponectin concentrations decrease as fat mass 
increases [20]. Both hormones have been directly linked to the regulation 
of food intake. If fat mass increases, circulating leptin concentrations 
increase, which, acting on the arcuate nucleus (ARC) of the hypothalamus, 
decrease food intake [21]. If fat mass decreases, circulating adiponectin 
concentrations increase, with contradicting findings about the effects on 
food intake [22].  
Overall, WAT is known to secrete numerous compounds into the 
circulation, including pro-inflammatory cytokines, most prominently tumor 
necrosis factor (TNF) and interleukin (IL)6, the hormone resistin and non-
esterified fatty acids (NEFA) and circulating concentrations of these are 
higher in obese subjects [23-26], and this increase in inflammatory 
molecules is associated with adverse health outcomes.  
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1.2.4. Characteristics of white adipose tissue 
With increasing fat storage, adipocytes can grow by hypertrophy and/or 
hyperplasia. Plasma leptin concentrations are influenced more by 
hypertrophic adipocytes than hyperplastic adipocytes [27] since leptin 
production and secretion increases with adipocyte size, as does the 
production and secretion of inflammatory cytokines [28]. Koenen et al. 
hypothesise that this increased inflammatory activity of hypertrophic 
adipocytes also leads to decreased insulin sensitivity [29].  
WAT is generally divided into visceral adipose tissues such as those 
surrounding inner organs including kidney, intestine, gonads and heart and 
subcutaneous tissues. These tissues differ in characteristics associated with 
higher replication rates in subcutaneous adipose tissues [30]. Adipose 
tissue characteristics and depot size are also dependent on sex, age, 
nutrition and level of adiposity [31]. There are distinct differences between 
human and rat visceral and subcutaneous fat with regards to adipocyte 
size and metabolic activity. In rats, visceral depots have bigger cells [32] 
and higher rates of lipogenesis and lipolysis compared to subcutaneous 
depots [33] but in non-obese humans subcutaneous fat has larger 
adipocytes [34], and higher rate of lipolysis and leptin production as 
compared to omental fat [35]. Feeding high-fat diet increases cell size in 
visceral adipose tissues sooner than in subcutaneous adipose tissues and 
visceral, rather than subcutaneous, adipocyte size seems to be specifically 
correlated with hepatic and systemic insulin resistance [36]. 
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1.3. Metabolic syndrome 
In 2007, the cost of treating obesity-related conditions in the UK through 
the National Health Service (NHS) was estimated as £4.2 billion per year 
[37], i.e. about 5% of the overall 2007 NHS budget of £80 billion [38]. 
Morbidity and mortality rates, especially of T2DM and cardiovascular 
diseases, are significantly higher in obese as compared to lean individuals 
and are even further increased in obese individuals who develop the 
metabolic syndrome [2, 39].  
The metabolic syndrome is defined as meeting at least three of a group of 
risk factors, most importantly visceral adiposity as measured by waist 
circumference and insulin resistance demonstrated as elevated fasting 
glucose. New, standardised criteria for the metabolic syndrome were 
agreed by several international societies in 2009 [40] and are summarised 
below (Table 1.1). 
Table 1.1: Criteria to define the metabolic syndrome. 
Marker In men In women 
Elevated waist circumference FP FP 
Elevated triglycerides1 P0 
Reduced HDL cholesterol1 <1.0 mM <1.3 mM 
Elevated blood pressure1 6\VWROLFPP+J and/or GLDVWROLFPP+J 
Elevated fasting glucose1 P0 
HDL: high density lipoprotein; 1 or drug treatment against this criterion. 
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1.4. Insulin resistance 
1.4.1. Pathogenesis: influence of obesity 
Insulin resistance is defined as an inadequate response of skeletal muscle, 
liver and WAT to the physiological effects of insulin. The incidence of 
insulin resistance and, subsequently, T2DM is much higher in overweight 
and physically inactive individuals than in lean counterparts [41, 42]. 
There are several reasons for this. With obesity, plasma NEFA 
concentrations are increased [25], with visceral adipose tissues being 
specifically lipolytically active [43, 44]. NEFA induce insulin resistance in 
the major metabolic organs, including skeletal muscle and WAT itself [45], 
by direct inhibition of the insulin receptor signalling cascade [46] and 
induction of lipotoxicity and a proinflammatory cytokine profile. 
Furthermore, they induce insulin resistance in the liver, disturbing the 
inhibition of gluconeogenesis and further contributing to hyperglycemia 
[47]. Since insulin also regulates the storage of NEFA in muscle and WAT, 
a lack of insulin signalling increases lipolysis [48], again increasing plasma 
NEFA concentrations. Furthermore, adiponectin is a promoter of insulin 
sensitivity [49, 50] by decreasing inflammatory signalling and by 
promoting uptake of NEFA into WAT [51], and its concentrations decrease 
with increasing body fat mass [20]. 
A third factor is the recruitment of macrophages to excessive WAT [52], 
which causes a proinflammatory profile of circulating cytokines. 
Hypertrophic adipocytes and hepatocytes in obese individuals secrete pro-
inflammatory cytokines as well, both, therefore, contributing to the 
systemic chronic, low-grade inflammatory state observed in obese subjects 
[52-54]. Finally, with excess adiposity, ectopic adiposity also increases, 
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especially in men [55], which is the excessive deposition of adipocytes in 
non-adipose tissue sites including heart, pancreas, liver and skeletal 
muscle. Hepatic lipid content is linked with hepatic hyporeactivity to 
increased plasma glucose concentrations, i.e. a disturbed ability to stop 
gluconeogenesis and glycogenolysis postprandially [56, 57]. Pancreatic 
steatosis, together with chronic hyperglycemia, may contribute to 
increased apoptosis of ß-cells and decreased insulin secretion [58, 59]. 
Insulin-dependent control of lipolysis is stronger in subcutaneous 
compared to visceral fat tissues, even in nonobese subjects [60] and 
visceral fat secretes more pro-inflammatory cytokines than subcutaneous 
fat [61], both at least partially explaining the increased insulin resistance 
in individuals with a high waist circumference [62].  
The resulting hyperinsulinemia is, at first, sufficient to regulate blood 
glucose WRQRUPDOFRQFHQWUDWLRQVXQWLOWKHVHFUHWRU\FDSDFLW\RIǃ-cells 
declines [63, 64], so that hyperglycaemia follows, which can progress to 
T2DM [65]. 
1.4.2. Insulin secretion and effects 
From the diet, macronutrients are taken up into circulation. As pancreatic 
ß-cells take up glucose through an insulin-independent transporter, 
glucose is metabolised and the increased ratio of adenosine triphosphate 
(ATP) to adenosine monophosphate (AMP) induces secretion of insulin from 
vesicles within pancreatic ß-cells into draining blood vessels. This effect is 
increased by the presence of NEFA but a chronic increase in NEFA 
concentrations leads to oxidative stress and ß-cell damage [66]. Insulin is 
released into the portal vein and, therefore, has a direct effect on hepatic 
glucose homeostasis. Therefore, insulin concentrations rise postprandially 
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and, additionally, there is an increase of blood insulin concentrations in 
obesity due to the onset of insulin resistance [67-69]. 
Insulin has anabolic effects as it induces uptake and storage of glucose as 
glycogen and lipid in muscle and liver [70], and of NEFA and triglycerides 
in WAT and muscle [71, 72] and inhibits gluconeogenesis in the liver [73]. 
Glucose uptake into peripheral tissues is induced by insulin-dependent 
translocation of the glucose transporter GLUT4 to the membrane [74] 
whilst hepatocytes take up glucose through GLUT2 and neurons through 
GLUT3, both of which are not influenced by circulating insulin [75]. 
1.4.3. Measuring insulin sensitivity and glucose tolerance 
In humans, insulin resistance can be screened for by measuring fasted 
plasma glucose, glycated hemoglobin (Hba1c) and/or by performing an 
oral glucose tolerance test (GTT) [76]. The most reliable test of insulin 
resistance is the application of a hyperinsulinemic euglycemic clamp, 
during which time the glucose infusion necessary to maintain stable 
plasma glucose concentrations under high insulin concentrations is 
measured. This directly equals the amount of glucose taken up into 
metabolic tissues during the time of the clamp. Both the GTT and clamp 
are accompanied by frequent blood sampling and measurement of plasma 
glucose and insulin concentrations and are, therefore, rarely used to 
screen populations for T2DM or in large epidemiological studies [76, 77].  
The homeostatic model assessment for insulin resistance (HOMA-IR) is a 
measure calculated from fasted plasma insulin and glucose concentrations 
and correlates very well with the euglycemic clamp [78], therefore making 
the much more expensive and time-intensive method of the 
hyperinsulinemic euglycemic clamp superfluous if the only outcome of 
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interest is insulin resistance. The clamp is necessary as a tool to 
distinguish between hepatic glucose production and peripheral glucose 
uptake [79]. 
1.5. Appetite regulation 
As excess adiposity is the result of a misbalance of food intake and energy 
expenditure, appetite regulation and the ways it can be disturbed is central 
to the understanding of the manifestation of overweight. Appetite is a very 
complex system regulated by various regions in the brain in response to 
metabolic and endocrine signals from the periphery. The part of the brain 
involved in appetite regulation which is most thoroughly investigated to 
date is the hypothalamus. Even though an understanding is emerging how 
peripheral signals influence central regulation, the afferent side of food 
intake and physical activity are less well understood and may involve the 
reward centres of the brain, hypothalamic-pituitary-adrenal (HPA) axis and 
the sympathetic nervous system. Appetite regulatory networks are a very 
active field of research but many mechanistic details remain unknown. For 
a graphic overview of the main pathways and nuclei involved, see Figure 
1.1.  
Most of this research is conducted in rodents and is, therefore, not 
necessarily the same as in higher mammals. However, specific mutations 
occuring in humans, e.g. of leptin, the leptin receptor or melanocortin 
receptor, show symptoms which are consistent with the networks 
described in rodents. Differences between species have been found in 
coexpression of neurotransmitters, e.g. cocaine and amphetamine related 
transcript (CART) and pro-opio melanocortin (POMC) are co-expressed in 
neurons in the rodent but are expressed in separate populations of the 
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ARC in the non-human primate whereas CART is co-expressed with 
neuropeptide Y (NPY) and AgRP in humans [80]. 
1.5.1. Primary neurons 
The ARC has 2 distinctly different types of neurons, generally called the 
primary neurons, which directly react to peripheral signals and which 
project to so-called secondary neurons, further integrating those signals. 
The peripheral signals are transported over the blood brain barrier from 
the systemic circulation into cerebrospinal fluid. The most important 
peripheral signals are thought to be leptin, insulin, adiponectin, ghrelin and 
glucose. The ARC is situated on the surface of the hypothalamus near the 
median eminence and is, therefore, both exposed to cerebrospinal fluid in 
the third ventricle and lies in close proximity to blood flow.  
1.5.1.1. Neuropeptides 
The first of two types of primary neurons are those co-expressing 
neuropeptide Y (NPY) and AgRP as their neurotransmitters and which 
generally induce an orexigenic response. These are inhibited by leptin [81, 
82] and insulin [83] and activated by ghrelin [84, 85]. The second type of 
primary neurons co-expresses POMC and CART, induces an anorexigenic 
response and is generally activated by leptin [86], insulin [87] and glucose 
[88] and inhibited by ghrelin [89]. POMC is a polypeptide hormone 
precursor, which is spliced after translation and forms, amongst other 
products, ɲ-melanocyte stimulating hormone (ɲ-MSH), which in turn binds 
to melanocortin receptor 3 and 4 (MC3R, MC4R) on the secondary neurons.  
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Adiponectin also binds to receptors on ARC neurons [90] but its effect on 
food intake is controversial with its orexigenic or anorexigenic effects 
perhaps depending on species and fed/fasted state of the animals [22]. In 
a study of intracerebroventricular (i.c.v.) adiponectin injections there was 
no effect on NPY/AgRP or POMC expression in the ARC and no effect on 
appetite regulation [91] but increased corticotropin releasing hormone 
(CRH) and thyroid releasing hormone (TRH) in the paraventricular nucleus 
(PVN), with subsequent positive effects on energy expenditure [92]. An 
anorexigenic effect after adiponectin injection was shown in fasted rats, as 
adiponectin increased intracellular pathways similarly to those induced by 
insulin and leptin [93]. On the other hand, an orexigenic effect of 
adiponectin could be shown by inducing AMP-activated protein kinase 
(AMPK) activity in the ARC of fed mice by increasing NPY and decreasing 
POMC expression [94].  
Secondary neurons, i.e. those that primary neurons project onto, or 
neurons that are otherwise involved in appetite regulation, have a wide 
variety of functions and are found in several nuclei of the hypothalamus, 
including the PVN, ventromedial nucleus (VMN), lateral hypothalamic area 
(LHA), dorsomedial nucleus (DMN), the cortico-limbic system nucleus 
accumbens and amygdala, the latter of which are involved in food reward, 
and, in the brain stem, nucleus tractus solitarius (NTS), dorsal motor 
nucleus of the vagus (DMNV) and raphe nucleus. 
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Figure 1.1: Graphic overview of appetite regulating network between 
hypothalamic nuclei (red), the pituitary (green, PT), the cortico-limbic 
system (purple), and the brain stem nuclei (blue). 
Nuclei are: arcuate nucleus (ARC), ventromedial nucleus (VMN), lateral 
hypothalamus (LHA), dorsomedial nucleus (DMN), paraventricular nucleus 
(PVN), nucleus accumbens (NAC) and amygdala (AM), nucleus tractus 
solitarius (NTS), dorsal motor nucleus of the vagus (DMNV) and raphe 
nucleus (raphe). 
NPY, neuropeptide Y; AgRP, agouti-related peptide; POMC, pro-opio 
melanocortin; CART, cocaine and amphetamine related transcript; OT, 
oxytocin; CRH, corticotropin releasing hormone; BDNF, brain-derived 
neurotrophic factor; PP, pancreatic polypeptide; MCH, melanin 
concentrating hormone; ACTH, adrenocorticotropic hormone; TRH, thyroid 
releasing hormone; TSH, thyroid stimulating hormone; TRP,tryptophane; 
5HT, serotonin; CCK, cholecystokinin; PYY, peptide YY; GLP2, glucagon-like 
peptide 2; SNS, sympathetic nervous system. 
This figure is based on the papers as referenced throughout this section 
and especially reviews [95-99]. 
1.5.2. Further hypothalamic nuclei 
The VMN is a mainly anorexigenic nucleus, expressing oxytocin and CRH, 
which are both potent in inhibiting food intake [100, 101]. These neurons 
are excited through leptin and this excitation is inhibited by NPY [102, 
103]. Brain-derived neurotrophic factor (BDNF) promotes expression of 
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CRH and its expression is increased by ɲ-MSH through the MC3R/MC4R 
[104]. The VMN also projects back onto the ARC, increasing POMC 
expression in a positive feedback loop [105]. The action of NPY on the VMN 
is inhibited by BDNF [106], thereby increasing the anorexigenic signal.  
CRH is also expressed in the PVN and is found to be decreased in response 
to short term [107] but not long term fasting [108]. Although NPY and 
POMC have opposite effects most of the time, CRH is induced by both 
POMC [107] and NPY [109], which may be explained by the specific nuclei 
projecting onto the PVN, so that fasting still induces a decrease in CRH 
[107]. It is also increased in stress, e.g. restraint stress [110], increasing 
activity of the HPA axis. CRH induces expression of oxytocin in the PVN, 
mediating the anorexigenic response [101]. Both oxytocin and CRH are 
taken into the pituitary from the PVN, going into the circulation [111] and 
initiating ACTH production [112], which results in adrenal release of 
cortisol, respectively. The PVN also includes NPY neurons, which are 
induced by ghrelin [89] and inhibited by serotonin [113].  
Both DMN and LHA are generally orexigenic nuclei. The LHA expresses 
melanin concentrating hormone (MCH) and orexin [114, 115], which are 
reduced by leptin [114]. MCH induces activity in the nucleus accumbens 
[116, 117] and orexin induces NPY expression in the ARC [118]. However, 
in a negative feedback loop, NPY from the ARC inhibits orexin expression in 
the LHA [119]. Leptin also induces expression of MCH [120] and orexin 
[121]. Signalling in the nucleus accumbens further induces orexigenic 
signalling of the LHA [122]. A subset of inhibitory neurons of the LHA 
express obRb and binding leptin induces a reduction of dopaminergic 
signalling in the nucleus accumbens [123]. 
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Hedonic regulation of food intake is thought to be regulated in the 
amygdala and nucleus accumbens, which has dopaminergic, opioid, 
cannabinoid, GABA-ergic and acetylcholine neurotransmission, which are 
all involved in food reward [124]. Reward value is assigned to specific 
foods, dependent on olfactory input, which decreases when hunger 
subsides during a meal [125]. 
BDNF is involved in several of these nuclei, mediating the anorexigenic 
response. It is crucial for the regulation of synaptic activity, 
neurotransmission and neuroplasticity [126] and is especially highly 
expressed in early postnatal development [127]. Expression of BDNF can 
be epigenetically regulated by hypermethylation and acetylation in 
association with perinatal restraint stress [128] and social environment 
[129]. Circulating BDNF is, furthermore, found to be lower in obese and 
Type 2-diabetic individuals [130, 131]. Chronic i.c.v. injection of BDNF 
decreases body weight gain [132] through several potential mechanisms: 
BDNF is crucial for the survival of serotonergic neurons involved in control 
of appetite [133]; in the VMN, BDNF increases anorexigenic signalling of 
MC4R-positive neurons by inhibiting the orexigenic signal of NPY and 
increases energy expenditure [106, 134]; BDNF induces expression of CRH 
[135], which is appetite-inhibiting [110]. Additionally, BDNF has been 
shown to be involved in regulation of the dorsal vagal complex [136], in 
hedonic feeding regulation [137] and in the response to leptin [138]. 
1.5.3. Insulin and leptin signalling 
Both insulin [83, 139] and leptin [81] directly change activity of NPY/AgRP 
and POMC/CART neurons in the ARC by binding to their receptors 
expressed on both cell types. They show an anorexigenic influence by 
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increasing expression of POMC and inhibiting NPY expression. However, 
AgRP is increased by insulin whilst it is decreased by leptin [140]. 
Furthermore, leptin decreases orexigenic signalling of ghrelin and orexin on 
NPY neurons. In obesity, signalling of insulin [141, 142] and leptin [81] to 
the ARC is reduced despite high circulating concentrations, due to lower 
transportation rates over the blood brain barrier [143, 144] or due to 
resistance at the receptor and signalling cascade. This resistance is 
mediated through a higher expression of the inhibitory molecules protein 
tyrosine phosphatase non-receptor type 1 (PTP1B) and suppressor of 
cytokine signalling 3 (SOCS3) [145, 146]. Leptin resistance seems to 
mainly affect signalling in the ARC. However, this does not occur in the 
VMN [147], where leptin induces activation of the sympathetic nervous 
system (SNS) [148]7KH616FDUULHVRXWWKHERG\¶VVWUHVV-related 
responses including increased heart rate, blood pressure, muscle 
catabolism and metabolic preparation for energy expenditure [149] and 
this may be one way through which obesity-related hypertension is 
mediated [150, 151]. 
Leptin, furthermore, inhibits the conversion of tryptophane to serotonin in 
the medial and dorsal raphe nucleus of the brain stem [152]. These 
serotonergic neurons project from the raphe nucleus to the ARC, where 
release of serotonin decreases expression of POMC and MC4R [153]. 
Serotonin has both orexigenic and anorexigenic effects, depending on the 
receptor type mediating the response, as serotonin shows a decrease in 
NPY when binding to the PVN [113]. 
In a pathway connecting peripheral energy status signalling with the 
hedonic regulation of food intake, leptin binding to inhibitory neurons of 
the LHA has been shown to decrease dopaminergic signalling in the 
nucleus accumbens [123]. A resistance to leptin seems to occur, as a 
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chronic increase in leptin concentrations generally decreases the reward 
value of food [154].  
For individuals in positive energy balance, depending, in part, on leptin 
concentrations and induced by ɲ-MSH signalling onto the PVN [155], the 
thyroid hormone system is stimulated [156], whilst it is decreased in the 
fasting state [157, 158]. Secretion of thyroid hormones into the circulation 
is induced by thyroid stimulating hormone (TSH) from the pituitary gland. 
TSH secretion is, in turn, induced by TRH and inhibited by somatostatin, 
both secreted from the hypothalamus. The thyroid hormones thyroxine 
(T4), and the active form triiodothyronine (T3), increase energy 
expenditure by promoting resting oxygen consumption and adaptive 
thermogenesis [159]. 
1.5.4. Signalling molecules derived from the gastro-intestinal system 
and the afferent vagal nerve 
Ghrelin is released in the fasted state from enteroendocrine cells of the 
stomach [160], it decreases activation of the SNS [161, 162] and fasted 
concentrations are negatively correlated with body weight and fat content 
[163]. Circulating ghrelin has a direct effect on NPY neurons in the ARC 
[85]. From the stomach, it additionally suppresses firing of the afferent 
vagal nerve [164], which connects the gastro-intestinal system and liver 
with the brain stem. At the same time, CCK, an anorexigenic hormone 
[165, 166] released postprandially from the mucosa of the small intestine 
[167], increases vagal firing [164]. Similarly, other anorexigenic 
compounds secreted in peripheral organs including leptin [168], peptide YY 
(PYY) [169] and glucagon-like protein (GLP)-2 [170] can all increase vagal 
activity. Ghrelin induces vagal inactivity which causes inactivity of the NTS 
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of the brain stem and, through projections to the ARC, is associated with 
NPY secretion there [95].  
Gastro-intestinal tract-derived peripheral signals also have direct 
interactions with appetite regulatory nuclei mediated through the blood 
circulation. Pancreatic polypeptide is released from the pancreas in 
response to food intake [171] and induces an anorexigenic respone in the 
hypothalamus by inhibiting the release of orexin from the LHA and by 
inducing the secretion of BDNF in the VMN [172].  
1.5.5. Effects of glucose and NEFA on appetite regulation 
As glucose and NEFA are taken up into cells and metabolised, they directly 
influence intracellular energy sensing mechanisms. Their metabolism is 
interrelated and influence activity of AMPK and mammalian target of 
rapamycin (mTOR), which are discussed in Section 1.5.6 below.  
The effects of high NEFA and glucose concentrations are generally 
anorexigenic. Glucose concentrations in the hypothalamus and interstitial 
fluids are highly correlated with circulating concentrations [173], so that 
any effects normally occur in the postprandial state and also in metabolic 
dysregulation, e.g. in T2DM. During times of high glucose and NEFA 
concentrations, glucose is glycolysed to acetyl-CoA, converted to malonyl-
CoA, which subsequently blocks fatty acid ß-oxidation, so that NEFA 
concentrations are not reduced in the cell [174].  
These metabolic processes seem to induce regulation of appetite directly, 
as an increase of malonyl-CoA concentration result in anorexia and 
increased physical activity [175, 176] whilst a decrease of malonyl-CoA 
induces hyperphagia [177]. Injection of NEFA into the cerebral ventricular 
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system reduces hypothalamic expression of NPY and AgRP and, 
subsequently, food intake, but this effect is blunted in obese animals 
through an unknown mechanism [178, 179].  
On the other hand, dietary fat and sugar increase palatability and, through 
the reward centre, can increase food intake and promote obesity, as has 
been widely demonstrated by the numerous studies feeding a high-fat diet 
RUVXFURVHLQWKHDQLPDOV¶GULQNLQJ water to induce obesity. Dietary fat also 
has a direct effect on endocrine control of food intake as feeding a 
controlled amount of a high-fat diet, which does not induce obesity, 
decreases central insulin sensitivity as compared to feeding an isocaloric 
amount of a low-fat diet [141].  
Glucose induces POMC expression in the ARC directly [88] and it may also 
be involved in appetite regulation as a marker of low energy levels since 
hypoglycemia induces release of orexin in the LHA and, with that, 
increased food intake [180].  
1.5.6. Intracellular energy homeostatic signalling  
AMPK is a kinase, which is allosterically activated by AMP and inhibited by 
ATP and is, therefore, generally activated in a low intracellular energy 
state. It is also directly activated by endocrine signals of the fasted state, 
including ghrelin, and is inhibited by endocrine signals of the fed state, 
including leptin, insulin and GLP1 [181]. For a graphic representation of 
intracellular energy sensing see Figure 1.2. 
In fasting, ghrelin binds to its membrane-bound receptor, growth-hormone 
stimulating receptor (GhSR), induces phosphorylation and, with that, 
activation of AMPK, which in turn decreases acetyl-CoA carboxylase (ACC) 
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and fatty acid synthase (FAS) activity in the VMN of the hypothalamus 
[182]. Subsequently, the concentration of malonyl-CoA is decreased [182], 
which reduces glycolysis and an increase in mitochondrial ß-oxidation by 
induction of carnitine palmitoyl-transferase (CPT1) expression [182, 183]. 
How exactly this AMPK pathway induces increased expression of NPY/AgRP 
and reduces POMC expression is not clear but it is likely to involve 
induction of transcription factors in response to alterations in intracellular 
lipid metabolism. Ghrelin induces expression of the brain-specific 
homeobox transcription factor (BSX) through induction of CPT1 [184]. Both 
expression of NPY and AgRP are induced by this transcription factor, in 
combination with cAMP-responsive element binding protein (CREB) and 
forkhead box O1 (FOXO1), respectively [185].  
Leptin, on the other hand, decreases phosphorylation of AMPK in the fed 
state, with opposite effects on intracellular lipid metabolism, therefore 
increasing intracellular malonyl-CoA, inhibiting CPT1 and inhibiting BSX-
dependent expression of NPY and AgRP. Furthermore, it inhibits FOXO1 
and, in this way, inhibits AgRP production [186]. POMC expression is 
repressed by FOXO1, an effect that is alleviated through signal transducer 
and activator of transcription 3 (STAT3) [186], which is induced by insulin 
and leptin [187]. NPY suppression by leptin acts through a STAT3-
independent mechanism. At least part of the NPY suppression is signalled 
through a MAPK-dependent inhibition of voltage-dependent calcium 
channels and, with that, inhibition of firing rates of NPY neurons of the ARC 
[188]. FOXO1 is further deactivated by Akt, which is induced by insulin and 
leptin through the phosphoinositide-3-kinase (PI3K) pathway [189, 190]. 
However, there appears to be another, AMPK-dependent pathway to 
induce NPY expression, which has not been widely described [191]. 
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Figure 1.2: Graphic overview of intracellular energy signalling. In the 
fasted state, ghrelin induces AMPK activity whilst it is inactive in the fed 
state through insulin, leptin and ATP derived from glucose. Sensors 
including AMPK, mTOR and STAT3 induce or inhibit cell growth, 
intracellular metabolism and transcription of neurotransmitters NPY, AgRP 
and POMC. Signalling of insulin and leptin receptors is reduced through 
mTOR activity and through PTP1B and SOCS3, which are induced through 
inflammation and as a product of STAT3-induced gene transcription.  
ACC, acetyl-CoA carboxylase; AGRP, agouti-related peptide; AMPK, AMP-
activated kinase; BSX, brain-specific homeobox transcription factor; CPT1, 
carnitine palmitoyl-transferase 1; FAS, fatty acid synthase; FOXO1, 
forkhead box O1; GHSR, growth-hormone secretagogue receptor; IR, 
insulin receptor; IRS, insulin receptor substrate; JAK, janus kinase; MAPK, 
MCOA, malonyl-Co$0725PDPPDOLDQWDUJHWRIUDSDP\FLQ1)ǉ%
QXFOHDUIDFWRUǉ%13<QHXURSHSWLGH<2%5OHSWLQUHFHSWRU3'.
pyruvate dehydrogenase kinase 1; PGC1ɲ, PPAR ɀ coactivator 1ɲ; PI3K, 
POMC, pro-opiomelanocortin; phosphoinositide-3-kinase; PPAR, 
peroxisome proliferator-activated receptor ɀ; PTP1B, protein tyrosine 
phosphatase non-receptor type 1; SHP2, protein tyrosine phosphatase 
non-receptor type 11; SOCS3, suppressor of cytokine signalling 3; SREBP1, 
sterol regulatory element-binding protein 1; STAT3, signal transducer and 
activator of transcription 3; TG, triglyceride; TNF, tumour necrosis factor; 
TSC1/2, tuberous sclerosis 1 and 2. 
This figure is based on the papers as referenced throughout this section 
and especially reviews [182, 184, 185, 192]. 
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Induction of PI3K through insulin and leptin leads to the activation mTOR 
[193], which is, in complex with regulatory-associated protein of mTOR 
(RAPTOR, mTOR complex 1), another crucial part of cellular energy 
sensing. MTOR promotes protein synthesis and cell growth by inducing 
messenger ribonucleic acid (mRNA) translation [194] and inhibiting 
autophagy [195]. Importantly, mTOR also induces transcription of specific 
target genes by activition of transcription factors sterol regulatory 
element-binding protein (SREBP) [196, 197], peroxisome proliferator-
activated receptor ɀ (PPARɀ) [198] and peroxisome proliferator-activated 
receptor ɀcoactivator 1- ɲ (PGC1ɲ) [199], promoting triglyceride storage 
and mitochondrial fatty acid oxidation. It directly suppresses 
phosphorylation of insulin receptor substrate 1 (IRS1) and is, therefore, 
involved in insulin sensitivity in a negative feedback loop [200]. During 
fasting, mTOR is suppressed through a decrease in insulin and leptin 
signalling, a decrease in intracellular amino acid [201] and ATP 
concentration signalled through AMPK [202], therefore improving insulin 
sensitivity, whilst the opposite occurs in overfeeding. In the hypothalamus, 
mTOR activation itself induces satiety [203], although it is unclear what 
downstream events are responsible for this effect.  
Peripheral and central insulin and leptin resistance associated with obesity 
are also mediated through other mechanisms. Crucial proteins involved in 
this process are SOCS3 and PTP1B. In a negative feedback mechanism, 
activation of STAT3 through leptin induces expression of SOCS3 [204], 
which chronically inhibits leptin signalling through its receptor when 
circulating leptin concentrations are elevated in obesity. SOCS3 diminishes 
phosphorylation and thus activation of janus kinase (JAK)2, protein 
tyrosine phosphatase non-receptor type 11 (SHP2) and STAT3 through the 
leptin receptor [205, 206] whilst PTP1B blocks both the insulin and the 
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leptin receptor [207], JAK2 and STAT3 [208]. Expression of both SOCS3 
and PTP1B is induced by TNF through nuclear factor țB (NFțB), suggesting 
a mechanism through which inflammation induces insulin resistance [209]. 
On the other hand, muscle-specific insulin sensitivity is improved through 
exercise through intracellular signalling involving PI3K [210, 211], AMPK 
[212], Akt [210], resulting in an increase in ß-oxidation of fatty acids [213, 
214].  
1.5.7. Most relevant hypothalamic molecules 
The key transmitters of hypothalamic appetite regulation are, therefore, 
NPY and POMC, as they are almost consistently signalling the increase and 
decrease of food intake, respectively. Further, the influence of circulating 
hormones on the hypothalamus can be approximated by measuring the 
amount of insulin, leptin, ghrelin and adiponectin receptors, and the 
inhibiting molecules PTP1B and SOCS3. AMPK and mTOR are key 
regulators of intracellular energy sensing.  
1.6. Developmental programming 
In the last 20 years, the concept of perinatal programming of adult health 
and disease has gained considerable attention. Programming is defined as 
a persistent change induced in early life and which will be potentially 
increasing the risk of developing specific diseases much later on in life. The 
range of diseases which are thought to be susceptible to programming is 
wide, including obesity, respiratory and cardiovascular diseases, plus 
certain types of cancer and osteoporosis. As research progresses, 
mechanisms mediating programming are becoming clearer. Here, I will 
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concentrate on the fields of most relevance to the studies presented in this 
thesis, i.e. programming of appetite regulation and metabolic health with 
focus on obesity and insulin resistance.  
1.6.1. Long term effects of birth weight 
Babies display a range of weight at (term) birth, with those in the lowest 
and the highest 10% birth weights defined as small and large for 
gestational age (SGA and LGA), respectively, influenced by prenatal 
developmental conditions. Weight at birth is dependent on many factors, 
including parental height [215] and ethnicity [216], placental size [215] 
and maternal nutrition [217], maternal health such as preeclampsia [218] 
and maternal nicotine exposure [219] during pregnancy. Additionally, the 
time period of growth restriction may be approximated by measurement of 
ponderal index, with a low (<10th percentile) index indicating growth 
restriction in late pregnancy, as skeletal growth is less impaired than 
muscle, fat mass and organ growth, which is termed asymmetric SGA 
[220, 221]. The ponderal index is defined as 
݌݋݊݀݁ݎ݈ܽ݅݊݀݁ݔ ൌ ݓ݄݁݅݃ݐሺ݇݃ሻ݈݁݊݃ݐ݄ሺ݉ଷሻ 
From 1992 onwards, Barker presented data of relationships between adult 
diseases and birth weight in several cohorts in the UK. These studies 
showed a negative relationship between birth weight throughout the whole 
range, i.e. not simply an effect of SGA, and death from coronary heart 
disease, a strong negative relationship with Type 2 diabetes and a weaker 
one with plasma low-density lipoprotein (LDL) concentration and blood 
pressure [222, 223].  
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Similarly, in a Swedish male cohort, low birth weight or small ponderal 
index was associated to a higher rate of insulin resistance at 50 years, 
even after adjustment for BMI at 50 years [224]. Adult development of 
insulin resistance has also been described as following a U-shaped 
relationship with birth weight [225], especially in a highly obese population 
[226], as heavy babies are often born to mothers with a high pre-
pregnancy BMI and gestational diabetes, as will be discussed in Section 
1.6.2. This U-shaped relationship is removed if offspring risk of diabetes is 
adjusted by current BMI when it is replaced by a negative correlation, i.e. a 
higher risk of developing diabetes with low birth weight [225]. An increase 
in factors associated with insulin resistance is seen in those of low birth 
weight as early as 8 years of age [227]. The negative association of birth 
weight and later diabetes also includes a higher risk of gestational diabetes 
in women, showing a non-genetic pathway through which predisposition 
for metabolic disease can be passed on to subsequent generations [228]. 
The size of a neonate is mostly determined in late pregnancy, the trimester 
characterised by exponential fetal growth. Using birth weight as a 
determinant of adult health without further definition of the timing of 
adverse effects is an imprecise descriptor since a baby which was growth-
restricted throughout pregnancy is likely to develop differently from a baby 
growth-restricted in the third trimester alone. Additionally, growth 
restriction in early gestation has not been associated with a change of birth 
weight [229, 230] (and these children would, therefore, not be included in 
the low birth weight category) but has major impacts on adult health 
outcomes as described below [231].  
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1.6.1.1. The Dutch Famine cohort study 
Differences in the consequences of the timing of adverse environment can 
be seen in the cohort of individuals who were born during or shortly after 
the Dutch Famine and who were, therefore, affected by extreme maternal 
nutrient shortage during specific parts of their intrauterine development. 
During a six month period in the winter of 1944/45, there was an extreme 
shortage of food supplies in the western part of the Netherlands, due to 
German occupation at the end of the Second World War. A railway 
embargo on food could not be circumvented by transportation over water 
because an unusually severe winter froze the water ways. This resulted in 
average food intake of approximately 800-1000 kcal/d for pregnant women 
[231] as opposed to the recommended intake of approximately 2170, 2365 
and 2600 kcal/d in the 3 trimesters for women of a normal pre-pregnancy 
BMI [232] (based on 2100 kcal/d pre-pregnancy requirement). Individuals 
who had been affected by the famine during pregnancy were followed up 
at 50-60 years in several studies. As a comparison group, health outcomes 
of individuals from the same area of the Netherlands who were born 
shortly before the famine or conceived after the end of the famine were 
included. Data on health outcomes were analysed by the trimester which 
was most affected by the famine. Maternal famine during the second and 
third trimester resulted in a lower body weight whereas famine during the 
first trimester did not result in a change of birth weight [229]. Mothers 
affected in the third trimester had a low weight gain during the third 
trimester whilst mothers affected in both mid or in early gestation had a 
higher weight gain in the third trimester as compared to mothers not 
affected. This change in weight gain rate is likely a reaction to restoration 
of food supplies, making up for earlier slow growth [231]. 
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Generally, individuals who were affected early on in pregnancy were of 
normal birth weight but showed the most distinct changes in adult health, 
with an increase in adult obesity, BMI and waist circumference [233], 
disadvantageous plasma lipid concentrations [229, 234], an earlier onset 
of coronary heart disease [231], a propensity to consume a high-fat diet 
[234] and were susceptible to generally poorer health [231]. These long 
term associations suggest the influence of environmental signals during the 
periconceptional period. Individuals affected in mid gestation were shorter 
in adulthood [233] and developed higher rates of microalbuminuria and 
obstructive airway diseases [231]. Male individuals affected in late 
pregnancy were found to weigh less in early adulthood [235] but were of 
similar body weight and BMI at 50-60 years of age [233]. Both male and 
female individuals also had disadvantageous changes in plasma lipid profile 
[229] and, importantly, showed a higher insulin resistance in a GTT with 
increased glucose and insulin at 120 minutes after glucose intake and 
higher fasted proinsulin concentrations [231, 236]. Based on this data, 
diseases of the metabolic syndrome are programmed in late pregnancy 
without a modification of body weight or body composition and these are 
the changes we assessed further in the sheep study. 
1.6.2. Long term effect of maternal overweight and diabetes 
Birth weight is associated with later BMI in a J-shaped relationship, which 
is influenced by maternal BMI to take a U-shaped relationship, i.e. both a 
low and a high birth weight is associated with a higher adult BMI in the 
offspring, independently of maternal BMI [237]. Additionally, poorly 
controlled maternal diabetes, gestational diabetes or impaired glucose 
tolerance during pregnancy increase the chance of the baby being large at 
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birth and the offspring to become obese and glucose intolerant [238-240]. 
The hypothesis is that if mothers are hyperglycaemic, more glucose passes 
through the placenta and chronically increases fetal plasma concentrations. 
The fetus then responds with a higher insulin secretion from the pancreas 
and this chronic high plasma insulin concentration has an anabolic effect 
on peripheral tissues [239, 241] and may result in higher leptin 
concentrations in cord blood [241, 242].  
1.6.3. Long term effects of rapid early postnatal growth 
Early postnatal growth can be accelerated if birth weight is low for 
gestational age and the infant grows up to be a normal-sized or obese child 
or when a normal-sized infant develops childhood obesity. For growth to be 
DFFHOHUDWHGVXIILFLHQWQXWULHQWVKDYHWREHVXSSOLHGDQGWKHFKLOG¶V
appetite control plays a role in this process. Early postnatal growth is 
associated with a higher rate of adult diabetes. However, in both scenarios 
it is difficult to dissect the developmental cause of adult diabetes since low 
birth weight and later obesity are both associated with diabetes. 
Epidemiological evidence for this is important as it shows the relevance of 
long term programming in human populations but animal models are 
essential to show the isolated effect of early postnatal growth on later 
health. The age period used to assess early growth is very heterogeneous 
in the epidemiological studies, ranging from the first week of neonatal life 
[243] up to three years of age [244]. Subject populations commonly 
include both prematurely born children and those born at term, regardless 
of the physiological differences between these groups. In humans, studies 
conducted are either observational or intervention studies, i.e. by 
randomising infant feeding method, through which differences in early 
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postnatal growth are attained. Exclusive breast feeding results in a rather 
slow growth rate whilst feeding formula generally result in faster growth 
[245]. The reasons for this difference in growth rate is generally unclear 
but can be partially explained by higher protein content of formula milk 
[246, 247] and a slightly higher intake of volume when feeding is 
controlled by the mother through the bottle rather than by the infant itself 
through suckling [248]. The slower growth of breast-fed infants may also 
be mediated through leptin contained in breast milk, but not in formula 
milk, which has been shown to have acute anorexigenic effects in some 
studies and it has been suggested that leptin also has long term effects 
resulting in a suppression of excessive weight gain [249].  
Children who grow rapidly in the first 6 months of life are more likely to be 
overweight or obese at 6-8 years of age than children who had normal or 
slow early postnatal growth. In the same cohort, children who show a slow 
growth in early postnatal life also have a higher birth weight than rapidly 
growing children [250]. In a observation of a shorter time period, rapid 
growth rates both in the first 8 days of life and in the first 4 months are 
correlated with adult overweight (OR of 1.28 and 1.04 per 100g weight 
gain in the observed period, respectively [243]), whilst other studies also 
show an association between growth in the first 4-6 months of life and 
childhood or adult overweight [251-253]. When looking at longer periods 
during childhood, studies found a relationship between growth in the first 3 
years of life and BMI and decreased insulin sensitivity at 8 years [244] or 
growth throughout childhood up to 12 years and obesity and T2DM in 
middle age [254, 255]. Especially in the latter studies, it is less clear 
whether early growth is merely a predictor of growth rates in later 
childhood and adulthood caused by persisting environmental, social or 
genetic factors, or if these studies point towards a specific developmental 
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period which is more vulnerable for programming of later weight and 
metabolic health. As most of these studies [243, 244, 251-253] are large 
prospective studies, the risk of a systematic bias is low.  
Studies concentrating on possible mediators of growth give some insight 
into this: SGA babies have low cord blood leptin concentrations [256] but, 
as they are growing rapidly in early postnatal life, have higher plasma 
leptin concentration at 1 year of age regardless of BMI [257]. Leptin 
concentrations are also higher in adulthood as compared to individuals with 
normal birth weight of the same adult BMI but in both these studies fat 
mass was not determined, i.e. leptin may still be correlated with fat mass, 
which is thought to be higher in later life of individuals born SGA [258]. 
Whether leptin has similar effects on the energy balance of fetus and 
newborn as it does in adult individuals is unknown. When preterm babies 
are fed a preterm formula high in fat and protein rather than a standard 
term formula or breast milk, they gain weight faster and have higher 
plasma leptin concentrations relative to fat mass at pubertal age although 
weight and fat mass, measured by impedance analysis, are not changed 
[259]. This, therefore, demonstrates that leptin expression is over-
proportionately increased in these individuals but it is unclear whether this 
effect is specific for individuals born preterm or whether it could be 
extrapolated to rapid growth following low birth weight. In the same study, 
the individuals fed preterm formula also have higher fasted 32±33 split 
proinsulin concentration at pubertal age, a marker thought to be 
representative of glucose intolerance [260]. It is, therefore, feasible that a 
change in early growth pattern has effects both on the amount of fat mass 
in adulthood and on the adipokine characteristics of this adipose tissue, at 
least in individuals born preterm.  
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1.7. Perinatal development 
1.7.1. Sheep and rat as models for human pregnancy and early 
postnatal life 
To directly explore potentially disadvantageous health outcomes of 
nutritional interventions, especially during development, animal models 
need to be used for ethical reasons. Secondly, in order to understand the 
mechanisms behind the outcomes, tissues need to be investigated directly 
and the availability of histological samples from human subjects is very 
limited. Both rodents and larger mammals are commonly used as models 
for mechanisms in humans. Generally, no animal model represents 
perfectly all mechanisms affecting humans and different models are used 
depending on the research questions. 
With regards to develomental stages, rodents are not directly comparable 
to humans and bigger mammals like sheep are a better model as they are 
following human development more closely. Rats have a much shorter 
gestation time of 21-22 days than human gestation of about 270 days 
whilst sheep, depending on breed, have a gestation time of 145-150 days. 
Both humans and sheep carry one or two fetuses per pregnancy whilst 
rodents carry litters of around ten pups, which are born relatively 
immature, i.e. some of the developmental steps that occur in utero in 
humans and sheep occur postnatally in rodents, including hypothalamic 
and pancreatic development. If the research question regards development 
of a specific organ, the intervention period has to be considered carefully, 
i.e. as pancreas development is prenatal in humans but predominantly 
postnatal in rodents, interventions during pregnancy cannot be compared 
between the two species. Therefore, conclusions have to be drawn 
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carefully. An abundance of studies of developmental origins of adult health 
and disease are carried out in rodents, also due to their obvious advantage 
with regards to costs and short generational time span. 
In the studies in this thesis, sheep were selected to study programming of 
insulin resistance and appetite regulation by interventions in late 
pregnancy and early postnatal life. Adipose tissue mass plays a decisive 
role in both systems. The corresponding organs, i.e. adipose tissue, 
pancreas and hypothalamus, develop in similar stages of pregnancy in both 
humans and sheep. In the rat study of this thesis, the intervention was 
during the lactation period and effects on brain, adipose tissue and 
pancreas were assessed again. These organs predominantly develop in 
early postnatal life in rats whilst they are developing in late pregnancy in 
humans. The timing of intervention is, therefore, coinciding with the main 
developmental period of these organs. The evidence for developmental 
periods is summed up in the following sections for sheep, human and rats. 
1.7.2. Development of adipose tissue 
In sheep, adipose depots are first visible around day 70 of gestation (50% 
completion of gestation) around the kidney and heart with the appearance 
of brown adipose tissue, whilst subcutaneous fat is detected from day 85 
(60% gestation), increases in mass and then decreases again to a very 
small depot at term [261]. Total lipid content at term is at about 3% but 
this is dependent on breed [261]. The thermogenic activity of BAT in 
perirenal adipose tissue increases from 140 days of gestation (97% 
gestation) [262], which is induced by the pre-partum rise in fetal plasma 
cortisol [263]. 
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In humans, some subcutaneous and visceral fat, mostly perirenal fat, is 
present at birth [220], with a total body fat mass of 8-16%, highly 
dependent on birth weight [264] and maternal diabetes status [265]. The 
number of adipocytes is determined in childhood with obese children 
having more and bigger adipocytes than lean children [266]. Later changes 
in fat mass are thought to be mostly mediated through a change in 
adipocyte volume, not number [267] with the adverse consequences for 
metabolic health as described in section 1.2.4. After birth, human and 
sheep BAT around the central organs is replaced by WAT [268] and only 
specific BAT depots persist in the adult [13]. 
In the rat neonate, white fat is non-existant but grows rapidly after birth 
[269]. Total fat mass is at 5-7% at 3 weeks of age in the rat, which 
primarily consists of gonadal, perirenal and subcutaneous fat and only 1% 
of body weight as interscapular fat with predominant brown adipose 
characteristics [270]. 
Glucocorticoids have been shown to be involved in the perinatal maturation 
of adipose tissues [271, 272]. Human and sheep are born with a mature, 
functioning HPA axis and steady increase in fetal cortisol concentrations 
during pregnancy, especially before birth [273], as opposed to rodents, in 
which the offspring start producing corticosterone at 2 weeks postnatal 
[274].  
1.7.3. Development of hypothalamus 
Both in humans and sheep the main neurotransmitters, NPY, AgRP, POMC 
and CART, and receptors for insulin and leptin are expressed in the 
hypothalamus from mid-gestation, i.e. 21 weeks (52% gestation) in 
humans [275] and 81 days (56% gestation) in sheep [276, 277]. Even 
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though further developmental steps have not been investigated in humans 
and sheep, Grayson et al. showed in non-human primates that the number 
of neurons expressing neurotransmitters increases with gestational age 
[80]. Projections are formed between different nuclei of the hypothalamus 
and the brain stem as the hypothalamus goes through morphological 
changes [80]. An i.c.v. injection of NPY induces swallowing of sucrose 
solution in the ovine fetus at 130 days of gestation (90% gestation) [278], 
showing that at least basic regulatory mechanisms are functional 
antenatally. 
In the rodent, low levels of NPY are detected in the hypothalamus from day 
14 of gestation (67% gestation) [279] but projections from the brainstem 
to the hypothalamus continue to develop in the first two weeks of 
postnatal life [280] and projections from the ARC to the PVN and VNM are 
established by 16 and 21 days of postnatal life, respectively [279, 281]. 
Bouret et al. showed that leptin was crucial for the development of 
projections and that the perinatal leptin surge observed in neonatal 
rodents is likely to be important in brain development [282]. 
The hypothalamus is part of the hypothalamic-pituitary-adrenal axis. CRH 
and AVP from the hypothalamic PVN induce release of ACTH from the 
pituitary which, in turn, induces the release of cortisol into the blood 
stream. In a negative feedback loop, cortisol inhibits the release of both 
CRH/AVP and ACTH [283]. Hypoglycemia decreases CRH secretion from 
the hypothalamus and this effect is inhibited by leptin [284]. Consistent 
with this, intraperitoneal injection of leptin decreases ACTH and 
glucocorticoid response in a stress test in rodents [284]. Besides their 
other physiological stress response effects, AVP and cortisol both increase 
blood pressure. A normal pregnancy in human and sheep is associated with 
a steady increase in maternal CRH, ACTH and cortisol concentrations and, 
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in sheep, these increase exponentially immediately before parturition 
[285]. Cortisol is also involved in maturation processes, for example 
glucocorticoids routinely administered antenatally during preterm labour 
promote lung surfactant production [286]. Although substantial changes in 
offspring physiology can be induced by administering glucocorticoids during 
pregnancy, changes in nutrition in early and mid gestation only reduces 
maternal cortisol, which has not been shown to affect the fetus [287].  
1.7.4. Development of pancreas 
In development of the fetal sheep and human, the pancreas forms as a 
bud from the endoderm very early on in pregnancy, which then grows in 
size and forms islets. Single cells of the epithelium of the pancreatic duct 
start expressing the mature form of their secretory protein, including 
insulin, and migrate out of the epithelium to form islets, losing the 
epithelial characteristics at the same time. In sheep, insulin-positive cells 
can be detected from 24 days gestation (16% gestation) and islets form at 
about 29 days (20%) [7]. In the human fetus, secretory proteins are 
expressed from 52 days of gestation (20% of gestation) and primitive 
islets form at 12 weeks of gestation (30% of gestation) [288]. Later in 
gestation, the pancreas increases in mass, islets form by proliferation of 
secretory cells and the insulin response to a glucose challenge increases 
[289]. In rats, development of the pancreas is distinctly later as compared 
to sheep and human. Cells start producing mature secretory proteins at 17 
days of gestation, i.e. in late gestation (80%) [290]. A robust insulin 
response to glucose is only present at 1 week after birth, following a period 
of ß-cell apoptosis [291], during which highly amino acid-responsive ß-cells 
are replaced with glucose-responsive ones [292]. 
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1.8. Mechanistic effects underlying perinatal 
programming 
Perinatal programming is now often attributed to different mechanisms, 
including differences in growth patterns of specific organs, differences in 
endocrine system development and epigenetic mechanisms regulating 
expression of specific genes. Even though detailed descriptions of 
mechanisms in long term programming of adult diseases are emerging, the 
exact contribution of each factor is not easily defined and programming of 
diseases is most likely an interaction of, at least, the three mediators 
described in the following. 
Growth patterns are not similarly regulated for all tissues and organs, an 
effect which may be mediated by differential sensitivity e.g. to insulin and 
insulin-like growth factors [293]. In intra-uterine growth restriction 
(IUGR), low birth weight can result from reduced availability of nutrients 
with, at least when nutrients are not critically limited, sparing of brain, 
heart and adrenal gland growth. Therefore, the weight of these organs is 
greater relative to body weight than in neonates of appropriate birth 
weight [294, 295]. Other organs and tissues show a lack of development 
of structure and reduced numbers of specific cell types at birth, including 
nephrons [296], cardiomyocytes [297] and pancreatic ß-cells [298]. 
 Endocrine systems of the offspring are also affected by changes in 
maternal hormones or environmental hormone-like substances, e.g. 
changing sensitivity of these systems in the offspring [299]. Hormones 
that are having long term effects in this way include insulin, glucocorticoids 
and bisphenol A, which has estrogenic effects [300, 301].  
37 
 
Long term health outcomes depend strongly on the developmental timing 
of environmental stimuli and the timing of pre- and postnatal development 
of humans is different to rodents but similar to sheep. Roughly, many of 
the developmental changes happening in late pregnancy in humans and 
sheep occur in early postnatal life in rodents. Therefore, a low growth rate 
in late pregnancy may have similar effects on humans and sheep as a low 
growth rate during suckling has on rats with regards to e.g. pancreas 
development and subsequent susceptibility to glucose intolerance. As 
species are not necessarily directly comparable, I discuss evidence of 
programming mechanisms in the two groups, i.e. larger mammals and 
rodents, separately and concentrate on the effects of differences in 
macronutrient intake and/or the subsequent differences in growth rates 
with regards to later metabolic health. 
1.8.1. Epigenetic mechanisms  
Epigenetic methylation refers to methylation of DNA, especially in the 
promoter region of genes, at CpG-islands (repetition of cytosine-
phosphate-guanidine sequence) [302, 303]. The more closed conformation 
of methylated DNA and modified histones is associated with lower gene 
expression levels, i.e. with gene silencing. These modifications can vary 
between neighbouring genes, allowing for selective, long term regulation of 
gene expression and subsequent protein concentrations, which can have 
influence on specific phenotypes [304]. Epigenetic alterations are subject 
to changes in response to environmental factors during a period of 
sensitivity to environmental influence that is thought to range from 
preimplantation [305] to early postnatal life [306-308], at least in rodents. 
During this period of early life, stable methylation patterns of the DNA are 
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established [309, 310]. At least in rats, influential environmental factors 
can be over- or undernutrition [311], a diet high in methyl-donors [303, 
312], or extremes of maternal care behaviour [313]. Epigenetic 
modifications can, furthermore, change during DNA replication or repair, a 
mechanism called epimutation [314]. Epigenetic changes occur in some, 
but not all, genes and results in up- or down-regulated transcription. After 
conception, but before implantation, all DNA is demethylated and 
methylation patterns are re-established after implantation [315]. This 
occurs similarly in imprinted genes, which make up about 0.5% of rodent 
genes, i.e. genes of which only one copy, maternal or paternal, is used for 
transcription and the other is highly methylated [310].  
As DNA methylation heavily relies on the availability of methyl donors from 
the diet, e.g. methionine, betaine and folate, global nutrient restriction or 
protein restriction have direct influences on these processes. This is well 
established in rodents [303, 312] but evidence in humans is sparse [316]. 
In rodents, feeding excess methyl donors whilst restricting caloric or 
protein intake prevents some of these effects [317] but also induces other 
changes [318]. Surprisingly, both protein and global nutrient restriction 
during fetal development can lead to hypo- [317] and hypermethylation 
[311] of the same genes with corresponding effects on gene expression in 
the adult offspring. This implies that the regulation of promoter 
methylation has to be more specific than merely influenced by methyl 
donor shortage.  
1.8.2. Programming of glucose metabolism 
In IUGR babies, both the pancreatic endocrine mass and the insulin 
response to glucose are reduced [298, 319]. Depending on the timing of 
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intervention and the method used to induce IUGR in sheep models it can 
have quite different effects on the pancreas. Hyperthermia induced 
through most of the period of fetal pancreatic development, i.e. during 
mid-gestation, leads to a decrease of ß-cell mitosis, a lower ß-cell mass 
despite a normal total pancreatic mass relative to body weight [320] and 
islets which produce and secrete less insulin [321]. On the other hand, 
hypoglycemia from day 115 to 135 of gestation does not decrease 
pancreatic or ß-cell mass [322] but decreases ß-cell responsiveness [323]. 
There is little information on the long term development and physiological 
outcomes of these ß-cell defects in either sheep or humans. However, 
fasting insulin is higher in 1 year old children born SGA who catch up in 
weight compared to either children born of appropriate weight for 
gestational age or those born SGA without then showing rapid postnatal 
growth [324]. This suggests an over-compensatory effect, which might 
persist into adulthood. In a sheep model with 50% nutrient restriction in 
late gestation, at 12 months of age offspring have a greater insulin 
response to a GTT although pancreas weight is not significantly different 
[325]. 
IUGR also induces an increase in fetal cortisol, which is correlated with 
hypoglycemia [326] and, if the glucocorticoid betamethasone is injected 
into mother or fetus in late pregnancy, offspring show a stronger insulin 
response at 6 months and 1 year of age [327]. However, repeated 
administration of glucocorticoid to the mother also decreases birthweight 
[327], so that causality is not entirely resolved. Maternal food intake was 
not reported in this study but since glucocorticoids are known to suppress 
appetite in a dose-respondent manner [328], this effect may mediate the 
change in insulin metabolism observed. 
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Newborn sheep who experience growth restriction throughout their fetal 
development have a lower relative liver weight [329]. Growth restriction 
from mid gestation induces a higher expression due to lower promoter 
methylation of hepatic phosphoenolpyruvate carboxykinase [330, 331] and 
higher expression of glucose-6-phosphatase [332], key enzymes in 
gluconeogenesis. In these animals, insulin sensitivity is increased by a 
higher expression of insulin receptor and hepatic glycogen content is not 
reduced despite hypoglycemia [332]. Gluconeogenesis is normally not 
observed before birth because glucose is transferred from the mother 
through placenta [273]. However, the hypoglycemic fetus has to 
compensate for lacking glucose by inducing gluconeogenesis as described 
above. Whether these changes in hepatic gene methylation and expression 
persist or what compensatory effects follow is not well understood. Ectopic 
fat mass in liver and skeletal muscle has been linked to insulin resistance 
[57, 333] but, in a study with adults who were born SGA, insulin 
resistance, including a lack of inhibition of hepatic gluconeogenesis, has 
been shown to develop in the absence of changes in fat deposition in liver 
or muscle [334]. In the latter study, individuals born SGA had higher 
cortisol and growth hormone concentrations whilst insulin-like growth 
factor (IGF)1 concentrations were lower and these changes may be linked 
to hepatic and muscle insulin resistance through, as yet, unclear 
mechanisms.  
1.8.3. Programming of body composition 
Individuals born SGA have a higher fat mass at a given BMI, especially 
abdominal fat mass, even at a young age [335-337] and, if they grow 
rapidly in early life, have a higher rate of obesity than individuals with 
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median birth weight [237]. Body fat is dependent of birth weight [264] in 
humans but, in sheep, body fat is present at a low percentage and 
independent of birth weight [338] but is influenced by maternal caloric 
intake [339]. Timing of nutrient restriction has direct influence on neonatal 
fat mass since growth restriction in late pregnancy, detected as 
asymmetric SGA, leads to lower subcutaneous fat mass as compared to 
symmetric SGA [220].  
Low birth weight sheep are also born with less muscle mass [340] and gain 
muscle mass slower overall, specifically slower in some, i.e. 
semitendinosus, extensor digitorum lateralis and extensor carpi radialis, 
but not all muscle groups compared to high birth weight offspring [341]. 
Similarly, it has been shown in humans that birth weight is negatively 
associated with adult lean mass [336]. As muscle is one of the main 
tissues to take up and metabolise glucose, this could have an impact on 
glucose tolerance. However, in a 50% caloric restriction in late pregnancy, 
expression of insulin receptor and PI3K in muscle of 1 year old offspring 
were not changed and insulin resistance was found in perirenal adipose 
tissue which had increased expression of insulin receptor and PI3K but a 
lower expression of GLUT4 [325]. This suggests that increased fat mass, 
not decreased muscle mass is the main mediator of insulin resistance after 
IUGR. 
1.8.4. Programming of food intake 
There is very little information on the long term effects of perinatal events 
on hypothalamic appetite control in large mammals. However, near term 
offspring of mothers undernourished in late gestation showed an orexigenic 
response as NPY was more highly expressed in the hypothalamus as 
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compared to controls [342], which is consistent with higher growth rate 
subsequent to small birth weight. On the other hand, offspring of overfed 
mothers had a transient higher milk intake in the first 3 weeks postnatal 
and at 4 weeks displayed an anorexigenic response with increased POMC 
and non-significantly decreased NPY expression [343]. However, 
interpretation of this study is complicated by the fact that the overfed 
group and the control group had strikingly different numbers of twin and 
singleton offspring.  
1.8.5. Effects of modulation of postnatal growth rates in rats 
In rodent models, early postnatal growth rates are often manipulated by 
controlling litter size. Remmers [344, 345] demonstrated that rats raised 
in abnormally large litters (20 pups), resulting in food restriction during 
suckling, showed smaller body length, weight and BMI throughout life as 
compared with rats raised in normal-sized litters (10 pups). A significant 
part of the RIIVSULQJV¶ growth occurs after weaning and this was decreased 
by early postnatal life in a large litter. The effect on long term weight 
control through this intervention suggests that there is a critical period of 
body weight regulation during suckling. In this study, rats were sacrificed 
at postnatal days 10, 25 and 380. Analysis of hypothalamic gene 
expression during early life (at postnatal day 10 and 25) showed an 
increased ratio of orexigenic to anorexigenic signalling as compared to 
control rats, which was proposed to account for the higher food intake of 
10-20% after weaning in males until day 35 [344, 345]. After this time, 
food intake did not differ between groups and no difference in the 
hypothalamic ratio of orexigenic to anorexigenic signalling was found at 
age 380 days. 
43 
 
In a similar study, rats were raised in litters of either 4 or 10 pups to study 
the effects of rapid postnatal growth and it was shown that increased food 
intake during suckling (mediated through reduced competition for maternal 
milk from litter-mates) resulted in greater rate of weight gain before 
weaning and increased weight and central fat mass, specifically epidydimal 
fat mass, throughout life [221]. At 90 days, isolated epidydimal adipocytes 
were less insulin sensitive after rapid early growth and had decreased 
abundance of glucose transporters GLUT-4 and GLUT-1. These adaptations 
were accompanied by reduced intracellular insulin signalling, including a 
lower abundance of insulin receptor and IRS-1, and a failure to activate the 
Akt pathway in response to insulin. Despite this, glucose tolerance tests at 
90 days did not show a difference in blood glucose regulation between the 
two groups, perhaps suggesting that offspring can compensate for these 
changes at this young adult age. The results of these studies, however, 
clearly demonstrate that, in rats, growth in early postnatal life modulates 
some aspects of the long term regulation of both body weight and insulin 
sensitivity.  
1.9. Interventions described in this thesis 
In order to explore long term effects of perinatal nutritional environment 
on metabolic health and appetite regulation, studies of maternal 
macronutrient restriction in late gestation followed by variable early 
postnatal growth rates and of maternal choline intake during lactation were 
conducted. These complimentary studies were undertaken in Nottingham, 
UK and Edmonton, Canada to utilise the local expertise in the use of the 
respective models. The former study was conducted in Nottingham in a 
sheep model, which is a good model for human development and periods 
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of organ development are at equivalent stages of gestation and suckling. 
The latter study was conducted in Edmonton in a rat model, for which 
previous knowledge about choline metabolism and requirements exists and 
which is a good model for human development, provided differences in 
organ developmental periods are considered. Both models have been used 
before in the respective research groups and animal research staff with 
expertise in conducting interventions in these animals carried out each 
study. 
1.9.1. Nutrient restriction 
In the sheep study conducted in Nottingham, a 40% reduction in maternal 
macronutrient intake during late pregnancy was used. The main effect of 
nutrient restriction leading to microsomia is hypoglycemia of mother and 
fetus and may be accompanied by hypoinsulinemia and hypoleptinemia. As 
described in more detail above, nutrient restriction during late gestation 
has long term effects on the offspring, including a higher risk rate for 
disturbed glucose metabolism in adulthood. This effect is believed to be 
aggravated by an accelerated early postnatal growth rate. Although 
adiposity and especially visceral fat mass are prominent risk factors, the 
lower glucose tolerance observed after slow growth in late pregnancy and 
accelerated postnatal growth appears to not be accompanied by an 
increase in fat mass. Mechanisms mediating the change in glucose 
tolerance are not clear but may include changes in ß-cell responsiveness, 
hepatic glucose production and peripheral glucose uptake. Nutrient 
restriction during late pregnancy also coincides with development of 
hypothalamic networks regulating food intake in humans and large 
mammals but the acute and long term effects are not well established. As 
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nutrient availability directly affects appetite regulation, the hypoglycemia 
experienced in utero could change settings of the hypothalamic regulatory 
system as well as systemic glucose tolerance. 
1.9.2. Choline 
In the rat study conducted in Edmonton, mothers were fed one of 3 diets 
from birth to weaning, either containing no choline at all or containing an 
amount of choline which is recommended to meet requirements (1g/kg 
free choline or 2.5 g/kg choline bitartrate [346]). Choline was fed as 
bitartrate or as phosphatidylcholine (PC). Choline is a micronutrient with 
vitamin-like characteristics. It is both taken up from dietary sources, such 
as egg yolk and animal livers, which are rich in free choline and PC, and 
endogenously synthetised. PC can be derived either from attaching 
diacylglycerol to choline, ie. the cytidine diphosphate (CDP)-choline 
pathway, or from methylating phosphatidylethanolamine (PE), i.e. the PE 
methyl transferase (PEMT) pathway. 
Choline is involved in the one-carbon cycle as betaine, in the functioning of 
cell membranes and vesicles as part of PC and in neural transmission as 
acetyl-choline, which are described in more detail below. The most 
important forms of choline are choline as a salt, e.g. in conjunction with a 
bitartrate (Figure 1.3), or as PC, a phospholipid called lecithin in the 
specific form when isolated from egg yolk, consistent of choline, a 
phosphate group and two fatty acids (Figure 1.4). Further important 
choline metabolites found both in the diet and tissues are sphingomyelin 
consisting of choline, phosphate group, one fatty acid and one sphyingosin; 
betaine, an oxidised form of choline; acetylcholine, choline with an acetyl 
group; lyso-phosphatidylcholine, PC with one fatty acid removed by 
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phospholipase A2; phosphocholine, choline with a phosphate group 
attached but no fatty acids; glycerophosphocholine, phosphocholine with a 
glycerol attached to the phosphate group. 
  
Figure 1.3: Chemical formula of choline bitartrate, with A, the positively 
charged choline and B, the negatively charged bitartrate. 
                 
Figure 1.4: Chemical formula of PC with its 2 fatty acids attached to the 
phosphate group indicated as [FA-OH
-
].  
1.9.2.1. Choline bioavailability 
As main dietary forms of choline are free choline and PC, this study of my 
PhD includes a direct comparison between consuming choline salt, i.e. the 
free form of choline, and PC. In human studies, ingestion of the same 
amount of choline as chloride, the free choline form, and as PC on separate 
days showed a rapid increase in serum choline concentrations and return 
to baseline within 8h after choline chloride ingestion and a slower increase 
but plateauing of choline concentration when ingestion occurs as PC [347]. 
In rats, ingestion of both choline chloride [348] and PC [349] results in 
increased brain and adrenal choline and acetylcholine concentrations 
subsequent to an increase in serum choline. When 15 day old rats were 
FA-OH- 
FA-OH- 
A B 
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intubed with formula containing radioactively labelled choline metabolites 
including free choline and PC, ingested free choline was found in the liver 
mainly as betaine, phosphocholine and PC whilst the majority of ingested 
PC was not converted before storage in the liver. This suggests 
fundamental differences in systemic metabolism but differences in effect of 
the 2 metabolites has not been well studied as the majority of the studies 
discussed below included choline as free choline alone. Both free choline 
and PC as well as glycerophoshphocholine and, to a lower extent, betaine 
and sphingomyelin are contained in vegetables, cereals, eggs and meat, 
especially liver, the main storage organ for choline [350]. 
1.9.2.2. Functions of choline 
One-carbon metabolism 
Various methylation processes rely on availability of methyl groups from 
the one-carbon cycle. In this cycle, methyl donors, mainly betaine and 
folate, enable methylation of homocysteine to methionine. This can then be 
converted to S-adenosylmethionine (SAM), subsequently transferring the 
methyl group to various targets including CpG islands of DNA. SAM can 
also be used to de novo synthesise PC from PE by adding three methyl 
groups. Whilst some of the converting enzymes of the one-carbon 
metabolism (Figure 1.5) are expressed in various tissues, the main 
conversion of homocysteine to methionine and SAM takes place in the liver 
[351].  
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Figure 1.5: Schematic depiction of choline metabolism.  
Hcy, homocysteine; PC, phosphatidylcholine; PE, phosphatidyl-
ethanolamine; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; 
5-CH3-THF, 5-methyl-tetrahydrofolate; THF, tetrahydrofolate; DMG, 
dimethylglycine; PEMT, phosphatidylethanolamine methyltransferase; 
DNMT, DNA methyltransferase; BHMT, betaine-homocysteine 
methyltransferase. 
This figure is based on the review [351]. 
Cell membranes 
Due to their amphipathic nature with a hydrophobic and a hydrophilic 
group, phospholipids make up the main part of all cell membranes in a 
bilayer. Sphingomyelin (SM) is preferentially deposited in the outside 
leaflet and PE, phosphatidyl-serine (PS) and phosphatidyl-inositol (PI) are 
preferentially in the inside leaflet of membranes whilst PC and cholesterol 
are found in both leaflets [352]. Changes in the distribution of specific 
phospholipids in the leaflets can alter cell signalling, the most well-studied 
example is PS changing from the inside to the outside of the leaflet, which 
occurs during apoptosis and induces phagocytosis of the cell [353]. Each 
phospholipid has the hydrophilic head group, e.g. choline, and 2 fatty acids 
on its hydrophobic side. Membrane characteristics like phospholipid and 
fatty acid composition can influence numerous signalling pathways and 
transmembrane transport [354]. In choline deficiency, membrane content 
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of PC is reduced whilst that of PE is increased [355]. In vitro, the 
homeostasis of PC or of the ratio of PC to PE [356] in the membrane has 
been shown to be crucial for cell growth and survival.  
An important system relying on membranes is the transport of lipids 
through the blood. Triglycerides and cholesterol are transported from the 
liver to peripheral organs as very low-density lipoproteins (VLDL) [357]. PC 
is crucial for the formation of VLDL [358] and, in males, choline deficiency 
leads to hepatic steatosis [359]. 
Acetylcholine 
Acetylcholine (ACh) is a common neurotransmitter, used by brain and 
peripheral neurons including the parasympathetic and sympathetic nervous 
system and in the innervation of muscles, inducing contraction through 
nicotinic receptors [360], whilst ACh affects contraction of cardiac muscles 
through muscarinic receptors [361]. It is cleared from the synaptic space 
by degradation through acetylcholinesterase to stop excitation or inhibition 
[362]. ACh plays a role during neurodevelopment [363] as a modulator of 
plasticity and is, therefore, involved in learning processes and memory 
[364].  
1.9.2.3. Choline deficiency and sensitive periods 
In adult men, choline requirements are 550 mg/d whilst they are 425 mg/d 
for women and requirements increase to 450 mg/d in pregnancy and 550 
mg/d in lactation [365]. Epidemiological data suggests that actual choline 
intake in women is at around 400mg/d with a high interindividual variation 
[366]. In rodent studies, choline is given as free choline with a standard 
intake of 1 g/kg diet for control animals, choline-devoid diets are 0 g/kg 
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and treatment of supplemented animals can differ but they often receive 
additional choline with diet (e.g. 5 g/kg, [367]) or with their drinking water 
at a concentration of 25 mmol/L [368-370]. 
Since early development is a period associated with high demands on 
methylation and expansion of cell membrane surface area, choline has 
been widely investigated in human pregnancy and deficient 
periconceptional maternal choline intake increases the risk of neural tube 
defects in the offspring, similar to periconceptional folate deficiency [366, 
371]. 
In rodent studies, a choline-deficient diet during pregnancy leads to altered 
expression of proteins involved in cell cycle regulation of the fetal 
hippocampus which are, in part, associated with diminished methylation of 
promoters of the genes of these proteins in this region [372, 373]. The 
adult offspring showed changes in hippocampal function [374, 375] and 
decreased memory performance [376] and attention to stimuli [368]. At 
the same time, choline-rich diets led to increased hippocampal proliferation 
[374, 375, 377] and enhanced memory in the adult offspring [378, 379].  
Whether altered gene promoter methylation status is the driving force 
behind these changes is unknown. Besides its functions in forming 
acetylcholine, dietary choline also has a neurotrophic function [380]. A 
study by Garner et al. suggests that maternal supplementation with 
choline chloride (25 mmol/L in their drinking water) during pregnancy does 
not lead to higher choline or PC concentrations but higher phosphocholine 
concentration in the fetal brain, whilst acetylcholine concentrations were 
not measured [370]. This finding supports the concept that differences in 
brain acetylcholine abundance may be the cause of the better spatial 
memory in maternally choline-supplemented offspring. Other mechanisms 
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demonstrated are an increase in IGF2 and IGF2 receptor and IGF2-induced 
acetylcholine release in adult offspring of mothers choline-supplemented 
during pregnancy [381] and preserves hippocampal plasticity into 
adulthood and increases concentrations of vascular endothelial growth 
factor and neurotrophin 3 [367]. Even though the importance of each of 
these mechanisms is not entirely clarified, feeding dietary choline during 
pregnancy is clearly necessary for brain development of the offspring, at 
least for memory function in the hippocampal region [368, 374-379]. 
In the early postnatal period, supplementation with choline (offspring 
intubation with 25 mg choline chloride, day 2-21) only improved spatial 
memory of adult rats if they were prenatally damaged by maternal ethanol 
consumption [382], suggesting a critical period for adequate choline 
availability if brain development was disturbed during pregnancy. Although 
rodent brain development has not been completed by the time of birth 
[383-385] and could, therefore still be sensitive to choline availability after 
birth, a postnatal intervention of choline intake alone (offspring intubation 
with 0.9-1.8 mg choline chloride, day 1-24 [386]; artificial rearing on day 
5-18 with formula containing 250 mg choline chloride per liter as control 
and 1250 mg/L as higher choline intake [387]) does not seem to affect 
spatial memory after a normal pregnancy [386, 387]. Studies with early 
postnatal choline supplementation are few and, to my knowledge, only 
examine spatial memory.  
Feeding adult mice a choline-devoid or a high choline diet for 4.5 months 
influences their memory significantly as measured in an age-dependent 
test, with mice on the high choline diet having a better memory than both 
a standard choline control group and the choline-devoid group, which had 
the lowest score (feeding intervention diets at 8.5-13 months of age, 
choline-devoid diet contained less than 1g choline per kg diet, control 1.6 
52 
 
g/kg, high choline 12-15 g/kg [388]). Mice with dementia produced by 
selective inbreeding of mice with low memory scores had lower brain 
acetylcholine concentrations than control mice. Feeding these mice with 
dementia a high dose of PC (100 mg/d) for 45 days normalised their brain 
choline and acetylcholine concentrations and improved their memory whilst 
the same feeding regiment in normal mice increased their brain choline but 
not acetylcholine concentrations or memory performance [389]. 
Intraperitoneal injection with choline (saline, 50, 100, 120 mg choline 
chloride per kg body weight) increased brain choline and release of 
acetylcholine in a dose-dependent manner [390]. As mentioned above, 
cultured neurons have a drastically increased apoptosis rate if maintained 
in choline-free medium [391]. In humans, treatment with choline esterase 
inhibitors has been found to improve symptoms oI$O]KHLPHU¶VGLVHDVHDV
acetycholine improves vasodilation and blood flow [392]. These studies 
suggest that choline is important for adult brain function both as the 
structural form, PC, and as the neurotransmitter acetylcholine.  
A choline-deficient diet consumed by adults results in damages in liver and 
muscle [393]. As choline is necessary in the liver to secrete triglycerides 
and cholesterol in the form of lipoproteins [358], a choline-deficient diet 
leads to steatosis [355] as described above. Additionally, choline deficiency 
has been shown to induce apoptosis in liver and muscle and neither effect 
is reverted when adding other methyl donors [355, 394, 395], suggesting 
that PC as part of the cell membrane may be involved in the changes 
observed. Organ damage is mostly observed in men or postmenopausal 
women [396]. Premenopausal women are protected from choline depletion 
as oestrogen increases PEMT activity and premenopausal women have 
been shown to be more affected if they carry a single nucleotide 
polymorphism in the PEMT gene which reduces PEMT activity [396]. 
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Choline intake and activity of biosynthetic enzymes have also been 
described to have effects on food intake, leptin and body weight regulation 
[397, 398] but the picture emerging is very incomplete. In few studies, 
GHSOHWLQJDQLPDOV¶GLHWVRIFKROLQHFRPSOHWHO\FDXVHGDVXEVWDQWLDO
reduction of their food intake [397] although most studies do not show any 
effect on food intake, which might, therefore, depend on specific 
developmental period of intervention, e.g. the increased nutritional 
requirements during lactation period.  
Furthermore, mice deficient of PEMT but with a normal dietary choline 
intake are resistant to the metabolic effects of a high-fat diet, e.g. obesity 
and insulin resistance, and this phenotype was reversed when increasing 
choline intake [398]. It is not clear from the limited amount of research 
how the effects of choline on appetite control are regulated and my thesis 
aims to contribute to this field of research. 
In summary, even though choline is an essential micronutrient throughout 
life, both pregnancy and lactation are periods of increased choline intake 
requirements. This is reflected by recommendations of Adequate Intake in 
humans and by rodent studies observing a disadvantagous effect of 
feeding diets lacking choline during pregnancy and, to a lesser extent, 
during lactation period on spatial memory of the offspring. Present 
research in rodents primarily focuses on the role of choline intake during 
pregnancy and in adulthood but lactation period, when recommended 
LQWDNHLVKLJKHVWLQDZRPDQ¶VOLIHLVOHVVZHOOGHILQHGZLWKUHJDUGVWRlong 
term outcomes in offspring. Furthermore, there is little research with 
regard to the form of choline and the study presented in this thesis aims to 
address the differences between choline fed as free choline or as PC during 
lactation period. 
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1.10. Main hypothesis and aims 
As described, the perinatal nutritional environment has been shown to 
have long term effects on insulin sensitivity and body composition in both 
epidemiological and interventional studies. However, there are limited 
studies describing the influence on the appetite regulatory system in 
appropriate animal models of obesity and insulin resistance. To further 
elucidate this relationship, two studies were used in the course of my PhD. 
In sheep, my primary hypothesis was that sheep who were subjected to 
maternal nutrient restriction in late pregnancy would develop insulin 
resistance at an adult age, independent of changes of body mass or 
composition. Accelerated growth in early postnatal life would further 
aggrevate insulin resistance. 
Since there is very little data on appetite regulation in IUGR individuals, 
my hypothesis with regards to hypothalamic gene expression was that 
insulin resistance would also develop centrally. In addition, I hypothesised 
that it would be consistent with central insulin resistance if appetite 
regulation was overall more orexigenic in offspring of mothers receiving 
60% of their nutrient requirements during late pregnancy as compared to 
sheep not subjected to maternal nutrient restriction. 
In the rat study, the aim was to determine the acute and long term effects 
of a maternal diet devoid in choline and of diets with phosphatidylcholine 
rather than free choline during lactation on maternal and offspring appetite 
regulation and metabolic health. Primarily, I hypothesised that feeding a 
choline-devoid diet would decrease maternal food intake, reduce maternal 
choline stores and delay offspring growth. I also hypothesised that 
offspring would develop glucose intolerance and changes in structure of 
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tissues which are highly dependent choline and/or phospholipids. Ingesting 
the different forms of choline may affect tissue concentrations of choline 
metabolites, specifically the liver, both in mothers and their offspring. 
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2. Methods and Materials 
My thesis was designed and carried out in 2 parts, at 2 different locations. 
First, a sheep study was carried out in Nottingham, UK, in 2006-2007. I 
started my PhD in January 2009 and performed analyses on tissues as 
described below in Nottingham. Separate analyses of plasma metabolome 
was performed in Nantes, France. I then moved to Edmonton, Alberta, 
Canada in summer 2010 where there had been rat studies carried out 
when I came and the previous summer (2009/2010). I performed tissue 
analyses on these studies and then helped with a new rat study in spring 
2011, which I also analysed tissues for. All methods are described below, 
first for the sheep study and then the rat study. Whenever methods 
overlap between the two studies, i.e. glucose tolerance test, plasma 
analyses and histology, they followed the same principles but details may 
differ, based on equipment available and standard techniques of the 
respective laboratory. 
2.1. Sheep macronutrient restriction study 
All sheep procedures were performed at the farming facilities on the Sutton 
Bonington Campus of the University of Nottingham. Procedures were in 
accordance with the UK Animals (Scientific Procedures) Act, 1986 with 
approval from the local Ethics Committee of the University of Nottingham 
(Nottingham, United Kingdom). The study was carried out as part of the 
Early Nutrition Programming Project of the Sixth Framework Programme of 
the European Union (EARNEST, project number FOOD-CT-2005-007036). 
The study protocol was designed by Professor Michael Symonds, Dr. David 
Gardner and Dr. Sylvain Sebert, at the University of Nottingham.  
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The study was set up with three subsequent interventional stages: during 
late gestation and postnatally before and after weaning (Figure 2.1, Figure 
2.2).  
 
Figure 2.1: Schematic depiction of full study design.  
Interventions were applied in 3 stages: mothers remained on a standard 
diet (100%), were restricted in macronutrients (60%) or were fed ad 
libitum (150%). At birth, twin were both maintained with the mother for a 
standard growth rate or separated for and accelerated growth rate whilst 
the other twin was raised on formula. After weaning at 3 months of age, 
offspring were maintained in an obesogenic or in a unrestricted 
environment. 
The aim of the study is to distinguish the effects of: 
1) macronutrient restriction in late gestation 
2) early postnatal growth rate 
3) postnatal development of body weight. 
For this, only 4 groups of offspring of the study are used, i.e. only the 
restricted group in comparison with the group fed to requirements and not 
including the twins which were raised with formula (Figure 2.2). 
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Figure 2.2: Schematic depiction of the groups used in this study.  
Twin pregnant ewes were randomly assigned to one of two diets for late 
gestation (110-145 days): R diet meeting requirements or macronutrient 
restricted diet meeting 60% of caloric requirements (N). After birth twins 
were either both reared by their mother (standard early postnatal growth 
rate, S) or separated with only one twin being reared by the mother 
(accelerated early postnatal growth rate, A). After weaning most animals 
were kept in restricted space, representing a mildly obesogenic 
environment but part of the NS group were kept in a wider space, leading 
to leaner animals. Throughout the study, blood samples were taken from 
mothers and offspring and a glucose tolerance test (GTT) carried out at 7 
and 16 months before tissue collection at 17 months of age. Discrepancies 
between numbers (n) of mothers and offspring are due to additional 
offspring intervention groups which were not included in my research, see 
Figure 2.1).  
2.1.1. Experimental design  
At 100 days of gestation, 24 Bluefaced Leicester cross Swaledale twin 
bearing sheep were housed individually. Mothers were randomly allocated 
to one of two diets from day 110 of gestation to term delivery (145 ± 2 
days): a calorically sufficient diet meeting all requirements (R, n=8) or a 
diet only providing 60% of caloric requirements (N, n=16). Nutritional 
requirements were based on recognised amounts for pregnant sheep 
(Council AaFR 1993 Technical Committee on Responses to Nutrients. In: 
Technical Committee on Responses to Nutrients. Wallingford, UK: CAB 
International; pp 812±815), and depended on maternal body weight, 
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increasing with stage of pregnancy. All mothers were fed 40% 
concentrated pellets and 60% straw nuts (Manor Farm Feeds, Oakham, 
UK) and had unrestricted access to a mineral block to ensure adequate 
micronutrient supply. Mothers were weighed weekly before feeding and 
dietary requirements adjusted accordingly. Blood samples were taken from 
WKHMXJXODUYHLQDIWHUDQRYHUQLJKWIDVW8h) on day 130 of gestation and 
collected into heparinised and EDTA-coated tubes. Plasma was separated 
by immediate centrifugation (10 min, 4000 g, 4°C). 
After delivery, all mothers were fed to their full requirements throughout 
lactation. Offspring were separated and only one offspring stayed with the 
mother in order to accelerate postnatal growth (A) whilst the other 
offspring was formula-reared (not analysed for this thesis). Some N 
offspring were also both reared by their mother as twins for a standard 
postnatal growth rate (S). These interventions gave rise to three groups 
during lactation: RA (n=8, 4 males and 4 females), NA (n=9, 2 males and 
7 females) and NS (n=17, 7 males and 10 females). All offspring were 
weighed twice during the first month after birth and then weekly until the 
end of lactation at 3 months of age. A blood sample was collected from 
each animal at 3 months of age as described above for the mothers. 
After weaning, a majority of the offspring were raised in a mildly 
obesogenic environment (O) with limited opportunity for physical activity 
(i.e. a stocking rate of 6 animals on 19 m2). A subgroup of the NS animals 
were kept in an outdoor area with a stocking rate of 6 animals on 1125 m2 
(NSL, n=10, 5 males and 5 females). Animals were weighed once a month 
and blood samples taken at 7 and 16 months of age, as described above, 
as part of the glucose tolerance test (Section 2.1.2).  
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2.1.2. Glucose tolerance test 
A glucose tolerance test measures the plasma concentrations of glucose 
and insulin after administering a standardised amount of glucose. Analysis 
of the data allows assessmHQWRIWKHSDQFUHDWLFǃ-cell function to 
increasing plasma glucose both by measuring the time to maximal insulin 
concentrations and the peak of insulin concentration in itself [399]. How 
quickly the plasma glucose concentrations return to a range comparable to 
the fasted glucose concentration assesses peripheral tissue sensitivity, 
mostly white adipose tissue and muscle, to insulin.  
To test glucose tolerance at 7 and 16 months of age, all sheep received 0.5 
g/kg glucose intravenously after an overnight IDVW8h), and glucose 
and insulin plasma concentrations were measured at baseline and over a 
120 minute period after injection (glucose tolerance test, GTT). 
Homeostatic model assessment for insulin resistance (HOMA-IR) is 
calculated by multiplication of fasted concentrations of glucose and insulin:  
ܪܱܯܣ െ ܫܴ ൌ ݈݃ݑܿ݋ݏ݁ ൬݉݉݋݈ܮ ൰௙௔௦௧௘ௗ כ ݅݊ݏݑ݈݅݊ ቀߤ݃ܮ ቁ௙௔௦௧௘ௗ 
The glucose tolerance test was carried out under supervision of Dr. Sylvain 
Sebert. 
2.1.3. Individual food intake 
At 16 months of age, 2 weeks before the end of the study, all offspring 
were housed individually indoors in UK Home Office designated floor pens 
(3 m2) to monitor food intake. For each animal, daily ad libitum energy 
intake was assessed over 10 days. Feed offered was weighed in the 
morning and remaining feed weighed again the following morning, with the 
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difference representing feed eaten. Feed was based on a mix of low (i.e. 3 
kg/d straw nuts; 8.5 MJ/kg) and high (800 g/d of concentrate pellets; 12.5 
MJ/kg) energy dense food. NSL animals were fed only the low energy straw 
nuts during this food intake observational period. Coming from a lower 
energy density food source (i.e. grass), the feeding of an energy-dense 
feed would have skewed the results of regular food intake and the 
comparison between NSO and NSL animals would be confounded.  
In a second, shorter food intake test, also conducted at 16 months of age, 
sheep were fasted for 18h and had then feed available ad libitum 
continually over a 24h period starting at 9 a.m., during which the intake 
was measured by weighing feed offered at the beginning of the period and 
left over feed weighed again at the end of the period. Periods within the 
24h test were 0-2h, 2-4h, 4-8h and 8-24h relative to beginning of feeding. 
At 0, 2, 4, 8 and 24h blood samples were taken and analysed for glucose, 
non-esterified fatty acids (NEFA), insulin, leptin and cortisol as described 
below. Besides their absolute concentrations, plasma hormone and 
metabolite concentrations were also expressed relative to the fasted 
measurement, in order to describe their dynamics:  
e.g. ݈݁݌ݐ݅݊݀ݕ݊ܽ݉݅ܿሺ ? ሻ݄ ൌ ݈݁݌ݐ݅݊ሺ ? ሻ݄ െ ݈݁݌ݐ݅݊ሺ ?݄ሻ 
2.1.4. Physical activity 
An Actiwatch accelerometer (Actiwatch, Linton Instrumentation, Diss, UK) 
was used to measure spontaneous physical activity of offspring at two time 
points, at 1.5 and at 15 months of age. The accelerometer measures 
intensity, amount and duration of movement by sampling acceleration at a 
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frequency of 32 Hz and recording one value per second. Values were 
accumulated over each minute and these averaged over a 24h period. 
2.1.5. Tissue collection 
At 17 months of age, aQLPDOVZHUHIDVWHGRYHUQLJKW18h) and then 
humanely euthanased by electrical stunning and exsanguination. All 
visceral fat depots were dissected, weighed and samples snap-frozen in 
liquid nitrogen and stored at -80°C. Entire hypothalami were dissected 
using the rostral border of the optic chiasm and the caudal border of the 
mamillary bodies as landmarks on the ventral surface and the lateral 
hypothalamic sulci as the lateral boundaries. These were then snap-frozen 
and stored at -80°C.  
2.1.6. Postnatal growth and fat mass 
Body weights were recorded throughout the study as described above. Fat 
mass was measured with the use of dual energy X-ray absorptiometry 
(DXA) scans at 16 months of age in sedated sheep. Post mortem dissection 
and weight of the omental, perirenal and pericardial fat tissues in 
comparison with total body weight were used as an additional estimate of 
the metabolically most active fat mass. All of these measurements were 
carried out by Dr. Sylvain Sebert.  
2.1.7. Plasma analyses 
Plasma from fasted animals at all age points (maternal at 130 days of 
gestation, offspring at 3 months, 7 months and 16 months) and from all 
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time points during the feeding test at 16 months of age were analysed for 
concentrations of cortisol, insulin, leptin, glucose, non-esterified fatty acids 
and triglycerides. Similarly, blood samples from all time points throughout 
the GTT were examined for insulin and glucose concentrations. For all 
measurements, plasma samples were gently thawed on ice and, if 
necessary, reagents brought to room temperature before use. 
2.1.7.1. Cortisol assay  
Plasma cortisol concentrations were measured with use of a competition 
radioimmunoassay. Both cortisol contained in a given volume of plasma 
and 125I-labeled cortisol in liquid form were added to tubes that were 
coated with an antibody specific for cortisol. The endogenous cortisol and 
the labelled cortisol bind competitively to the antibody. After an incubation 
time of 45 min at 37°C all fluids were aspirated and only the amount of 
labelled cortisol bound to the antibody on the tube was determined by 
measuring the decay of 125I with a gamma counter. The higher the 
concentration of cortisol in the plasma, the more unlabelled cortisol was 
bound to the antibody and the tube would, therefore, contain less 
radioactive label. Solutions containing known amounts of cortisol were 
measured with each assay to establish a standard curve.  
Coated tubes, 125I-labeled cortisol solution, standards (of 0, 1, 5, 10, 20, 
50 nM concentration) were provided with the kit (Diagnostic Products 
Corporation Coat-a-Count, Siemens, Camberley, UK). As controls, a total 
count (measuring the total radioactivity of the labelled cortisol added) and 
a non-specific binding (adding and decanting labelled cortisol to a regular, 
not antibody-coated tube) sample were included.  
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25 µl of plasma, standard or calibrator and 1 ml of the labelled cortisol 
solution were mixed in each coated tube and incubated on a shaker at 
37°C for 45 minutes. All fluids are aspirated without disturbing the coating. 
Radioactive decay in tubes was measured for one minute in a gamma 
counter (Wizard 1470 automatic gamma counter, Perkin Elmer, Waltham, 
MA, USA).  
Counts per minute were corrected in comparison with the non-specific 
binding sample, plotted against concentrations of the standards and 
extrapolated in a semi-logarithmic curve to determine concentrations of 
cortisol in plasma. The standard curve was carried out in duplicates and 
had an acceptable coefficient of variance (<10%).  
2.1.7.2. Plasma leptin 
The radioimmunoassay for ovine leptin was developed by Delavaud [400] 
and the analysis of our plasma samples was carried out by the laboratory 
of Professor Keisler at the Department of Animal Science of the University 
of Missouri.  
In each tube of the assay, 100 µl plasma or 50 µl standard (at 
concentrations of 1.7, 2.5, 5, 8, 15, 40, 50, 80 ng/ml, in triplicates) were 
mixed with 50 µl primary rabbit anti-ovine leptin antibody (1:1500, raised 
to establish this assay), brought to 400 µl with incubation buffer and 
incubated at 4°C for 24h. Radioactively labelled ovine leptin (125I-leptin, 
100 µl at 20,000 cpm) was added and again incubated for 20 h at 4°C. 100 
µl secondary ram anti-rabbit antibody is added and incubated for 1h. To 
precipitate the bigger complex of antibody-bound leptin, 2 ml 4.4% 
polyethylene glycol 6000 (BDH Prolabo, VWR, Radnor, PA, USA) are added. 
Unbound leptin was removed from tubes by aspiration. Remaining 
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radioactivity was measured in a Cobra II gamma counter (Packard Inc, 
Downers Grove, Australia). The more leptin present in the plasma sample, 
the less radioactive leptin will be bound in the precipitant. 
2.1.7.3. Insulin assay 
Sandwich Enzyme-Linked Immuno-Sorbent Assay (ELISA) 
An ELISA is an immunological assay which determines the concentration of 
a protein in a liquid, usually plasma. Antibodies specifically binding to this 
protein are applied to a 96-well plate and leftover binding capacity of the 
plate surface reduced by blocking it with unspecific protein, which does not 
bind to the antibody. The antigen contained in the plasma binds to the 
captivating antibodies and a detection antibody is added to the well to bind 
to a different sequence on the same antigen. The detection antibody is 
conjugated with biotin, which forms a strong bond with streptavidin. 
Through this bond, horseradish peroxidase, a detection enzyme, is bound 
to the well in the same proportion as antigen was present in the plasma. 
All unbound detection antibody and enzyme are washed off the well. The 
substrate tetramethylbenzidine (TMB) is added to the wells, converted by 
horseradish peroxidase to a blue colour. This reaction is stopped by 
acidification with sulphuric acid, which produces a yellow colour. The 
principle of ELISAs is depicted in Figure 2.3.  
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Figure 2.3: Schematic depiction of a Sandwich ELISA. A, Wells were coated 
with a capture antibody which was specific for the antigen; B, Wells were 
blocked with non-specific proteins and samples containing the antigen 
were added; C, Detection antibody binds to antigen; D, Horseradish 
peroxidase binds to the detection antibody through a strong non-covalent 
interaction between biotin and streptavidin, substrate was converted into 
a yellow compound after acidification. 
Plasma insulin measurement with ELISA 
Plasma insulin was measured using a Sheep Insulin ELISA (Mercodia, 
Uppsala, Sweden). The 96-well plate included in this kit is pre-coated with 
antibodies, which bind specifically to sheep insulin. To each well, 25 µl of 
the sample and 50 µl of a reagent containing the detection antibody and 
the streptavidin-conjugated enzyme were added and the mixture was 
incubated on a shaker at room temperature for 2 hours. The plate was 
washed thoroughly six times and fluid was removed from the plate by 
tapping it firmly onto absorbent paper. 200 µl of a TMB solution was added 
to each well and again incubated for 15 minutes. The reaction was stopped 
by adding 50 µl sulphuric acid (0.5 mol/L) and the optical density was 
measured on a plate reader (µQuant, Bio-tek Instruments Inc, Potton, UK) 
at 450 nm wavelength. Results were corrected in comparison to a blank 
(all reagents with distilled water as sample). Standards are included in the 
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kit and a linear standard curve with 5 points (0.1-2.5 µg/L) was used to 
determine the insulin concentration of samples.  
2.1.7.4. Plasma metabolites 
TG, NEFA and glucose concentrations were analysed by colorimetric tests, 
in part manually on 96-well plates and in part on a Randox RX Imola auto-
analyser (Randox Laboratories, Crumlin, UK). Reagent and plasma 
volumes used for the auto-analyser were as specified by Randox. The 
principles between both methods are very similar but for the automated 
analysis all reagents were provided by Randox Laboratories whilst in the 
manual analysis reagents from Wako (Neuss, Germany) were used for 
NEFA. In both methods samples were compared to standards as described 
and whilst it cannot be guaranteed that both methods would produce the 
exact same result, samples of a set, e.g. all GTT samples, or all 3 months 
plasma samples, would be run with the same method and not compared to 
samples assessed with the other method. 
All measurements were corrected in comparison with a blank (all reagents 
with distilled water as sample). All samples and standards were run in 
duplicate and samples with a variation coefficient of <5% were considered 
valid. 
Plasma triglyceride measurements 
For the measurement of plasma TG concentration, 2 µl plasma was mixed 
with 200 µl reagent containing the enzymes lipase, glycerol-kinase, 
glycerol-3-phosphate oxidase and peroxidase. The mixture was incubated 
at room temperature for 10 minutes and colour intensity measured on the 
plate reader (as before) at 500 nm wavelength. Intensities were then 
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compared to a standard curve derived from a standard in a twofold serial 
dilution to five standard points (12.2-195 mg/dl).  
During the incubation, TG were broken down to glycerol and fatty acids by 
the lipases in the reagent mix. Glycerol kinase then phosphorylated 
glycerol to glycerol-3-phosphate, which was in turn turned to 
dihydroxyacetone-phosphate and hydrogen peroxide under the presence of 
glycerol-3-phosphate oxidase and oxygen. Hydrogen peroxide was 
subsequently reacting with 4-aminophenazone and chlorophenol, which 
were also contained in the reagent mix, to form a quinone imine of pink 
colour.  
Plasma non-esterified fatty acid analysis 
For measurement of NEFA concentrations, 2 µl plasma were mixed with 
100 µl reagent A, containing acyl-CoA-synthetase and coenzyme A. The 
mixture was incubated at room temperature for 15 minutes. After that, 
100 µl reagent B was added, containing acyl-CoA-oxidase and peroxidase. 
After another 15 minute incubation, the colour intensity was measured on 
a plate reader (as before) at 550 nm wavelength. The results were 
compared to a linear standard curve of three points at NEFA concentrations 
of 0.25, 0.5 and 1 mmol/L, which were run on the same plate.  
During the first incubation, NEFAs were converted to acyl-CoA by the 
Coenzyme A and acyl-CoA-synthetase included in reagent A. During the 
second incubation, acyl-CoA was oxidised to 2,3-trans-enoyl-CoA under 
production of hydrogen peroxide by the acyl-CoA-oxidase contained in 
reagent B. The hydrogen peroxide then reacted with 4-aminophenazone 
and 3-methyl-N-ethyl-N-(ß-hydroxyethyl)aniline to form a pink-coloured 
quinone imine.  
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The automated measurement with the kit produced by Randox differed 
from this method only in so far as the hydrogen peroxide was used to 
convert 4-aminoantipyrine and N-ethyl-N-(2hydroxy-3-sulphopropyl)-m-
toluidine to a purple adduct. 
Plasma glucose analysis 
For glucose measurements, 2 µl were mixed with 200 µl reagent, 
containing glucose oxidase, 4-aminophenazone, phenol and peroxidase. 
The plate was mixed, incubated at room temperature for 25 minutes and 
the optical density measured on a plate reader (as before) at 500 nm 
wavelength. Results were compared to a single standard of 5.49 mmol/L in 
a linear relationship. 
During the incubation, glucose was oxidised to gluconic acid and hydrogen 
peroxide. This was subsequently reacted with 4-aminophenazone and 
chlorophenol to form a quinone imine of pink colour.  
2.1.8. Adipose tissue histology 
Histology analyses were carried out both in the sheep study and the rat 
studies as described in Section 2.2.9. For histology, tissues are preserved, 
dehydrated and blocked in paraffin to enable very thin sectioning. Sections 
are transferred onto glass slides and immunohistochemistry is performed 
by binding a primary antibody to the protein of interest. Antigens need to 
be prepared for the primary antibody binding as preservation with formalin 
can change the structure of proteins. This antigen retrieval is often done 
by heating the sections in buffer. Primary antibody is then bound with a 
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secondary antibody bound to either a peroxidase resulting in a change of 
colour where antibodies are bound to antigen, or to a fluorescent marker. 
At dissection, omental adipose tissue samples were immediately 
submerged in 10% formalin (Sigma-Aldrich, Gillingham, UK) and remained 
in formalin for 7 days. Samples were then transferred to a tissue processor 
(Shandon Excelsior, Thermo Scientific, Wilmington, DE, USA) with 6 
subsequent baths in ethanol (industrially modified spirit, IMS, Sigma-
Aldrich, as before) for 1 hours, 3 baths in xylene (Fisher Scientific, 
Loughborough, UK) for 1 hour and 3 baths in paraffin wax (Tissue Tek II 
embedding wax, Sakura, Tokyo, Japan) at 60°C for 80 minutes. Tissue 
samples are blocked in paraffin, sectioned to 5 µm on a rotary microtome 
(AS200, Anglia Scientific, Cambridge, UK) and transferred to slides 
(Superfrost plus, Thermo Scientific, as before).  
For analysis of adipocyte size, sections stained for tumour necrosis factor 
(TNF) were used. Methods used were as previously described [401]. In 
brief, in an automated immunohistochemistry processor (Bond-Max, Leica, 
Milton-Keynes, UK), slides were treated with a primary antibody binding 
TNF and a secondary antibody bound to a horseradish peroxidase complex 
for imaging. Shortly, sections were dewaxed in 2 baths of xylene for 5 
minutes, then immersed in 2 baths of ethanol for 5 min. Peroxidase 
activity within the sample was quenched for 45 min by immersion in 3% 
hydrogen peroxide to reduce background staining. Samples were then 
washed 3 times with a wash solution (containing surfactant and 
methylisothiazolinone in Tris-buffered saline, all standard reagents used in 
the Bond-Max provided by Vision Biosystems, Newcastle Upon Tyne, UK) 
and a 1:150 dilution of the primary antibody (mouse anti bovine, AbD 
serotec, Oxford, UK) applied and incubated for 15 min. Samples were 
washed 3 times again and treated with a solution containing 
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methylisothiazolinone and animal serum in Tris-buffered saline for 8 
minutes, which enhances sample penetration of the subsequent polymer. 
After further 3 washes, the polymer, i.e. the complex of secondary anti 
mouse antibody and horseradish peroxidase, was applied and incubated for 
8 min. Samples were washed twice with wash solution and once with 
GHLRQLVHGZDWHUDQG¶-diaminobenzidine (DAB) was applied and 
incubated for 10 min. After 3 washes with deionised water, haematoxylin 
was applied for a 5 min incubation for visualisation of nuclei. Finally, 
samples were washed in deionised water 3 times, dehydrated in IMS twice 
for 2 minutes and in xylene twice for 2 and 3 minutes each. A drop of DPX 
mounting medium (Fisher Scientific, as before) was applied onto the 
sample and covered with a cover glass. All chemicals except for xylene, 
IMS and the primary antibody but including the secondary antibody were 
provided by Leica (as before) as Bond Polymer Refine Detection. 
Slides were viewed on the brightfield setting of a microscope (Leitz DMRB, 
Leica, as before) at 20x magnification, imaged (camera C4742-95, 
Hamamatsu, Welwyn Garden City, UK) and the area of adipocytes analysed 
using Volocity software (version 6, PerkinElmer, as before). For each 
sheep, an average of 33 adipocytes were cropped and area and 
circumference of cells was measured and averaged. Samples were 
processed and analysed by Dr. Vivek Saroha. 
2.1.9. Gene expression analysis 
The hypothalamus is a very heterogeneous tissue, with the expression of 
neurotransmitters restricted to certain cell types and nuclei within the 
hypothalamus. Examining the frozen hypothalami by eye it was not 
deemed possible to isolate nuclei of interest like the arcuate nucleus (ARC) 
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and the ventromedial nucleus (VMN). Hypothalami were, therefore, 
homogenised as a whole. Therefore, expression of a gene within an aliquot 
of the homogenate reflects expression of this gene in any cells within the 
hypothalamus. 
From each sample, messenger ribonucleic acid (mRNA) was isolated, 
quantified and 4 µg reversely transcribed to complementary DNA (cDNA). 
For the semiquantitative polymerase chain reaction (qPCR), primers were 
designed, from which standards were produced. Both were used for the 
quantification of cDNA in the qPCR, which represented the amount of 
mRNA of the gene of interest present in the original hypothalamus sample.  
2.1.9.1. Principle of PCR 
Primers are short oligonucleotides of approximately 20 base pairs (bp). 
When annealing to DNA, a pair of primers bind to complementary 
sequences on the gene they are designed for. Primer design is successful if 
the primers only bind to this specific locus and not to any other part of the 
genome. The two primers in a pair each bind to one strand of double-
stranded DNA, called the forward and reverse primers, respectively, and 
their binding sites are mostly between 100 and 200 bp apart from each 
other on the gene. The part of the gene between the primers is the 
sequence that is amplified during PCR, called the amplicon or PCR product. 
7KHERXQGSULPHULVHORQJDWHGE\ELQGLQJIUHHSKRVSKRQXFOHRWLGHVLQWKH¶
WR¶GLUHFWLRQE\DWKHUPRVWDEOHSRO\PHUDVH6XEVHTXHQWO\ERWKVWUDQGV
± the original template and the newly synthesised strand including the 
primer ± are denatured and the primers can bind to both of them again. If, 
for example, PCR is repeated for x cycles, the final amount will ideally be 
2x the number of original copies of DNA present. If the sample used is 
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cDNA, the final amount of amplicon copies is representative of the number 
of intact mRNA molecules for this gene present in the tissue of interest at 
the time of RNA isolation.  
2.1.9.2. Isolation of messenger RNA  
Offspring hypothalami which had been dissected and snap frozen 
immediately after humane euthanasia were homogenised in a buffer 
FRQWDLQLQJǃ-mercaptoethanol (RLT buffer, Qiagen, Hilden, Germany). RNA 
was extracted from homogenised hypothalami with the use of a phenol-
based method (TRI reagent, Ambion, Applied Biosystems, Foster City, CA, 
USA) before removing DNA and washing and eluting RNA with the use of 
the RNeasy Plus kit (Qiagen, as before).  
100 mg of tissue homogenised in 200 µl RLT buffer was mixed with 1 ml 
TRI reagent and centrifuged for 3 minutes at 12,000 g to remove cell 
debris. 200 µl chloroform was added to the supernatant, mixed thoroughly 
and incubated at room temperature for 10 minutes. Cooled centrifugation 
at 12,000 g for 15 minutes separated the aqueous phase that contains 
nucleotides from the phenol phase. The aqueous phase was transferred 
onto a gDNA column of the RNeasy Plus kit and centrifuged for 30 seconds 
at 12,000 g to filter out genomic DNA. 570 µl 70% ethanol was added to 
the flow-through, mixed and transferred onto the RNA column provided in 
the RNeasy Plus kit. By a rapid centrifugation, RNA was filtered from the 
solution onto the membrane of the column, which was then washed with 
RW1 and RPE buffers provided with the kit. RNA was then eluted from the 
membrane by adding 30 µl RNAse-free water and centrifugating for a short 
time. 
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Concentrations and purity were measured with NanoDrop 1000 (Thermo 
Scientific, as before). RNA concentration was measured spectrometrically 
at 260 nm wave length in a 1.5 µl aliquot of the eluted RNA solution. A 
second measurement of optical density at 280 nm was used to detect any 
contamination with protein as a ratio of optical density at 260 nm/280 
QPLVFRQVLGHUHGXQFRQWDPLQDWHG&RPSOHWHUHPRYDORIJHQRPLF'1$
gDNA) and integrity of the RNA were ensured by gel electrophoresis of 1 
µg of RNA of each sample.  
2.1.9.3. Reverse Transcription 
RNA were reverse transcribed (RT) to cDNA with use of the High Capacity 
RNA-to-cDNA kit (Applied Biosystems, as before). 4 µg of RNA in a total 
volume of 18 µl was added to 2 µl reverse transcription enzyme and 20 µl 
buffer, both included in the kit. After mixing, samples were incubated at 
37°C for 60 minutes to transcribe RNA into double stranded DNA. An 
incubation at 95°C for 5 minutes followed for denaturation of double 
stranded to single stranded DNA, which could then be used for PCR. Both 
incubations were carried out in a thermal cycler (Touchgene Gradient, 
Techne, Burlington, NJ, USA).  
&RQWUROVLQFOXGHGDUHDµQRWHPSODWHFRQWURO¶HYHU\UHDJHQW excluding the 
VDPSOHDQGµQR57FRQWUROV¶HYHU\UHDJHQWDQGVDPSOHH[FOXGLQJWKH
reverse transcription enzyme) for each sample to ensure that reagents 
were not contaminated and that the RNA was free of gDNA, respectively.  
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2.1.9.4. Primer design 
If there were no primer sequences published for the gene and species of 
interest, I designed primers with the use of web-based databases and 
programmes.  
The sequence of the gene of interest was searched for in the Ensembl data 
base [402]. This database has the added value of showing the exon 
borders for each gene. Designing the primers to be on opposite sides of an 
exon border gives another opportunity to check for contamination of the 
isolated mRNA with genomic DNA because, if gDNA is amplified, it will 
produce a bigger amplicon, i.e. including the exon sequence that was 
spliced out to form mRNA. This bigger amplicon would show alongside the 
smaller mRNA-derived amplicon when running the PCR products on a gel 
(see Section 2.1.9.6). Sequences are searched for specifically for ovine 
species. If there are no known sequences for this species, sequences of 
cow or pig often work successfully in sheep samples.  
From the original sequence, primers are designed using the Primer3 
algorithm [403]. A product size of 100-200 bp and a primer size of 18-27 
bp are chosen. Primer3 presents four possible primer pairs, which are then 
analysed for their probability to form hairpins or primer dimers using 
NetPrimer software (http://www.premierbiosoft.com/netprimer/; Premier 
Biosoft International, Palo Alto, CA, USA). The primer pair with the best 
NetPrimer rating was chosen, produced (Sigma Aldrich, as before) and 
tested in a PCR (see section entitled Real-time semiquantitative PCR 
below), including a no-template control. PCR products were run on a gel. If 
the negative control showed a band of the same product size as the 
desired amplicon, this may point to use of nucleotide-contaminated water. 
If the gel of the sample PCR product showed multiple bands or if the 
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amplicon appeared to be of an unexpected size as compared with the DNA 
ladder included in the gel this primer pair was dismissed and primers had 
to be designed again for this gene. The identity of the amplicon was 
confirmed by sequencing and comparison with the original gene sequence 
(as described below in the Section 2.1.9.7). 
2.1.9.5. Production of standards for the qPCR 
For each gene of interest, regular PCR was carried out to produce the 
amplicon defined by the specific primer sequences in a high purity and high 
concentration. The concentration was measured using the NanoDrop (as 
above) and the amplicon was diluted. These dilutions were used as 
standards during the qPCR. Double-stranded cDNA was denatured to its 
single-stranded state at 94°C. At 60°C primers annealed to the single-
stranded cDNA and nucleotides were added during the elongation step at 
72°C. At the denaturation step of the next cycle, the strands were 
separated again so that both the original strand and the new copy could 
serve as templates.  
For the PCR, 10 µl master mix including nucleotides and a buffer (Thermo-
Start PCR master mix, Thermo Scientific, as before), 1 µl of both forward 
and reverse primers and 6µl water were added to 2 µl cDNA, equivalent to 
0.2 µg mRNA before reverse transcription. PCR cycles were carried out in a 
thermal cycler (as before): 45 cycles of 94°C for 30 seconds, 60°C for 30 
seconds and 72°C for 60 seconds. In the last cycle, 72°C was held for 7 
minutes before cooling down to 4°C.  
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2.1.9.6. Gel electrophoresis and gel extraction 
PCR products were separated on an agarose gel to ensure that the primer 
pair selected generated only one product. Nucleic acids are negatively 
charged at the phosphate group, resulting in a migration towards the 
anode when electrophoresis is applied. PCR products of a smaller size 
migrate through the gel faster than a larger size amplicon, therefore 
separating into bands [404]. The size of the product in each band can be 
determined by comparing it to a DNA ladder which contains DNA fragments 
of known sizes and which has been run alongside the PCR products on the 
gel.  
Agarose was melted at a 2% (w/v) concentration in TAE buffer (0.04 mol/L 
Tris hydroxymethyl amino-methane (Sigma Aldrich, as before) 0.02 mol/L 
glacial acetic acid (Fisher Scientific, as before) and 0.001 mol/L EDTA (pH 
8.0; VWR, as before) in distilled water) and 0.004% ethidium bromide 
(v/v), a dye that fluoresces under UV light when intercalated into DNA, 
were added. The mixture was poured onto a tray with a comb inserted to 
create pouches and let to cool to room temperature to form a gel. Tray and 
gel were placed in an electrophoresis chamber filled with TAE buffer. 20 µl 
PCR products with 5 µl gel loading buffer (12.5% Ficoll 400 (Qiagen, as 
before), 0.1% bromophenol blue in 5x concentrated TAE buffer) were 
inserted into the wells alongside a DNA ladder (5 µl, 100 bp DNA marker, 
Bioron, Ludwigshafen, Germany). A voltage of 100 V was applied for 30-60 
minutes. Product bands were viewed and photographed with a camera 
chamber at -26°C (LAS-3000, Fujifilm, Tokyo, Japan). Bands were excised 
and DNA was extracted from the gel as described by the manufacturer 
(QIA quick gel extraction kit, Qiagen, as before). Gel was dissolved in a 
buffer at 50°C, isopropanol was added and the mixture was filtered 
through a column. After washing, PCR products were eluted from the 
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column membrane using an elution buffer. Concentrations and 
contamination with protein were determined with the NanoDrop as 
described before.  
2.1.9.7. DNA sequencing 
Extracted DNA and corresponding primers were submitted to the DNA 
Sequencing Laboratory in the School of Biomedical Sciences at the 
University of Nottingham. Amplicon sequences were compared to a 
nucleotide collection database using the basic local alignment search tool 
for nucleotides (BLASTn) algorithm [405] to confirm identity.  
2.1.9.8. Real-time semiquantitative PCR 
Measurements of expression of specific genes were performed with a SYBR 
green system (Thermo Scientific, as before) on a Quantica machine 
(Techne, as before) which enables measurements of specific mRNA by 
incorporating fluorescent molecules into the RNA sections that are 
amplified during the PCR. SYBR green is a molecule included in the qPCR 
reaction that increases its fluorescent capacities when bound to double 
stranded DNA. Overall fluorescence is measured in every cycle after the 
elongation phase but before denaturation of double stranded to single 
stranded DNA. Therefore, the measured fluorescence increases with the 
amount of amplicons in the sample over the course of the qPCR run. The 
cycle during which fluorescence can be distinguished from the background 
noise is called the cycle threshold (ct). The qPCR programme also often 
includes a gradual increase of temperature at the end of its run, i.e. a 
µUDPS¶ to determine the melting temperature of the amplicons generated 
during the qPCR. This is a way of ensuring that only one product is formed 
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during the amplification because the melting temperature is product-
specific depending on the length of the amplicon and its distribution of G/C 
and A/T nucleotides contained.  
RNA samples were measured in comparison with a standard curve of serial 
dilutions of cDNA amplicon of the measured gene (10-4 to 10-9 ng/µl), 
which was produced with the same primer set as described above (in the 
section Production of standards for the qPCR). For all measurements, the 
same Quantica machine was used to ensure comparability of results. A 
standard curve was produced by plotting the log concentration of the 
standards against their Ct. Measurements were only deemed successful if 
the standard curve showed an R2 of >0.95 and an efficiency of between 
1.95 and 2.05. An efficiency of 2 indicated the ideal amplification, i.e. a 
doubling of the number of amplicon molecules with each thermocycle 
[406]. Housekeeping genes considered for normalisation were the 
ribosomal RNA subunit 18S, the ribosomal phosphoprotein gene RPO and 
the gene for tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein YWHAZ. Gene expression measurements were carried 
out in 3 separate batches, each a new 1:10 dilution of stock cDNA and 
expression of housekeeping genes was measured again in each batch. 
1RUPDOLVDWLRQDVVXPHVDQHIILFLHQF\RIEDVHGRQWKHƩƩ&WPHWKRG
developed by Pfaffl [407]) and was carried out using the equation 
݃݁݊݁݁ݔ݌ݎ݁ݏݏ݅݋݊ ൌ  ?ି ሺ௖௧௧௔௥௚௘௧ି௖௧௥௘௙௘௥௘௡௖௘ሻ 
 (ct: cycle threshold of the target gene and of the reference gene). 
Genes of interest and housekeeping genes and their respective primers are 
listed in Table 2.1. The genes of interest selected are involved in appetite 
regulation and the insulin system, as explained in Chapter 1. 
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Table 2.1: Primers used for measurements of hypothalamic gene 
expression.  
Gene Forward and reverse sequence  °C 
Amplicon 
length 
NPY 
TCATCACCAGGCAGAGATACGG 
59 140 
GAGCAAGTTTCCCATCACC 
PTP1B 
GGAAGAAGCCCAGAGGAGTT 
60 132 
CGAGCCTTTCTCCATCACTC 
SOCS3 
AGCTCCAAGAGCGAGTACCA 
60 176 
ACGCTGAGGGTGAAAAAGTG 
GCR 
ACTGCCCCAAGTGAAAACAGA 
59 150 
ATGAACAGAAATGGCAGACATTTTATT 
MC3R 
CGGTGTGGTGTTCATCGTCTAC 
59 82 
TGAGCAGCAACATGGCAAGG 
MC4R 
GGTGTCGGGCGTCTTGTTC 
59 64 
CGGTGATGAGGCAGATGATGAC 
IR 
CTGCACCATCATCAACGGAA 
59 161 
CGTAACTTCCGGAAGAAGGA 
obRb 
TGAAACCACTGCCTCCATCC 
60 130 
TCCACTTAAACCATAGCGAATCTG 
ADIPOR1 
CTTCCCTGGAAAATTCGACA 
59 154 
TCAGAGGAGGGAGTCGTCAG 
ADIPOR2 
GGCAAGTGTGACATCTGGTTTC 
59 107 
GAAACGGAACTCCTGGAGGTT 
AMPKA2 
GCTGGATTTTGAATGGAAGG 
59 153 
CAGCACCTCATCATCAATGC 
GHSR 
CTCGCTCAGAGACCAGAACC 
59 178 
GACGAAAGAGACGAGGTTGC 
BDNF 
CATGGGACTCTGGAGAGCAT 
58 198 
CAAAGGCACTTGACTGCTGA 
CRH 
CATCACAGCACCCCCAGCC 
59 227 
GCAGCGCTCGGAAAAAGTT 
mTOR 
GCCTTCCGACCTTCTGCCTTC 
59 96 
CCGCTGTCCGTTCCTTCTCC 
AVP 
CGACCTGGAGCTGAGACAGT 
59 143 
GGCAGGTAGTTCTCCTCTTGG 
FTO 
ACACATGGCTTCCCTACCTG 
60 220 
GAGGATGCGAGAGACTGGAG 
AGRP 
TGAAGCGGATAATGGAGGAAC 
58 148 
GAGAGGGTCAAGTAGAGATAG 
18S 
GATGCGGCGGCGTTATTCC 
59 125 
CTCCTGGTGGTGCCCTCC 
RPO 
CAGCAAGTGGGAAGGTGTAATCC 
59 74 
CCCATTCTATCATCAACGGGTACAA 
YWHAZ 
TGTAGGAGCCCGTAGGTCATCT 
59 102 
TTCTCTCTGTATTCTCGCCATCT 
For each gene, the nucleotide sequence is stated, together with the ideal 
annealing temperature (°C) and length of the amplicon (in base pairs). 
NPY, neuropeptide Y; PTP1B, protein tyrosine phosphatase, non-receptor 
type 1; SOCS3, suppressor of cytokine signalling 3; GCR, glucocorticoid 
receptor; MC3/4R, melanocortin receptor 3/4; IR, insulin receptor; obRb, 
leptin receptor, long form; ADIPOR 1/2, adiponectin receptor 1/2; 
AMPKA2, AMP-activated protein kinase ɲ2; GHSR, growth hormone 
secretagogue receptor; BDNF, brain-derived neurotrophic factor; CRH, 
corticotropin releasing hormone; mTOR, mammalian target of rapamycin; 
AVP, arginine vasopressin; FTO, fat mass and obesity associated; AGRP, 
agouti-related peptide; 18S, ribosomal RNA 18S; RPO, RNA polymerase; 
YWHAZ, tyrosine 3-monooxygenase activation protein, zeta polypeptide. 
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qPCR relies on the same reactive principles as a regular PCR. The 
programme starts with a denaturation at 95°C for 15 minutes followed by 
45 cycles of 95°C for 15 seconds and a gene-specific annealing 
temperature of 58-60°C for 30 seconds. qPCRs were carried out without an 
extra temperature step for extension of the primers because the 
polymerases used in qPCRs are less temperature-sensitive than the 
polymerase used in regular PCR. In the sample mix, the extension of short 
amplicons occurs in the time the machine (Quantica, Techne, as before) 
needs to heat up from the annealing temperature to 72°C. During the 
cycling, fluorescence is measured at the end of each annealing step. After 
F\FOLQJLVFRPSOHWHDµUDPS¶LVFDUULHGRXWZLWKWKHWHPSHUDWXUHVWHDGLO\
rising in 1°C increases from 65°C to 95°C with a 10 second hold and a 
measurement of fluorescence on each step.  
2.1.10. Analysis of the plasma metabolome 
Plasma samples from mothers at 130 days of gestation and from 7 month 
old offspring were analysed for a wide spectrum of metabolites with the 
use of liquid chromatography-high resolution mass spectrometry (LC-
HRMS). This work and the subsequent statistical analysis was carried out 
by Dr. Marie-Cécile Alexandre-Gouabau at the Unité Physiologie des 
Adaptations Nutritionnelles in the Department Alimentation Humaine of the 
Institut National de la Recherche Agronomique, Nantes, France.  
2.1.10.1. Metabolome analysis with LC-MS 
Plasma was gently defrosted on ice and filtered by centrifugation (Nanosep 
Omega, Pall, Port Washington, NY) at 6000 rpm for 30 min at 10°C to 
remove proteins of high molecular weight (over 10kDa).  
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For the metabolome analysis, reverse phase HPLC with positive 
electrospray mode was used, because it is known to have a large 
application range and because it has been used with success under the 
same conditions in previous metabolomic studies in the laboratory at the 
University of Nantes [408, 409]. The instrument used was a Finnigan 
Surveyor Plus HPLC system, coupled with an LTQ-Orbitrap hybrid mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany). All solvents 
and reagents were of analytical or HPLC grade quality and were purchased 
from Solvent Documentation Synthesis (Peypin, France). Fifteen mL of 
filtered plasma samples were injected onto a 150 x 2.1 mm Uptisphere 
HDO-C18 FROXPQZLWKǋPSDUWLFOHVL]H,QWHUFKLP0RQWOXoRQ, France). 
Elution was performed with a mobile phase consisting of water containing 
0.1% acetic acid (A), and acetonitrile containing 0.1% acetic acid (B). The 
elution gradient with increasing concentration of acetonitrile used was as 
follows: 0-4 min, 0% B; 4-15 min, 10% B (v/v); 15-25 min, 50% B; 25-30 
min, 100% B. The flow rate was 0.2 mL/min and the temperature of the 
column was maintained at 37°C. For mass spectrometry, the HPLC column 
was connected without splitting to the electrospray interface operating in 
positive mode with nitrogen. Spray voltage was set to 5 kV. The 
temperature of the heated transfer capillary was maintained at 350°C. Full 
scan mass spectra were acquired from mass-to-charge ratio (m/z) 50 to 
800 at a mass resolution of 30,000 (full width at half maximum) in 
centroid mode. Two types of quality control (QC) samples were used, 
which were injected 4 times in randomised order in each batch of injection. 
QC1 was a Milli-Q water sample and QC2 was a standard mixture solution 
consisting of methyltestosterone, stanozolol, medroxyprogesterone 
DFHWDWHWULDPFLQRORQHDQGSRQDVWHURQH$DWQJǋ/7RLGHQWLI\WKHSHDNV
in the chromatograms of samples, standards were used including amino 
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acids, carnitine and its derivatives, which were run on the HPLC in the 
same way as the samples (Sigma Aldrich, St Quentin-Fallavier, France). 
Standards were dissolved in 98% ethanol to a concentration of 0.1 mg/mL 
before LC-MS analysis. 
2.1.10.2. Metabolomic fingerprint processing 
The open-source XCMS software [410] was used for non-linear alignment 
of the data and automatic integration and extraction of the peak intensities 
for each mass-to-charge and retention time ([m/z; rt]) features (ions). 
XCMS parameters for the R language were implemented in an automation 
VFULSWZLWKWKHDOJRULWKP³PDWFK-ILOWHU´E\GHIDXOWH[FHSWWKHLQWHUYDORI
m/z value for peak picking that was set to 0.1, the noise threshold set to 
6, the group band-width set to 10 and the minimum fraction set to 0.5. 
After pre-processing, XCMS compares the signal abundances observed for 
identical ions in two groups of samples using a Student t-test, to identify 
metabolites presenting intensities significantly different between two 
groups and ranked these metabolites according to the associated statistical 
confidence level (p-value). A p-value lower than 0.05, and a fold change 
higher than 1.5, were used as selection criteria to identify the potentially 
most relevant metabolites. 
All multivariate data analyses and modelling were performed using SIMCA-
P+ software (version 12, Umetrics Inc., Umeå, Sweden) on log-
transformed data [411] submitted to a Pareto scaling procedure of 
common use in the field of MS-based metabolomic, due to the wide 
dynamic range typically observed in MS-based metabolomic data. A 
supervised method, partial least squares discriminant analysis (PLS-DA) 
was applied for each transformed data set analysed separately (mothers 
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and offspring) to maximise the discrimination between sample groups 
focusing on differences according to metabolic variations in mothers and in 
offspring in response to perinatal nutrition and to identify the variables 
(i.e. ions) which best explained this discrimination. In our study, the PLS-
DA model was performed with two principal components, t[1] and t[2]. 
PLS-DA was combined with a multivariate pre-processing filter, orthogonal 
signal correction (OSC). By removing within-class variability and 
confounders which might interfere with chemometric analysis such as LC-
MS technical variability, OSC can significantly improve PLS-DA 
performance, yielding a better discrimination of the clusters [412]. Due to 
the wide dynamic range typically observed in MS-based metabolomic data, 
these analyses were performed on log-transformed data, submitted to a 
Pareto scaling procedure commonly used in the field of MS-based 
metabolomics. The quality of the generated OSC-PLS-DA models was 
evaluated by several goodness-of-fit parameters: R2 (X), the proportion of 
the total variance of the dependent variables that is explained by the 
model; R2 (Y) defining the proportion of the total variance of the response 
variable (i.e. the class of the samples) explained by the model and the 
predictive ability parameter Q2 (Y), which was calculated by a seven-round 
internal cross-validation of the data. In addition, a permutation test 
(n=100) was carried out to validate and to test the degree of over fitting 
for OSC-PLS-DA models. The correlation coefficient between the original Y 
and the permuted Y is plotted against the cumulative R2 and Q2 and a 
regression line is calculated. Generally, the model was successfully 
validated when R2(Y) and Q2(Y) are above 0.6 and the R2- and Q2-intercept 
limits (when the correlation coefficient is zero) for a valid model should be 
less than 0.4 and 0.05, respectively. The score values from OSC-PLS-DA 
were subjected to ANOVA to test the OPLS-DA model and the validation 
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was considered successful with p<0.05. The variables which most 
significantly discriminate the metabolic signatures were pinpointed by their 
loadings on PLS-DA. 
The monoisotopic masses responsible for the metabolic differentiation 
between the intervention groups were used to make queries in the online 
Metabolite and Tandem MS Database (http://metlin.scripps.edu/) and 
Human Metabolome Database (http://www.hmdb.ca/) for obtaining 
corresponding possible chemical structures (raw formulas). The identity of 
annotated compounds was confirmed by analysis of the corresponding 
commercially available standard compound on the same analytical system 
(i.e., LC-LTQ-Orbitrap) under the same conditions (validation based on 
both retention time and mass spectra, i.e. the time point of the metabolite 
washing off the column relative to injection and the mass and charge of 
the metabolite).  
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2.2. Rat choline study 
Animals were treated in accordance with protocol, which had been 
approved by the Committee of Animal Policy and Welfare of the Faculty of 
Agricultural, Life and Environmental Sciences at the University of Alberta. 
All husbandry and animal work was carried out at the Health Sciences 
Laboratory Animal Services at the University of Alberta. 
Primiparous Sprague-Dawley rats (n=12) were obtained from Charles River 
Laboratories (Montreal, QC, Canada) on day 14 of gestation and caged 
individually. After giving birth (term at 21 days of gestation), mothers 
stayed in individual cages with their offspring and were maintained on one 
of three interventional diets as follows until postnatal day 21. Two days 
after birth, all litters were culled to 11 offspring. One male and one female 
offspring were dissected at 21 days of age, 7 offspring culled without 
dissection and 2 female offspring from each mother were kept until 11 
weeks of age. In this postweaning period, the 2 littermates were housed 
together (Figure 2.4). As 1 of the 4 D mothers (fed a choline-devoid diet, 
as explained below) died during giving birth it was decided to keep 3 
offspring of each of the remaining D mothers after weaning to have 
comparable numbers (n) to the offspring of PC and C groups (mothers fed 
a diet containing phosphatidylcholine (PC) or free choline (C)). 
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Figure 2.4: Schematic depiction of the rat choline study.  
After giving birth, rat mothers were fed one of three diets: containing 1g 
choline per kg diet as PC (PC), containing 1g choline per kg diet as choline 
bitartrate (C) or a choline-devoid diet (D). Offspring were weaned at 3 
weeks of age, when mothers and 2 offspring per mother were euthanased 
and tissue dissected. Two to 3 female offspring per mother were 
maintained on a basal diet with 1g choline per kg diet as choline bitartrate. 
Insulin sensitivity was measured in a glucose tolerance test (ipGTT) at 9 
weeks of age and animals were euthanased and tissue dissected at 11 
weeks of age. 
2.2.1. Diets 
Before giving birth, mothers were fed standard rodent chow (Lab diet 
5001; PMI Nutrition International, Brentwood, MO, USA). The different 
isocaloric choline diets were introduced on day 20 of gestation (term 21 
days of gestation). Intervention diets were fed ad libitum to the mothers 
until the offspring were three weeks of age. After weaning at three weeks 
of age, the remaining offspring were fed the basal diet containing the 
standard choline concentration. 
Diets were designed by Professor Catherine Field based on AIN-76 high fat 
diet as previously published [413] and made specifically for this 
experiment (Table 2.2). Mothers were randomised to one of three 
isocaloric, isonitrogenous diets which differed only in the choline source 
and content: a choline-devoid diet (D, n=3 due to one mother dying from 
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dystocia) containing no choline, a standard choline diet containing the 
recommended choline concentration as a bitartrate (C, 1.2 g choline per kg 
diet, n=4) and a diet containing choline in the form of PC (PC, 1.0 g 
choline per kg diet, n=4). Choline bitartrate was obtained from Harlan 
Teklad, Madison, WI, USA. Lecithin was isolated from chicken egg yolks, 
provided by Dr. Jonathan Curtis, University of Alberta, analysed for PC 
content and added to the diets accordingly. The amount of vegetable fat 
added to the diet was reduced and modified, so that the final PC diets were 
similar in fat content and fatty acid composition to the diets not containing 
PC. All diets contributed 25% of energy as protein, 34% of energy as 
carbohydrates and 41% of energy as fat (Table 2.2). 
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Table 2.2: Composition of experimental diets used during the lactation 
period and of the postweaning diet, per kg diet.  
Component (g/kg) D C PC 
Casein 1 270 270 270 
Starch 2 244 241 244 
Sucrose 1 126 126 126 
Vitamin mix (AIN 93) 1 19 19 19 
Mineral mix 1 50 50 50 
Calcium phosphate dibasic 3 3.4 3.4 3.4 
Inositol 3 6.3 6.3 6.3 
Cellulose 1 80 80 80 
Marinol 4 2.4 2.4 2.1 
Flax oil 5 7 7 6.2 
Olive oil 2 48 48 42.5 
Sunflower oil 2 67 67 59.3 
Canola tallow 6 75.6 75.6 66.9 
Cystine 7 1.8 1.8 1.8 
Choline bitartrate 1 0 2.5 0 
Egg lecithin 0 0 23.8 
Energy density kcal/g 4.3 4.3 4.3 
% of energy from protein 
 
25 25 25 
% of energy from 
carbohydrate 34 34 34 
% of energy from fat 41 41 41 
Choline g/kg diet 0 1.2 1.0 
D, choline-devoid diet; C, standard choline bitartate diet; PC, standard 
phosphatidylcholine diet. 1, Harlan Teklad (Madison, WI, USA); 2, Safeway 
(Calgary, AB, Canada); 3, MP Biomedicals (Solon, OH, USA); 4, Lipid 
Nutrition (Channahon, IL, USA); 5, Gold Top Manufacturing and 
Distributing Ltd (Edmonton, AB, Canada); 6, Richardon Oilseed Ltd 
(Lethbridge, AB, Canada); 7, North American Mogul Products (Chagrin 
Falls, OH, USA). 
The basal diet fed after weaning in the longer study has a lower energy 
density of 3.1 kcal/g and a lower fat content of 31% of energy and has a 
concentration of 1 g choline as bitartrate per kg diet (product number 
84172, Harlan Teklad, as above, with 20% vegetable fat mix added, see 
Table 2.3). 
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Table 2.3: Composition of the basal diet fed to offspring after weaning. All 
components are listed as g per kg diet.  
Component (g) Basal diet 
Basal diet mix 1 800 
Fish oil 4 2 4 
Flax oil 5 3 5 
Olive oil 2 4 46 
Sunflower oil 2 4 70 
Canola tallow 6 5 75 
Energy density kcal/g 3.1 
% of energy from protein 
 
25 
% of energy from 
carbohydrate 
44 
% of energy from fat 31 
Choline g/kg diet 1.0 
1, Harlan Teklad (Madison, WI, USA); 2, Lipid Nutrition (Channahon, IL, 
USA); 3, Gold Top Manufacturing and Distributing Ltd (Edmonton, AB, 
Canada); 4, Safeway (Calgary, AB, Canada); 5, Richardon Oilseed Ltd 
(Lethbridge, AB, Canada). 
Initially n=8 offspring were maintained per group but two offspring died in 
the C and D group, respectively, resulting in n=7 for these groups and n=8 
for the PC group.  
Mothers were weighed and food intake was recorded weekly until 
euthanasia. If mothers lost more than 15% of their original post partum 
weight during the lactation period, they were switched onto the standard 
diet, C, until weaning. After weaning, mothers were kept for another week 
for tests, which were not part of my study. This consisted of a fat 
challenge, i.e. feeding the mothers a pellet of dietary fat after an overnight 
fast and blood samples for 12 hours afterwards to assess their lipid 
absorption and metabolism. At the end of that week, all mothers were 
euthanased and dissected as described below. During this week, all diets 
continued as during lactation, except for mothers with weight losses over 
15% as described above, which were maintained on a modified diet. This 
modification is further described in Chapter 5. Before weaning, every week 
three randomly selected offspring of each litter were weighed. Growth rate 
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during suckling was determined by subtracting the weight of different 
ages, e.g.: 
݃ݎ݋ݓݐ݄ݎܽݐ݁ ? െ  ?ݓ݁݁݇ݏ ൌݓ݄݁݅݃ݐሺ ?ݓ݁݁݇ݏሻ െ ݓ݄݁݅݃ݐሺ ?ݓ݁݁݇ሻ 
Similarly, the two remaining of each offspring were weighed and measured 
weekly until sacrifice in postnatal week 11. Food intake was measured as 
detailed below weekly until postnatal week 10.  
2.2.2. The 2009/2010 studies 
In a previous study, conducted in 2 cohorts in 2009 and 2010, 26 similar 
animals were used from the same source. The same diets were fed during 
lactation as above except for the PC diet, for which the lecithin used was 
isolated from soy, not egg (USB Corp., Cleveland, OH, USA). Animal 
numbers were higher for this study with n=8 mothers fed PC diet, n=11 
IHG&DQGQ IHG',QWKLVVWXG\PRWKHUV¶GLHWRI'DQLPDOVZDVQRW
changed as the mothers did not lose weight as rapidly as they did in the 
2011 study. A similar but slower weight loss was observed in D mothers of 
this cohort. From each mother 2-3 offspring were euthanased at 21 days of 
age without being fasted and stomach content was collected as described 
below. Livers were dissected from all animals and their fat content 
analysed. Maternal small intestine was dissected and 1 cm pieces of 
duodenum, jejunum and ileum prepared for histology as described below 
(2.2.10. Intestine histology). 
It was intended to combine data from the 2009/2010 studies with the 
VWXG\LQRUGHUWRµHVWDEOLVK¶UREXVWQ-numbers. However, since 
several key measures including maternal weight, food intake, gonadal fat 
mass and offspring weight differed between years we decided that pooling 
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of the studies was not appropriate. Therefore, the 2011 study described 
here had to hold up to statistical tests despite low n-numbers. The cause of 
the difference LQPRWKHU¶VZHLJKWEHWZHHQWKHVWXGLHVLVQRWFOHDUDV
source, strain and age at breeding was the same between years. 
2.2.3. Food intake tests 
Food intake of mothers and of the offspring after weaning were measured 
by providing a known amount of their assigned diet and weighing the 
remaining amount of uneaten food 48h later. Results were calculated to 
represent food intake over 24h and, although their intake was not 
necessarily assumed to be similar, divided by the number of sharing a cage 
in the case of the post-weaning offspring. Some of the littermates sharing 
a cage would differ quite substantially in weight and their food intake 
would be assumed to be quite different but, since food intake was 
expressed relative to body weight, the impact of averaging food intake in 
this way is thought to be small. 
2.2.4. Intraperitoneal glucose tolerance test 
This glucose tolerance test follows the same principles as described in 
Section 2.1.2 of the sheep study. Each animal was fasted overnight, 
weighed and a fasted blood sample collected from the tail vein by clipping 
off the tip of the tail, which is painless for the animals as nerve endings do 
not extend into the tip of the tail. For each subsequent blood sample the 
wound is re-opened rather than clipping the tail again. Glucose solution 
was administered intraperitoneally at a dose of 1 g glucose per kg body 
weight, diluted to 25% glucose in sterile water. Tail blood samples were 
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then collected at 10, 20, 30, 60, 90 and 120 minutes after the injection. 
Blood was immediately applied to a strip of a blood glucose testing device 
(Accu-Chek Compact Plus, Roche, Laval, QC, Canada) from each time 
point. This device has been used in rats in other studies [414] and, during 
the GTT, our glucose measurements were comparable to the outcomes of 
other studies with non-diabetic rats using colorimetric assays (5-13 
mmol/L measured in our study, equivalent to 100-260 mg/dL) [415, 416]. 
Blood was additionally collected into heparinised capillaries (Fisher, 
Pittsburgh, PA, USA) and transferred into microcentrifuge tubes, kept at 
4°C. To obtain plasma, blood was centrifuged (10 minutes at 10000 rpm), 
the supernatant plasma transferred into new tubes and stored at -80°C for 
subsequent insulin measurements by ELISA as described below. This work 
was carried out with the help of Ms Nicole Coursen and Mr. Michael 
Wadowski. 
2.2.4.1. Plasma insulin concentrations 
To determine plasma insulin concentrations, the Insulin Rat Ultrasensitive 
ELISA (80-INSRTU-E01, Alpco, Salem, NH, USA) was used following the 
PDQXIDFWXUHU¶V instructions. Samples were compared to seven standards 
ranging in concentration from 0.15 to 5.5 ng/ml. Controls were included in 
all 96-well plates to correct for variance between plates.  
In each well, 5 µl of standards, controls and samples were pipetted in 
duplicate. A streptavidin-horseradish peroxidase conjugate was added and 
left to react with the insulin for 2h (with 700-900 rpm shaking, at room 
temperature). The plates were washed six times and tapped thoroughly to 
remove excess liquids. For detection, 100 µl TMB solution was added and 
incubated for 30 minutes under the same conditions as before. The 
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reaction was stopped by adding 100 µl of an acidic stop solution and the 
intensity of yellow colour was read on the plate reader at 450 nm wave 
length. Plasma insulin concentrations were calculated using a 4 parameter 
logistic fit in comparison to the known concentrations of standards. Each 
96-well plate contained, besides the standards, a duplicate of one same 
sample with unknown concentration to allow for observation and correction 
of inter-assay variability. 
2.2.4.2. Tissue collection 
Weanling offspring were fasted for at least three hours whilst adult animals 
were fasted overnight before tissue collection. Animals were euthanased by 
exposure to CO2 gas and death ensured by testing for pedal response and 
subsequent cervical dislocation.  
Blood was collected by cardiac puncture, transferred into an EDTA-coated 
tube (Vacutainer, BD, Franklin Lakes, NJ, USA) and kept at 4°C. Tubes 
were centrifuged at 3000 rpm for 10 minutes and plasma transferred into a 
clean tube. Blood from weanling offspring was pooled between littermates 
as the treatment n was the mother and this enabled to gain a higher tissue 
sample for analyses. 
Whole brains were removed from the skull and separated along the 
interhemispheric fissure. Each half of the brain was separated into three 
sections coronally, with the middle section containing the hypothalamus. 
This middle section was either prepared for immunohistochemistry by 
embedding in paraffin or was frozen for later lipid extraction. The left brain 
section was inserted into a tissue cassette and submerged in a mixture of 
10% formaldehyde (original concentration of 40% in water, resulting in a 
final concentration of 4% formaldehyde), 10% acetic acid and 80% 
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methanol (v/v) for 48h before transfer to 70% ethanol until further 
treatment as described in section Brain immunohistochemistry. The right 
brain section was embedded in OCT medium (Optimal Cutting Temperature 
medium; Shandon Cryomatrix, Thermo Scientific, Nepean, ON, Canada), 
snap frozen on dry ice and stored at -20°C until lipid extraction.  
Livers, gonadal and perirenal white fat and interscapular brown fat were 
dissected by an experienced technician (as below), weighed and snap-
frozen in liquid nitrogen. Tissues were stored at -80°C until further 
analysis. From all animals, the small intestine was removed between the 
pyloric sphincter and the ileocecal valve, the full length measured and a 
short section each of duodenum, jejunum and ileum immediately 
immersed in 20% Z-Fixx in formalin (v/v, Thermo Fisher Scientific, 
Edmonton, AB, Canada) for later histology. This work was carried out with 
the help of Ms Nicole Coursen, Ms Susan Goruk, Ms Kelly-Ann Leonard and 
Ms Howe-Ming Yu. 
2.2.5. Stomach contents 
For this, stomach contents of the earlier study (Section 2.2.2.2), carried 
out as described above, were analysed. Stomach contents of offspring 
were collected after euthanasia and stored at -80°C. They were then 
pooled in offspring from the same mother to ensure sufficient amounts for 
all analyses and ground together to a powder in a frozen ceramic mortar 
on dry ice. Total weights were recorded and 200 mg aliquoted for analysis 
of choline metabolites.  
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2.2.6. Choline metabolite and phospholipid analyses 
Brains were analysed for concentrations of phospholipid classes and 
maternal livers and stomach contents for choline metabolite classes. Lipids 
were extracted following the method of Bligh and Dyer [417]. Both liver 
and stomach content samples were carried out in duplicate. However, this 
was not undertaken for brain samples as these were dissected from brain 
halves in a block including the hypothalamus, in order to standardise the 
anatomical regions contained in each sample.  
The procedure of lipid extraction was the same for all of these samples: 
100 ± 0.5 mg tissue sample were weighed and homogenised with a 
polytron homogeniser in 2 ml of a chloroform : methanol : water mixture 
(in the proportions of 1 : 2 : 0.8 by volume). The homogenate was 
centrifuged at 3000 rpm for 5 minutes and the supernatant transferred 
into a new glass vial. Another 2 ml of the same solvent mixture was added 
to the tissue pellet and homogenised, centrifuged and transferred to the 
same vial as before. This step was repeated one more time to yield a total 
extract of 6 ml. Before analysis, 1 ml of this extract was filtered using a 
0.22 µm syringe filter (with PTFE membrane, catalogue number 28145-
491, VWR International, Edmonton, AB, Canada) and stored at 4°C. The 
remaining 5 ml lipid extract from the brain were dried down under nitrogen 
at 45°C and taken into solution again in 1 ml hexane for isolation of PC 
and PE and subsequent fatty acid analysis as described below. 
Phospholipid concentrations and choline metabolites were measured in 
these extracts based on the methods of Zhao et al. [418]. In summary, 
samples were analysed for choline metabolites with liquid chromatography-
mass spectrometry (LC-MS) using an Agilent 1200 series HPLC system 
coupled to a 3200 QTRAP mass spectrometer (AB Sciex; Concord, ON, 
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Canada) and compared against standards. Data were acquired and 
analysed with the use of Analyst 1.4.2 software. Samples were eluted from 
an Ascentis Express 150 x 2.1 mm HILIC column, 2.7 µm particle size 
(Sigma, St. Louis, MO, USA) in a gradient elution, increasing the 
concentration of 10 mmol/L ammonium formate in water at pH 3.0 (phase 
B) in acetonitrile (A) over time: 0-0.1 min, 8% B; 0.1-10 min, from 8% to 
30% B; 10-17 min, 95% B; and then back to 8% B at 17.1 min for column 
re-equilibrium prior to the next injection. Cycle time was 30 min per 
injection of 2 µl volume. The flow rate of the mobile phase was 400 µl/min 
for the period from 20 min to 27 min and 200 µl/min for all other periods. 
For mass spectrometry, a turbospray ion source was used in positive ion 
mode with nitrogen. The handling of samples on the LC-MS and 
quantification of metabolite and phospholipid concentrations was carried 
out by Mr. Yeping Xiong. 
2.2.7. Analysis of fatty acid moieties in brain phospholipids  
As described above, brain lipids were extracted and dissolved in 1 ml 
hexane. 100 µl of this extract were applied to an activated H plate using a 
glass syringe in a line of small droplets and allowed to dry (Uniplate silica 
gel H, Analtech Inc., Newark, DE, USA). These silica-coated glass plates 
are used for thin layer chromatography to separate lipid extracts into the 
different classes of phospholipids. Plates were run in glass chambers that 
accommodated two plates standing up, leaning against the upper edge of 
the chamber wall. To the bottom of the chamber was added 1 cm high 
solvent (34.1% chloroform, 10.2% methanol, 28.4% 2-propanol, 20.5% 
triethylamine and 6.8% KCl (0.25% in water) by volume) to act as a 
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mobile phase and a sheet of filter paper which coats the wall of the 
chamber to improve saturation with the solvent.  
 
Figure 2.5: Thin layer chromatography.  
Eight lipid extract samples were applied to an H plate, the plate was 
positioned in a closed chamber containing a solvent mixture. By capillary 
forces, the solvent moves up the plate, spreading the lipids into the 
different phospholipid classes. The plate was dried, sprayed with 0.1% 8-
anilino-1-naphthalenesulfonic acid (ANS) and viewed under UV light to 
reveal the position of phospholipid classes. The bands containing 
phosphatidylethanolamine (PE) and phosphatidylcholine (PC) were used in 
further analyses.  
The plate was then placed in the chamber, ensuring the samples were on 
the lower end of the plate but not touching the solvent and the chamber 
closed ensuring saturation of air with the solvent. During the 2h incubation 
the plate was saturated with the solvent and lipid components of the 
sample spread across the plate. The plate was then removed from the 
chamber, dried and then sprayed with a thin layer of 0.1% 8-anilino-1-
naphthalenesulfonic acid, a hydrophobic fluorescent molecule. Under UV 
light, the location of the different phospholipid classes can be determined 
as bands and relevant areas of silica containing PC and PE were scraped off 
and placed into separate glass vials. Two ml hexane and 1.5 ml boron 
trifluoride methanol (both from Thermo Fisher Scientific, as above) were 
added, the vials closed, vortexed thoroughly and boiled (110°C) in a 
heating block for 1h. They were then allowed to cool and 1 ml deionised 
water was added, mixed and left at 4°C overnight. The hexane layer was 
transferred into a new glass vial and was dried down under nitrogen gas. 
To achieve a concentration suitable for analysis with the GC, samples 
containing PC were redissolved in 50-100 µl hexane. Samples were applied 
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to the GC (Agilent Technologies 7890 A GC System, Santa Clara, CA, USA) 
and run on a 100-m CP-Sil 88 fused capillary column (Varian Inc., 
Mississauga, ON, Canada). 
2.2.8. Liver total fat content 
Total fat was isolated from mother and offspring livers using a modification 
of the Folch method [419]. After defrosting, 300 mg of liver tissue were 
homogenised in 1 ml 0.025% CaCl solution for 30 seconds at 6.5 m/s 
using a FastPrep-24 homogeniser (MP Biomedicals, as above). In glass 
tubes, 12 ml of 2:1 chloroform:methanol and 1ml 0.025% CaCl solution 
was added to the liver homogenate. These tubes were vortexed thoroughly 
and left overnight at 4°C. This treatment results in two layers and the 
lower, chloroform phase was transferred into a new, pre-weighed, glass 
tube and the remaining phase washed once more with 2:1 
chloroform:methanol. After one hour, the chloroform phase of the second 
wash was added to the first aliquot. The chloroform was evaporated under 
nitrogen until only the fat remained in the tube that was reweighed, with 
the difference between the two weights being the weight of the fat 
extracted. Total liver fat was expressed as mass of fat adjusted for original 
sample weight (mg/g). 
2.2.9. Brain immunohistochemistry 
2.2.9.1. Tissue preparation and sectioning 
After 48h immersion of brain tissue in FAM as described in Section 
2.2.2.4.2, samples were transferred to 70% ethanol until further 
processing using the Leica TP 1020 tissue processor. In the processor, the 
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tissues were left for one hour each in the following solutions: 70% ethanol, 
3 baths of 100% ethanol, 3 baths of xylene and 3 baths of paraffin wax. 
Tissues were subsequently blocked in paraffin wax. All materials were 
sourced from Thermo Fisher Scientific (as above). 
Brains were cut coronally and sections were designated as including the 
ARC of the hypothalamus if the hypothalamic region protruding into the 
third ventricle and the hippocampal arcs close to the interhemispheric 
fissure were visible at about 2 mm width. These two landmarks were 
observed to be present at the same depth as the arcuate nucleus with the 
aid of a rat brainmap (brainnav.com, Elsevier Inc.) and to be 
corresponding to a depth of -2.7 ± 0.3 mm Bregma (Figure 2.6). The 
appropriate depth was then cut into 6 µm thick sections using a rotary 
microtome (Leica RM2125RT, Nussloch, Germany) and transferred onto 
slides (Fisher Superfrost microscope slides, catalogue number 12-550-016, 
as above) with 2-3 sections per slide and at least 5 slides per sample to 
allow for repeats. Slides were left at 60°C overnight to improve adherence 
of tissue to the slide.  
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Figure 2.6: Schematic drawing of brain anatomy at coronal section Bregma 
-2.76 mm. ARC (blue) shows the location of the arcuate nucleus in relation 
to the third ventricle (3V) and hippocampus (both in red). Brainmap used 
from brainnav.com (Elsevier Inc.). 
2.2.9.2. Immunohistochemistry 
First, paraffin was dissolved by placing the slides in two 10 minute xylene 
washes. The tissues were then rehydrated in 3 minute graded ethanol 
baths of 100%, 95% and 75% ethanol in deionised water (v/v). Samples 
were then kept in tap water until antigen retrieval. After rehydration and 
until dehydration at the end of the staining process, the tissues were not 
allowed to dry in order to reduce non-specific staining. Antigens were 
retrieved in 1mM EDTA in water (pH 8) at 95-100°C for 10 minutes (for 
NPY (neuropeptide Y) staining) or 15 minutes (for ɲ-MSH (ɲ-melanocyte 
stimulating hormone) staining) in a vessel placed in a boiling water bath 
and then samples cooled slowly for 20 minutes. Slides were washed 3 
times for 3 minutes in deionised water. 
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Tissues were then blocked with PBS containing 4% goat serum and 0.5% 
Triton-X (v/v) for 1h and drained shortly. Primary antibodies were diluted 
in PBS containing 1% BSA (wt/wt) to 1:1000 (for NPY staining) or 1:12000 
(for ɲ-MSH staining) and 60 µl was applied per section. As a negative 
control 60 µl PBS with 1% BSA (wt/wt) was applied to one section per 
slide. The slides were incubated overnight at 4°C. 
The next day, slides were washed 3 times in PBS for 3 minutes and the 
diluted secondary antibody (AB) was added at a dilution of 1:100 (anti-
rabbit antibody (AB) for NPY staining) or 1:250 (anti-sheep AB for ɲ-MSH 
staining) and 60 µl was applied per section. To control for non-specific 
staining, blocking buffer without secondary AB was applied on 3-4 slides 
only treated with the primary AB. All steps after application of the 
secondary AB were performed with the slides covered in foil to reduce light 
exposure and thus prevent photo bleaching. After 1h (for NPY staining) or 
2h (for ɲ-MSH staining) incubation with the secondary AB, slides were 
washed twice for 5 minutes in deionised water. The slides were dehydrated 
in an ethanol bath with 20 seconds in 95% (v/v in deionised water) and 
then 100% ethanol and air dried. Fluorsave solution (Calbiochem, Merck, 
Darmstadt, Germany) was applied on the tissues to increase stability of 
the fluorescent markers and slides were covered with cover slips (Thermo 
Fisher Scientific, Edmonton, AB, Canada), the edges were then sealed with 
nail polish. 
Primary ABs used were from Millipore (Billerica, MA, USA): rat anti-NPY 
raised in rabbits (AB9608) and rat anti-ɲ-MSH raised in sheep (AB5087). 
Secondary ABs were obtained from Invitrogen (Burlington, ON, Canada): 
anti-rabbit raised in goat with AlexaFluor 532 label (A-11009) and anti-
sheep raised in donkey with AlexaFluor 488 label (A-11015).  
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Primary and secondary antibodies were initially tested in varying 
concentrations to obtain optimal staining. For NPY staining, the primary 
antibody was tested at 1:500, 1:1000 and 1:2000 dilutions. All three 
dilutions showed similar results with the clearest difference between slides 
stained for NPY and the negative control at 1:1000 dilution (Figure 2.7). 
For ɲ-MSH staining, the primary antibody was tested at 1:5,000, 1:10,000 
and 1:15,000. The dilution of 1:15,000 gave the most consistent result 
and was used for all analyses (Figure 2.8). 
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Figure 2.7: Images of arcuate nuclei stained for NPY at varying dilutions of 
primary antibody.  
A: staining with primary antibody diluted 1:500; C: staining with primary 
antibody diluted 1:1000; E: staining with primary antibody diluted 1:2000. 
B, D, F: respective negative slides, not containing primary antibody. Red 
lines in negative image indicate position of the third ventricle. White scale 
bar indicates 100 µm. 
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Figure 2.8: Images of arcuate nuclei stained for ɲ-MSH at varying dilutions 
of primary antibody.  
A: staining with primary antibody diluted 1:5,000; C: staining with primary 
antibody diluted 1:10,000; E: staining with primary antibody diluted 
1:15,000. B, D, F: respective negative slides, not containing primary 
antibody. Red lines in negative image indicate position of the third 
ventricle. White scale bar indicates 100 µm. 
All slides were viewed on an Axio Imager.Z1 microscope (Zeiss Ltd, 
Toronto, ON, Canada) and photographed with an AxioCam MRm camera 
(Zeiss Ltd, as above) and the software used for the image analysis was 
ImageJ (Research Services Branch, National Institute of Mental Health, 
Bethesda, Maryland, USA). The area corresponding to the ARC was 
determined in comparison with brain map images, measured and stained 
cells within this area counted. Images used for the analysis were taken 
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with a 10x objective at exposure time of 1 millisecond (ms, for NPY 
staining) or 15 ms (for ɲ-MSH staining).  
2.2.10. Intestine histology 
Sections of duodenum, jejunum and ileum were used to analyse general 
morphology of the small intestine. Maternal intestinal sections were fixed 
in 20% w/w Z-Fixx in formalin (Thermo Fisher Scientific, as above) for 48 
hours and then transferred to 10% buffered formalin (Thermo Fisher 
Scientific, as above) until blocking. All tissues were inserted in a tissue 
processor (Leica TP 1020, as above), placed in washes of 10% buffered 
formalin, 70% ethanol, 3 changes of 100% ethanol, 3 changes of xylene 
(Fisher Scientific, as above) and 3 changes of paraffin wax (TissuePrep 
Embedding Media, Fisher Scientific, as above) for one hour per bath. 
Samples were then embedded into paraffin wax and cut to 6 µm thickness 
as described in more detail above in section Brain immunohistochemistry. 
Sections were stained with haematoxylin and eosin following the 
SURGXFHU¶VLQVWUXFWLRQVDTXHRXVLQVWDQWG\HV6KDQGRQ7KHUPR)LVKHU
Scientific, as above).  
Samples were deparaffinised and re-hydrated with subsequent washes of 2 
changes of xylene for 10 minutes each, 2 changes of 100% ethanol for 5 
minutes each and 95% and 70% ethanol for 2 minutes each. They were 
ZDVKHGEULHIO\LQGLVWLOOHGZDWHUVWDLQHGLQ+DUULV¶VKDHPDWR[\OLQIRU
minutes and washed under running tap water for 5 minutes. The samples 
were differentiated in 1% acetic acid in ethanol for 30 seconds and washed 
again for 1 minute. Haematoxylin was blued in a 30 second wash in 0.2% 
ammonia in distilled water (v/v) and washed under running tap water for 5 
minutes, then rinsed in 95% ethanol. Samples were counterstained in 
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yellow eosin for 30 seconds. Finally, they were dehydrated in 95% ethanol, 
2 changes of 100% ethanol and 2 changes of xylene for 5 minutes each 
and mounted with a xylene-based mounting medium (permount mounting 
media, Thermo Fisher, as above). 
Slides were viewed and villus height and crypt depth were measured using 
computer-assisted microscopy (Zeiss Primo Star, Metamorpth Meta 
Imaging series by MDS analytical technologies).  
 
Figure 2.9: Jejunum section stained with haematoxylin and eosin showing 
examples of measurements for villus height (red arrows) and for crypt 
depth (black arrows).  
Villus height was measured from the tip of the villus to the top of the crypt 
whilst crypt depth was measured from the top of the crypt to its base as 
illustrated in Figure 2.9. At least four measurements were taken for each 
animal and intestinal section. Whilst all intestinal analyses were carried out 
by undergraduate project student Ms Chisom Ikeji, I have analysed the 
original data for inclusion in this thesis. 
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2.3. Statistical analysis 
Statistical analysis of data from both the sheep and the rat studies were 
principally the same. Data from mothers for each outcome was tested for 
normal distribution using a Kolmogorov-Smirnov test. If data were 
normally distributed, an ANOVA with an a priori comparison of contrasts 
between groups, i.e. 
PC vs C, C vs D, PC vs D in the choline study;  
RAO vs NAO, NAO vs NSO, NSO vs NSL in the macronutrient 
restriction study;  
was undertaken and a p-value determined dependent on whether or not 
equal variance was given between groups [420]. An a priori comparison, 
also called planned comparison, is more hypothesis-driven compared to a 
post-hoc test, as it allows comparison of specific group pairs rather than 
comparing all groups to each other, therefore leading to lower p-values 
without increasing the error rate [421]. 
For the plasma concentrations measured during the 24h feeding test in the 
sheep study, a paired t-test was used to compare concentrations at 2 time 
points, i.e. to test for a difference between the fasted and the fed morning 
samples. 
If data were not normally distributed, their logarithm (base 10) was again 
tested for normal distribution. If data were still not normally distributed, 
Mann-Whitney tests were used for the comparisons given above. For easier 
reading, both normally and non-normally distributed data were displayed 
as mean ± standard error of mean (SEM) throughout the thesis. 
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Offspring data collected during lactation were treated as multiple 
measurements of an outcome if offspring were born from the same 
mother. Therefore, the number (n) of offspring during lactation is the same 
as the number of mothers as the intervention has been applied to the 
mother rather than to the offspring individually/ independently. Data were 
averaged between siblings and then analysed as described above for 
maternal data. 
After weaning, sibling offspring showed differing phenotypes and it was, 
therefore, deemed appropriate to not treat them as multiple 
measurements but to block data by using a hierarchical model instead 
[421, 422]. With this model, siblings were considered separately but it was 
taken into account that they are offspring from the same mothers, i.e. as 
parts of a group (litter) within a group (diet). The test assesses whether 
the maternal intervention group had an influence on the outcome, doing 
multiple comparisons as stated above. 
All analyses were carried out on SPSS software version 17 (PASW, IBM, 
Portsmouth, UK). 
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3. Long term effects of maternal 
nutrient restriction on growth 
and insulin sensitivity  
3.1. Introduction and hypotheses 
This chapter investigates the acute and long term metabolic changes 
caused by manipulating the perinatal nutritional environment. The sheep is 
a good model for human intrauterine and neonatal development and the 
results have implications for human pregnancies, effects on children and 
their risk of developing metabolic disease as adults. The study was 
designed to examine the effects of nutrient restriction in late pregnancy, 
coincident with the period of maximal fetal growth. This is a period during 
which nutrient restriction can result in intrauterine growth retardation 
(IUGR). Subsequent to the manipulation of environment during pregnancy, 
I examined the influence of early postnatal growth rate, which has been 
postulated to be a separate risk factor for the development of insulin 
resistance. 
This work is important since early postnatal life is less well established to 
be a period sensitive for programming. In their review paper, Bateson et 
al. proposed that the difference in growth during development, i.e. slow 
growth in late pregnancy followed by faster growth in early postnatal life, 
is especially detrimental to long term metabolic outcomes [423]. Finally, 
metabolic diseases are increasing in prevalence, most likely due to the 
increase in obesity mediated by changes in lifestyle, which started in 
Western countries and is gradually spreading across the world. The 
obesogenic environment to which the offspring of mothers fed to 
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requirements and mothers nutrient restricted in late gestation were 
exposed consisted primarily of a restriction in their physical activity, 
leading to a modest elevation in their body weight, a study intervention 
most relevant to the majority of people with a sedentary lifestyle.  
Following data from the Dutch famine follow-up studies, described in more 
detail in the Introduction (Chapter 1),  
1) I hypothesised that the offspring of nutrient restricted mothers 
would be lighter at birth but would not be different in adult body 
weight compared to animals not subjected to maternal nutrient 
restriction.  
2) These offspring would, nevertheless, develop insulin resistance, 
which would be increased by an accelerated early postnatal growth 
rate.  
3) A combination of accelerated early postnatal growth rate following a 
reduced birth weight would lead to higher mature body weight and 
the obesogenic environment after weaning would amplify adverse 
metabolic effects.  
It should be noted that the offspring were only studied until they reached a 
young adult age. As metabolic effects only start to develop at this age, 
these would be expected to deteriorate further once impaired glucose 
tolerance was established. 
3.2. Materials and Methods  
The design of the study and all materials and methods used to establish 
the results described in this chapter are described in the Materials and 
Methods (Chapter 2) and Figure 3.1. Briefly, twin pregnant ewes were 
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either nutrient restricted from gestational day 110 to term, 145 days, (N) 
or kept on a diet providing all their nutritional requirements throughout 
pregnancy (R). After birth, twin offspring were either both raised by the 
mother to induce a standard early postnatal growth rate (S) or were 
separated with only one twin remaining with the mother so as to induce an 
accelerated growth rate (A). After weaning at 3 months of age, animals 
were maintained in an obesogenic environment with restricted opportunity 
for physical activity (O) or in a unrestricted environment to induce a lean 
phenotype (L). During gestation there were 2 groups, R and N, whilst 
during the lactation period there were 3 groups, RA, NA and NS, and, after 
weaning, 4 groups, RAO, NAO, NSO and NSL as summarised in Figure 3.1. 
Blood samples were taken regularly and analysed for metabolic and 
endocrine factors. Body weight gain and physical activity were monitored 
regularly and glucose tolerance tests carried out at 7 and 16 months of 
age. At 16 months, body composition was determined by Dual-energy X-
ray absorptiometry (DXA) and all offspring dissected. Comparisons were 
drawn between comparable groups i.e. offspring from groups differing only 
in one letter of their group abbreviation.  
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Figure 3.1: Schematic description of study groups of the sheep 
macronutrient restriction study.  
Twin-bearing mothers are fed meeting requirements until 110 days of 
pregnancy. From 110 days until term (145 days) mothers are fed either to 
requirements (R) or to 60% of macronutrients (N). After birth, accelerated 
growth is induced by separation of twins and only one twin remaining with 
the mother (RA and NA) or offspring had a standard growth rate (NS). 
After weaning, most offspring were subjected to an obesogenic 
environment (RAO, NAO, NSO) whilst others were maintained in a 
unrestricted environment (NSL).  
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3.3. Results 
3.3.1. Mothers 
When adjusted for their body weight at the beginning of the nutritional 
intervention, N mothers gained less weight in late pregnancy as compared 
to R mothers (Figure 3.2). 
 
            
Figure 3.2: Maternal body weight throughout gestation, relative to weight 
at 110 days of gestation, the start of the intervention.  
Mothers were fed a diet meeting requirements (R, blue, n=8) or a nutrient 
restricted diet delivering 60% of caloric requirements (N, red, n=18 
between gestational days 110 and 145. * p<0.05 between N and R 
mothers. Data are means with error bars representing SEM. 
At 130 d gestation plasma glucose concentrations were lower and plasma 
non-esterified fatty acid (NEFA) concentrations were higher in nutrient 
restricted mothers (Figure 3.3). 
Gestational age (d) 
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Figure 3.3: Maternal plasma glucose (A) and NEFA concentrations (B) at 
130 days of gestation. Mothers were fed a diet meeting requirements (R, 
n=8) or a nutrient restricted diet delivering 60% of caloric requirements 
(N, n=15) between gestational days 110 and 145. NEFA, non-esterified 
fatty acids. * p<0.05 for R versus N comparison. Data are means with 
error bars representing SEM. 
Plasma cortisol, insulin and triglyceride (TG) concentrations did not differ 
between R and N mothers (Table 3.1). 
Table 3.1: Maternal plasma cortisol, insulin and triglyceride concentrations 
at 130 d gestation.  
Maternal plasma concentration R N 
Cortisol (nmol/L) 17 ± 3 22 ± 3 
Leptin (ng/mL) 1.5 ± 0.3 1.0 ± 0.1 
Insulin (µg/L) 0.3 ± 0.01 0.3 ± 0.01 
Triglycerides (mg/dL) 29 ± 1 30 ± 1 
Mothers were fed a diet meeting requirements (R, n=8) or a nutrient 
restricted diet delivering 60% of caloric requirements (N, n=15) between 
gestational days 110 and 145. Data are means ± SEM. 
3.3.1.1. Maternal metabolome 
The analysis of maternal metabolome resulted in a total of 2629 (mass-to-
charge ration and retention time, [m/z; rt]) features, which showed a 
marked overall difference in metabolic patterns between R and N mothers 
in the OSC-PLS-DA score plot (Figure 3.4). 
0 
1 
2 
3 
4 
5 
R N 
M
a
te
r
n
a
l 
p
la
s
m
a
 
g
lu
c
o
s
e
 (
m
m
o
l/
L
)
 
A 
* 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
R N 
M
a
te
r
n
a
l 
p
la
s
m
a
 N
E
F
A
 
(
m
m
o
l/
L
)
 
B * 
116 
 
 
Figure 3.4: OSC-PLS-DA score plot to show differences in the overall 
PHWDERORPHRIPRWKHUV¶SODVPDDWGJHVWDWLRQ 
Mothers were fed a diet meeting requirements (R, blue, n=7) or a nutrient 
restricted diet delivering 60% of caloric requirements (N, red, n=17) 
between gestational days 110 and 145. Validation parameters: R2X 
(cum)=0.429, R2Y (cum)=0.928, permutation test (n=100) with R2 
intercept=0.371 and Q2 intercept=-0.342, ANOVA-p-value=2*10-8. 
Of the 2629 compounds, 195 were significantly different (XCMS t-test 
treatment with p<0.05) between N and R mothers. However, only 8 of 
these compounds could be identified with standards (Table 3.2). An 
additional 5 compounds with a trend to be different between N and R 
mothers could also be identified (p<0.1). 
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Table 3.2: List of metabolites which were significantly altered in maternal 
plasma at 130d gestation between N and R mothers.  
Compound RT M 
[M+H]+ 
observed 
fold 
change 
p-value 
Leucine 5.78 131.0946 132.1019 1.45 0.005 
Proline 2.54 115.0633 116.0676  1.35 0.035 
Tryptophane 13.45 204.0898 205.0972 2.97 <0.001 
Valine 2.36 117.0789 118.0862 -1.31 0.007 
Pyroglutamic  
acid 
5.02 129.0426 130.0498 1.37 0.031 
o-Acetyl- 
carnitine 
3.77 203.1157 204.1230 1.84 <0.001 
Hexanoyl- 
carnitine 
15.63 259.1784 260.1856 2.30 <0.001 
Cortisone 16.36 360.1936 361.2009 1.37 0.084 
Glycine 3.66 75.0320 76.0393 1.32 0.080 
Phenylalanine 11.37 165.0789 166.0863 1.25 0.087 
Riboflavin 6.76 376.1383 377.1455 1.43 0.067 
Isobutyric acid 14.55 88.0524 89.0597 1.43 0.063 
In the lower part of the table metabolites are listed which showed a trend 
(t-test with a 0.05<p<0.1) to a difference between N and R mothers. A 
positive fold change indicates that the compound has a higher 
concentration in N compared to R mothers, a negative fold change 
indicates a lower concentration in N compared to R mothers.  
Mothers were fed a diet meeting requirements (R, n=7) or a nutrient 
restricted diet delivering 60% of caloric requirements (N, n=17) between 
gestational days 110 and 145. RT, retention time; M, monoisotopic mass; 
[M+H]+, mass with one additional hydrogen atom; all compounds were 
identified using authentic standards. 
3.3.2. Offspring at weaning 
Mothers that were nutrient restricted in late gestation gave birth to lighter 
offspring as compared to R mothers (N, 3.8 ± 0.2 kg; R, 5.0 ± 0.2 kg). 
When raised alone by their mother after birth so as to induce an 
accelerated growth rate, NA offspring remained lighter than RA offspring 
throughout most of lactation period (and this reached statistical 
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significance between 5-38 d and 74-90 d of postnatal age). An acceleration 
of early growth rate in NA offspring led to a higher weight, which reached 
statistical significance in comparison with those N offspring raised by their 
mothers with their twin (NS) between 38-52 d and at 90 d of age. At 
weaning, RA offspring are significantly bigger than NA, and NA are 
significantly bigger than NS offspring (Figure 3.5). 
 
Figure 3.5: Offspring growth development between birth and weaning at 
90 d of postnatal age.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RA, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NA, red, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS, green, 
n=17). * p<0.05 for RA versus NA; # p<0.05 for NA versus NS. Data are 
means and error bars represent SEM. 
NA offspring increased their weight compared to birth weight more than NS 
offspring throughout the lactation period and, after 30 days, more than RA 
offspring, despite the lower body weight of NA compared to RA at weaning 
(Figure 3.6). 
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Figure 3.6: Fold change in body weight from birth weight throughout 
lactation.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RA, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NA, red, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS, green, 
n=17). * p<0.05 for RA versus NA; # p<0.05 for NA versus NS. Data are 
means and error bars represent SEM. 
At 3 months of age plasma hormone and metabolite concentrations did not 
differ between intervention groups (Table 3.3). 
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Table 3.3: Plasma concentrations of hormones and metabolites at 3, 7 and 
16 months of age divided by study group.  
Plasma  
conc. 
Age  RAO NAO NSO NSL 
Cortisol  
(nmol/L) 
3  32 ± 4 42 ± 10 40 ± 5  
7 74 ± 19 60 ± 14 54 ± 7 50 ± 12 
16 41 ± 9 56 ± 14 44 ± 10 22 ± 4 
Leptin  
(ng/ml) 
3  0.65 ± 0.10 0.46 ± 0.09 0.47 ± 0.07  
7  1.8 ± 0.2 2.5 ± 0.5 2.2 ± 0.4 1.5 ± 0.3 
16 4.1 ± 0.6 6.2 ± 0.9 a 3.7 ± 0.5 b 3.1 ± 0.2 
Insulin  
(µg/L) 
3  0.16 ± 0.09 0.07 ± 0.01 0.07 ± 0.01  
7 0.16 ± 0.01 0.17 ± 0.01 0.17 ± 0.01 0.18 ± 0.02 
16 0.36 ± 0.04 0.38 ± 0.02 0.43 ± 0.09 0.31 ± 0.01 
Glucose 
(mmol/L) 
3  3.0 ± 0.2 2.8 ± 0.1 2.6 ± 0.1  
7 3.76 ± 0.14 3.79 ± 0.19 3.12 ± 0.44 3.23 ± 0.26 
16 2.93 ± 0.20 3.15 ± 0.11 2.97 ± 0.12 3.17 ± 0.10 
TG  
(mg/dl) 
3 7.7 ± 0.4 7.6 ± 0.3 7.9 ± 0.4  
7 15.2 ± 1.0 14.8 ± 1.0 16.1 ± 3.6 20.7 ± 3.0 
16 15.9 ± 1.8 c 10.6 ± 2.6 d 10.7 ± 1.7 14.5 ± 1.3 
NEFA  
(mmol/L) 
3  0.46 ± 0.07 0.38 ± 0.04 0.32 ± 0.05  
7  1.3 ± 0.1 e 1.0 ± 0.1 f 1.3 ± 0.1 1.6 ± 0.3 
16 0.65 ± 0.06 0.49 ± 0.07 0.48 ± 0.08 0.40 ± 0.05 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RA, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NA, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS, n=17). 
After weaning, animals were maintained in an obesogenic (O) or 
unrestricted environment (L; NSO n=8, NSL n=9). Postnatal age is given in 
months. Data are expressed as mean ± SEM. Comparison a versus b, 
p=0.029; c versus d, p=0.036; e versus f, p=0.028. 
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At the age of 1.5 months all offspring had similar physical activity 
independent of intervention group (Figure 3.7). 
 
Figure 3.7: Mean physical activity measured in offspring over a 24h period 
at 1.5 months of age.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RA, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NA, red, n=7) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS, green, 
n=13). Data are means and error bars represent SEM. 
3.3.3. Offspring at puberty 
The differences in body weight, present at birth and through the lactation 
period, did not persist into adulthood when offspring were maintained on 
the same diet and in the same environment after weaning. Differences in 
offspring body weight that were present at weaning (3 months of age) did 
not persist after 5 months of age and all offspring are of similar weight 
between 6 and 12 months of age. Offspring raised in a restricted 
environment showed a higher body weight from 14 months of age than 
those raised in a free-living environment regardless of maternal intake in 
late gestation and postnatal feeding before weaning (Figure 3.8). 
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Figure 3.8: Offspring growth after weaning, divided by groups.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=9).  
SIRU5$2YHUVXV1$2SIRU1$2YHUVXV162ÁSIRU
NSO versus NSL. Data are means and error bars represent SEM. 
At 7 months of age, plasma cortisol, leptin and triglyceride concentrations 
were not influenced by intervention group and NEFA concentrations were 
slightly lower in NAO as compared to RAO (Table 3.3).  
At the same age, a glucose tolerance test (GTT) was carried out with the 
main finding that NSL offspring had a lower plasma glucose concentration 
as a response to the glucose injection compared to NSO offspring (Figure 
3.9).  
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Figure 3.9: Plasma glucose concentrations during a glucose tolerance test 
conducted in offspring at 7 months of age.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=5SIRU1$2YHUVXV162ÁSIRU162
versus NSL. Data are means and error bars represent SEM. 
Plasma insulin concentrations in the NAO group had a high inter-individual 
variance, but the data overall suggested that plasma insulin concentrations 
were highest in offspring which had experienced the NAO interventions 
(Figure 3.10). 
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Figure 3.10: Plasma insulin concentrations during a glucose tolerance test 
conducted in offspring at 7 months of age.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, green, n=8) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=9). * p<0.05 for RAO versus NAO; # p<0.05 for NAO 
versus NSO. Data are means and error bars represent SEM. 
These differences in glucose between NSO and NSL and in insulin between 
NAO and NSO are reflected in significant differences in the area under the 
curve of their plasma concentrations (Table 3.4).  
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Table 3.4: Plasma concentrations of glucose and insulin in offspring at 7 
months of age over the course of the GTT. Glucose and insulin are 
expressed as the area under the curve over the course of the 120 min GTT 
and a homeostatic model assessment for insulin resistance (HOMA-IR) 
calculated by multiplication of fasted glucose and insulin concentrations.  
Plasma conc. RAO NAO NSO NSL 
Glucose AUC  
(mmol/L) 
1167 ± 46 1070 ± 74 1252 ± 93 a 1015 ± 77 b 
Insulin AUC  
(µg/L) 
45 ± 12 67 ± 13 c 37 ± 7 d 23 ± 6 
HOMA-IR 0.61 ± 0.05 0.66 ± 0.07 0.52 ± 0.08 0.70 ± 0.21 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, n=8) whilst others were maintained 
in a less restricted environment, inducing a lean body weight (NSL, n=9). 
AUC, area under the curve. Comparison a versus b, p=0.048; c versus d, 
p=0.040. Data are displayed as means ± SEM. 
3.3.4. Adult offspring 
Body weight, fat and lean mass did not differ between offspring raised in 
the same restricted environment. Body weight and absolute fat mass but 
not relative fat mass were higher in NSO as compared to NSL. Relative 
visceral fat mass, a sum of omental, perirenal and pericardial fat mass 
expressed relative to body weight, was lower in NSL but was not different 
between offspring raised in a restricted environment (Table 3.5). 
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Table 3.5: Body and organ weight and body composition of offspring at 16-
17 months of age. Body composition was measured by DXA scan at 16 
months of age and expressed relative to the weight at that age. Offspring 
were dissected at 17 months of age and visceral fat (as a sum of omental, 
perirenal and pericardial fat mass), liver, heart and pancreas weight 
recorded. Adipocyte size was measured in histological sections of omental 
adipose tissue. 
  RAO NAO NSO NSL 
Weight  
(16 mo) 
kg 67.7 ± 3.9 59.2 ± 2.7 59.2 ± 4.3 a 46.8 ± 1.2 b 
Lean mass kg 53.5 ± 5.1 42.1 ± 3.4 45.5 ± 4.4 39.4 ± 1.5 
% 78.0 ± 3.7 71.1 ± 4.3 76.2 ± 2.4 84.0 ± 1.9 
Fat mass kg 14.4 ± 2.1 17.1 ± 2.8 13.7 ± 1.1 e 7.5 ± 0.9 f 
% 22.0 ± 3.7 28.8 ± 4.3 23.8 ± 2.4 16.0 ± 1.9 
Weight  
(17 mo) 
kg 74.5 ± 3.1 68.0 ± 3.1 69.6 ± 5.0 c 51.3 ± 1.7 d 
Visceral fat kg 2.6 ± 0.3 2.6 ± 0.6 2.5 ± 0.4 g 0.5 ± 0.1 h 
% 3.5 ± 0.5 3.8 ± 1.0 4.1 ± 0.5 i 1.0 ± 0.2 j 
Adipocyte size 
(µm2*1000) 
 4.8 ± 0.4 6.1 ± 0.9 5.5 ± 1.1 k 2.1 ± 0.2 l 
Liver % 0.8 ± 0.1 1.0 ± 0.1 1.1 ± 0.1 1.2 ± 0.1 
Heart % 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 0.5 ± 0.1 
Pancreas % 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, n=8) whilst others were maintained 
in a less restricted environment, inducing a lean body weight (NSL, n=9). 
Comparison a versus b, p=0.025; c versus d, p=0.009; e versus f, p=0.003; 
g versus h, p<0.001; i versus j, p<0.001. Data is displayed as means ± 
SEM. 
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At 15 months of age, physical activity was similar between the groups 
maintained in an obesogenic environment but nearly three times higher in 
NSL offspring (Figure 3.11). 
 
Figure 3.11: Mean physical activity measured over a 24h period at 15 
months of age in all offspring.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, green, n=6) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7ÁSIRU162YHUVXV16/Data are means and 
error bars represent SEM. 
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Figure 3.12: Plasma glucose concentrations during a glucose tolerance test 
conducted in offspring at 16 months of age.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=6), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, green, n=6) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=8). Data are means and error bars represent SEM. 
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Plasma insulin differed during the GTT, with a higher insulin response in 
NAO as compared to RAO and a higher response in NSO as compared to 
NSL at 10 and 30 minutes after glucose injection (Figure 3.13). 
 
Figure 3.13: Plasma insulin concentrations during a glucose tolerance test 
conducted in offspring at 16 months of age.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, green, n=6) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=9).  
SIRU5$2YHUVXV1$2ÁSIRU162YHUVXV16/'DWDDUH
means and error bars represent SEM. 
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Over the course of the GTT, plasma glucose area under the curve (AUC) 
did not differ between groups, insulin AUC was higher in NAO as compared 
to RAO and the HOMA-IR was higher in NAO as compared to both RAO and 
NSO (Table 3.6).  
Table 3.6: Plasma concentrations of glucose and insulin in offspring at 16 
months of age over the course of the GTT. Glucose and insulin are 
expressed as the area under the curve over the course of the 120 min GTT 
and a HOMA-IR calculated by multiplication of fasted glucose and insulin 
concentrations.  
Plasma conc. RAO NAO NSO NSL 
Glucose AUC  
(mmol/L) 
1302 ± 36 1226 ± 60 1215 ± 78 1148 ± 46 
Insulin AUC  
(µg/L) 
53 ± 14 a 94 ± 14 b 67 ± 15 22 ± 5 
HOMA-IR 0.92 ± 0.08 c 1.17 ± 0.05 d 1.00 ± 0.06 e 0.99 ± 0.03 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, n=8) whilst others were maintained 
in a less restricted environment, inducing a lean body weight (NSL, n=9).  
Comparison a versus b, p=0.022; c versus d, p=0.001; d versus e, 
p=0.008. Data is displayed as means ± SEM. 
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3.3.4.1. Metabolome in adult offspring plasma 
In adult offspring plasma, 2124 ([m/z; rt]) features were found and the 
three intervention groups were clearly separated on the OSC-PLS-DA score 
plot (Figure 3.14). 
 
Figure 3.14: OSC-PLS-DA score plot to show overall differences between 
offspring plasma metabolome at 16 months of age.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NSO, green, 
n=7). After weaning, offspring were maintained in a restricted 
environment. There is no data available for NSL offspring.  
Validation parameters: R2X (cum)=0.771, R2Y (cum)=0.573, permutation 
test (n=100) with R2 intercept=0.285 and Q2 intercept=-0.272, ANOVA-p-
value=0.012. 
Of the 2124 compounds, 22 showed a difference (t-test with p<0.05) in 
concentration between RAO and NAO and 4 showed a difference between 
NAO and NSO. However, only 1 compound, citrulline, could be identified 
with authentic standards (Table 3.7), which had a higher concentration in 
NAO as compared to RAO. Valine had a trend to be higher in NAO as 
compared to RAO (p=0.065). 
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Table 3.7: List of metabolites which were significantly changed or had the 
trend to be altered (0.05<p<0.07) in offspring plasma at 16 months of 
age. A positive fold change indicates that the compound has a higher 
concentration in NA offspring compared to RA and NS compared to NA, 
whilst a negative change fold indicates a higher concentration in NAO 
compared to NSO.  
    NAO/RAO NSO/NAO 
Compound RT M 
[M+H]+  
observed 
FC p FC p 
Citrulline 2.26 175.0957 176.1029 1.79 0.034 1.14 0.6 
Valine 2.36 117.0798 118.0863 1.53 0.065 -1.02 0.9 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NSO, n=7). 
After weaning, offspring were maintained in a restricted environment. 
There is no data available for NSL offspring. RT, retention time; M, 
monoisotopic mass; [M+H]+, mass with one additional hydrogen atom; FC, 
fold change; p, p-value; all compounds were identified using authentic 
standards.  
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3.4. Discussion 
Maternal nutrient restriction in late gestation has acute effects on the 
maternal metabolic profile and maternal and fetal growth and has long 
term consequences for the RIIVSULQJV¶ glucose tolerance and insulin 
secretion, especially when it is followed by an accelerated growth rate in 
early postnatal life.  
3.4.1. Nutrient restriction induces a change in maternal metabolome 
The metabolic changes seen in mothers at 130 days gestation, 20 days 
into the intervention, are consistent with mild food restriction. During food 
withdrawal, energy is provided from muscle, liver and adipose tissue and 
proteolysis enables continuance of synthesis of essential proteins [424]. 
This catabolic state is mediated through a decrease in insulin and increase 
in plasma glucagon and glucocorticoid concentrations as plasma 
concentrations of nutrients are reduced [425, 426]. Amino acids are 
broken down from liver and muscle and used for ATP production and to 
synthesise essential proteins to keep up physiological functions [426, 427]. 
Triglycerides from adipose tissue are lysed to NEFA and glycerol, which are 
utilised in ß-oxidation and transformed to ketone bodies and glucose. 
Hepatic glycogen is transformed to glucose and released into the blood 
stream. As the brain is dependent on the availability of glucose and ketone 
bodies [428], these metabolic adaptations are crucial for survival. These 
changes are indeed seen in N mothers as concentrations of amino acids 
(leucine, proline, tryptophane, pyroglutamic acid, glycine and 
phenylalanine), fatty acids (total NEFA and isobutyric acid) and the 
mitochondrial fatty acid transporter carnitine are increased whilst glucose 
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concentrations are decreased. For technical reasons, plasma 
concentrations of ketone bodies were not assessed in the metabolome 
analysis but it is likely that they were also increased. A decrease in plasma 
insulin was not observed but this may be due to the relatively mild form of 
nutrient restrictions used, which does not induce metabolic changes as 
markedly as stronger, or more prolonged, reduction in food availability 
would be expected to do. 
N mothers did not undergo significant weight gain in late gestation during 
the intervention and offspring were smaller at birth. Since nutrients pass 
the barrier between maternal and fetal blood stream in the placenta, it can 
be assumed that their fetuses were also subjected to a decrease in plasma 
glucose and increase in NEFA and amino acids. Hormones, with exception 
of cortisol, do not pass from the mother to the fetus but are produced by 
the placenta and the fetus itself. The decrease in maternal plasma glucose 
could, therefore, cause a lower secretion of insulin in the fetus, induce 
gluconeogenesis [330, 332] or alter development of ß-cells [298, 323] as 
these changes have been described in other studies with decreased fetal 
glucose as an intervention to induce IUGR. These acute changes could, 
WKHUHIRUHKDYHORQJWHUPHIIHFWVRQWKHRIIVSULQJV¶JOXFRVHWROHUDQFH 
3.4.2. Offspring born to nutrient restricted mothers have a higher 
growth rate in early postnatal life but perinatal growth rates do not 
influence adult weight 
Early postnatal growth is influenced by food availability, which explains the 
difference in growth rates from birth through lactation between NA and NS 
offspring. As was aimed for with this intervention, growth rates in offspring 
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having to share maternal milk were not as high as in those offspring who 
were separated from their twin (i.e. were raised singly). 2IIVSULQJV¶ milk 
intake, although not measured in this study, can be assumed to be higher 
in NA offspring as compared to NS as they grew faster.  
The difference in fetal growth rates in late gestation also influenced early 
postnatal growth rate, as NA offspring show a higher fold change in body 
weight from birth through lactation as compared to the RA group. This 
suggests that the low fetal growth rate in the period of late pregnancy 
established potential for a faster postnatal growth, when permitted by food 
availability. However, adult obese N offspring did not become heavier than 
5RIIVSULQJLQGLFDWLQJWKDWWKH\³FDXJKWXS´LQERG\ZHLJKWEXWGLGQRW
overshoot the expected growth trajectory as represented by RAO offspring. 
After weaning when all offspring were maintained in the same, restricted 
environment, body weight was the same between groups within 3 months. 
From studies of the Dutch famine birth cohorts, it would not have been 
expected that maternal undernutrition in late pregnancy would lead to 
higher obesity rates or higher body mass index (BMI) in adult offspring as 
subjects affected by the famine in late pregnancy were lighter at 19 years 
of age as compared to unaffected individuals [235] and had normal rates 
of adiposity at 50 [233] and 58 years of life [229]. However, these 
individuals were not subject to an obesogenic environment and results 
cannot be directly related to my study. However, sheep studies inducing 
nutrient restriction in late pregnancy showed a normal adult weight in the 
offspring when raised in an obesogenic environment [429]. 
It would have been consistent with human studies [243, 250-253] if an 
accelerated early postnatal growth rate had been associated with a higher 
adult body weight, i.e. for NAO offspring to be heavier than NSO at 17 
months, but this was not the case. In my study, neither growth rate in late 
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pregnancy or in early postnatal life resulted in changes in body weight or 
body composition of the resulting adults, further suggesting that offspring 
were well adapted to these challenges.  
At a late pubertal age of 10 months, animals maintained in the unrestricted 
environment kept a steady lean body weight of about 50kg until tissues 
were sampled at 17 months whilst all animals in the restricted environment 
continued gaining weight until about 15 months of age and then 
maintained weights of 65-75kg, i.e. 1.3-1.5 fold the weight of lean 
animals. Even allowing for the fact that there is no precise definition of 
sheep obesity, this difference seems large enough to designate these 
DQLPDOVµREHVH¶,QH[LVWLQJOLWHUDWXUHVKHHSUanging from 1.2 [429, 430] 
up to 2 fold [431] the body weight of their lean control groups are 
FRQVLGHUHGµREHVH¶7KHµREHVLW\¶LQGXFHGLQWKLVVWXG\ZDVGHOLEHrately 
limited by restricting physical activity and not, in addition, feeding animals 
to excess. Since the design of this study aimed to measure the effects of 
perinatal interventions on adiposity and its related diseases and as I 
postulate that these effects would be rather small, a too severe method of 
inducing obesity might have overpowered the effects I primarily wanted to 
investigate. For example, if excess obesity led to substantial ectopic fat 
accumulation this may have induced insulin resistance in all groups and the 
mechanism underlying the IUGR-induced insulin resistance would have 
presented less clearly. 
Total fat masses, both as measured by DXA scan and as mass of dissected 
YLVFHUDOIDWWLVVXHVZHUHKLJKHULQµREHVH¶DQLPDOVDVFRPSDUHGWRµOHDQ¶
animals. However, relative fat and lean mass were very similar between all 
groups, independent of the environment in which they were maintained. 
5HODWLYHGLVVHFWHGYLVFHUDOIDWZDVVWLOOFRQVLGHUDEO\KLJKHULQµREHVH¶
groups than in NSL offspring. This is important as visceral adiposity is 
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thought to specifically increase risk of developing metabolic diseases in 
humans and makes up one of the components of the metabolic syndrome 
[40, 432].  
3.4.3.  Metabolites and glucose tolerance in post weaning offspring 
are influenced by maternal nutrient restriction 
At 3 months, none of the metabolites and hormones measured differed 
between groups but since the growth rates maintained before this 
measurement could all be considered as physiological, a difference in 
metabolites and hormones would not have been expected. This is also true 
for a majority of plasma measurements carried out at 7 months of age.  
During the GTT at 7 months of age, plasma glucose concentrations in NSL 
offspring were lower at most time points as was the overall area under the 
curve. Since body weights at 7 months of age of NSL offspring were not 
lower than those of NSO offspring, this is most likely an effect of the higher 
degree of physical activity in NSL offspring, due to the lower number of 
animals housed in a given area. Physical activity is, in humans, both used 
as a preventive [433] and as a therapeutic intervention [434] against 
insulin resistance.  
NAO offspring had the highest plasma insulin after glucose injection, and 
the AUC reached statistical significance compared to NSO offspring. 
Increased pancreatic excretion of insulin has been described as an early 
stage of developing impaired glucose tolerance [435], which 
characteristically has a slow onset before ß-cell function and insulin 
secretion decreases and postprandial and fasted plasma glucose 
concentrations increase in susceptible individuals [435].  
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As the 16 month old offspring body weight and body composition were not 
different between the obese groups, the difference seen during the GTT in 
insulin secretion between RAO and NAO animals is not due to differences in 
fat mass by itself. This is consistent with the findings from the Dutch 
famine follow-up studies. NSL offspring show a much lower insulin 
response, as they already had at 7 months of age, now due to both a 
higher physical activity and a lower body weight as compared to the obese 
offspring.  
Interestingly, in the obese adult sheep, both NEFA and TG were not 
significantly higher than in lean animals and differed only slightly between 
perinatal intervention groups with a higher TG concentration in RAO as 
compared to NAO animals. Higher circulating NEFA and TG concentrations 
are thought to be major factors linking obesity with insulin resistance in 
humans [231, 436]. In humans and rodents, visceral fat is associated with 
increased circulating lipid concentrations [437, 438], which can lead to 
higher hepatic and pancreatic TG content and a subsequent decrease in 
insulin sensitivity [59, 439, 440]. As NEFA and TG were not strikingly 
different between any groups irrespective of current body weight, it is 
unlikely that insulin resistance is mediated through ectopic fat 
accumulation. Indeed, in a human study, individuals born small for 
gestational age (SGA) had reduced insulin sensitivity in liver and muscle 
but this could not be attributed to increases in fat deposition in these 
organs [59, 334], supporting the conclusion that ectopic fat accumulation 
is not the mechanism mediating insulin resistance after late gestational 
IUGR. 
Not only is the insulin AUC in response to glucose highest in NAO and NSO 
but also the baseline measure, HOMA-IR, calculated from fasted plasma 
glucose and fasted insulin concentrations, is higher in NAO than in both 
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RAO and NSO, although fasted plasma glucose and insulin concentrations 
by themselves did not differ significantly. This suggests that NAO animals 
of this age show a dysfunction of the glucose regulatory system that is not 
only affected in the postprandial state but which also expands to a 
dysfunction during the fasted state [441]. The glucose tolerance of RAO 
offspring may, therefore, have further deteriorated compared to that at 7 
months of age. Keeping in mind that the animals are still at a young adult 
age at the time of the later GTT, this is a striking finding.  
Since in both the NAO and NSO animals neither the amount of white 
adipose tissue (WAT) nor the circulating lipid concentrations were altered, 
insulin sensitivity and/or insulin secretion must have been influenced in 
other ways. It is likely that the change in maternal plasma glucose 
concentrations accompanying nutrient restriction causes a long term 
change of glucose regulation. Both maternal hyperglycaemia and 
hypoglycaemia lead to disturbed offspring glucose tolerance but through 
different mechanistic pathways [442]. Since most of the mechanistic 
studies were conducted in rodents it is still unclear which mechanisms 
exactly lead to adult insulin resistance in, for example, humans and sheep. 
One of the mechanisms suggested in rodents is a permanent loss of 
pancreatic tissue. Unlike a study inducing hypoglycemia in late gestation 
through more severe nutrient restriction [325], the maternal nutrient 
restriction in this study did not lead to lower offspring pancreatic weight at 
dissection at 17 months of age. However, since we saw an increase of 
insulin secretion during the GTT, this does not suggest a dysfunction of 
insulin secretion but of peripheral glucose tolerance.  
Disturbance of peripheral glucose tolerance can result from both a 
permanent increase in gluconeogenesis and from a decrease in glucose 
uptake by skeletal muscle, adipose tissue and liver. Fetuses of 
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normoglycemic mothers do not induce hepatic gluconeogenesis [273], but 
since fetuses subjected to hypoglycemia have been shown to express key 
enzymes of gluconeogenesis [330-332], it is possible that this pathway is 
permanently altered in these animals. To assess this component of glucose 
tolerance, a hyperinsulinemic, euglycemic clamp test carried out in the 
adult animals would have been ideal. Even though HOMA-IR can be used 
as an approximation of the overall glucose tolerance, the analysis of a 
clamp study allows calculation of glucose production rates [41, 79].  
Both skeletal muscle and white adipose tissue of these animals have been 
examined but not specifically with regards to insulin resistance. With 
expanding WAT, monocytes are increasingly attracted to the tissue, 
forming crown-like structures and excreting inflammatory cytokines which, 
in turn, further decrease insulin sensitivity of muscle and WAT itself [41, 
443]. Distinguishing between hyperplastic and hypertrophic adipocytes and 
identifying the number of crown-like structures could indicate a cause of 
insulin resistance. In histological analysis, adipocyte size could not be 
shown to be different between obese groups and an analysis of crown-like 
structures is now being undertaken. Seeing that the circulating leptin 
concentrations were higher in RAO than in NAO despite similar body fat 
mass suggests that WAT of RAO animals has a different phenotype 
concerning endocrine secretion, which may be accompanied by, for 
example, a difference in inflammatory profile.  
Whilst I attempted to measure proinflammatory cytokines interleukin (IL)-
6 and tumour necrosis factor (TNF) in plasma samples, concentrations 
higher than the negative control were not detected, possibly due to the 
very short half-life of these cytokines [444, 445].  
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Changes in basal endocrine and immunological state could be indirectly 
represented in the metabolomic fingerprint measured in the adult obese 
offspring. Specifically RAO and NAO differ from each other, with 22 
compounds differing in quantity, showing that the maternal nutrient 
restriction had a more general effect than the early postnatal growth rate 
with only 4 compounds significantly differing between NAO and NSO. Due 
to technical limitations, only one of the 22 compounds could be identified, 
citrulline, whilst none of the 4 compounds affected by postnatal growth 
rate could be identified.  
Citrulline is an amino acid which is part of the urea cycle and also accrues 
from arginine and oxygen in biosynthesis of the signalling molecule 
nitrogen oxide (NO). Citrulline, secondary to arginine and NO, may be 
linked to diabetes [446, 447] but the amino acid concentrations in plasma 
of adult offspring would have to be investigated more closely to allow any 
conclusions with regards to this biological system. 
The overall difference in the metabolomic fingerprint, approximated by the 
number of compounds differing in quantity between groups, is similar in 
extent to the difference in overall metabolic changes, e.g. plasma leptin 
concentrations and change in glucose tolerance. In order to have a better 
basis of interpreting the changes in single metabolites, it is necessary to 
have a higher rate of positive identification, as is achieved by comparing 
plasma LC-MS results with results for pure standards. In the current 
analysis, only about 10% of metabolites could be identified and this does 
not allow me to draw extensive conclusions about mechanisms involved in 
these metabolic changes. 
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3.5. Conclusions 
As is consistent with other studies, nutrient restriction in late pregnancy 
leads to a decrease in maternal plasma glucose concentrations, a 
difference in birth weight and early postnatal growth rates of the offspring 
but not to a change in offspring adult body weight and composition. 
Nevertheless, glucose tolerance is decreased in these offspring, with an 
earlier onset in offspring subjected to an accelerated growth rate in early 
postnatal life as compared to offspring subjected to a standard growth 
rate. These changes may be mediated by long term adaptations in 
pancreas, liver, muscle and white adipose tissue to the hypoglycemia 
experienced in utero. Potential mechanisms are summarised in Figure 
3.15.  
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Figure 3.15: Insulin resistance develops in offspring after maternal 
nutrient restriction. Insulin secretion from the pancreas is increased, 
suggesting peripheral insulin resistance. This could be due to insufficient 
capacity to inhibit hepatic glucose production or due to reduced glucose 
uptake in muscle and white adipose tissue. Plasma leptin concentration is 
increased and this may indicate further changes in the endocrine secretion 
of white adipose tissue. 
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4. The influence of perinatal 
interventions on food intake 
and the appetite and cortisol 
regulatory systems in the 
hypothalamus 
4.1. Introduction and hypotheses 
This chapter further explores the study introduced in Chapter 3 with focus 
on the long term consequences of accelerated perinatal growth on the 
RIIVSULQJV¶DSSHWLWHUHJXODWLRQ7KHVWXGLHVDURXQGWKH'XWFKIDPLQHFRKRUW
introduced earlier did not find an effect of famine in late pregnancy on 
RIIVSULQJV¶DGXOWERG\ZHLJKWRUIRRGLQWDNHSUHIHUHQFHV[234]. In contrast, 
individuals who were born with low birth weight but gained weight quickly 
in the early postnatal period are more likely to be overweight and diabetic 
as adults [243, 244]. Therefore, it appears that rapid early neonatal 
growth, not birth weight alone, has long term consequences for body 
weight regulation. Growth restriction during fetal life can lead to further 
changes, which are independent of alteration of body weight. Animal 
studies with larger species, i.e. not rodent studies, have not extensively 
investigated this possible mechanism. To assess this, offspring food intake 
and postprandial dynamics of hormones and metabolites were measured 
and hypothalamic gene expression analysed after perinatal interventions 
including maternal macronutrient restriction in late gestation and 
accelerated early postnatal growth. 
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1) As I have already found that there were no differences in adult body 
weight and physical activity between groups, I hypothesised that 
food intake would not be changed significantly.  
2) The insulin resistance seen in the adult glucose tolerance test (GTT) 
of NAO offspring (offspring whose mothers were subjected to 
nutrient restriction in late pregnancy, followed by accelerated 
growth in early postnatal life and an obesogenic environment after 
weaning) was hypothesised to affect the hypothalamus, since 
peripheral and central insulin sensitivity are related [448]. Central 
insulin and leptin resistance may be mediated through an 
upregulation of suppressor of cytokine signalling 3 (SOCS3) and 
protein tyrosine phosphatase, non-receptor type 1 (PTP1B) and/or a 
down regulation of insulin receptor (IR) and leptin receptor (obRb).  
3) However, since plasma insulin and leptin concentrations were 
higher in NAO animals, these may compensate for insulin resistance 
and overall there may be an anorexigenic effect in the primary and 
secondary neurons of the arcuate nucleus (ARC), i.e. an 
upregulation of pro-opio melanocortin (POMC) and melanocortin 
receptors 3 and 4 (MC3R/MC4R) and/or a down regulation of 
neuropeptide Y (NPY).  
4) Lastly, since plasma cortisol concentrations were not significantly 
changed, I hypothesised that there would be no change in 
hypothalamic expression of genes involved in the regulation of 
cortisol secretion from the adrenal glands. 
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4.2. Methods 
The study design in this part of the study was as described in Chapter 2. In 
brief, 4 groups were created from combinations of the 3 intervention 
periods: mothers were fed to requirements (R) or nutrient restriction in 
late pregnancy (N), offspring were subjected to accelerated (A) or standard 
(S) early postnatal growth rate and, after weaning, offspring were 
maintained in either an environment designed to induce obesity(O) or one 
to maintain lean animals (L). Within these groups, comparisons were 
drawn between animals if their interventions differed in only one factor, 
i.e. RAO vs NAO, NAO vs NSO and NSO vs NSL, allowing separate 
assessments of the impacts of maternal nutrient restriction, early postnatal 
growth rate and adult obesity, respectively.  
At 16 months of age, offspring were separated into single housing and ad 
libitum intake of their standard feed, i.e. straw nuts and high-energy 
pellets for obese animals but only straw nuts for lean animals, was 
recorded over 10 days. The difference of feed used in this test was due to 
the difference in environment they were in as lean animals only had access 
to grass and a mineral stone after weaning. Adding high-energy pellets to 
their diet for this test would have misrepresented their normal food intake. 
However, due to this difference, food intake between lean and obese 
animals is not directly comparable.  
Additionally, after an overnight fast of 18h, ad libitum food intake was 
observed for 24h in short intervals of 0-2h, 2-4h, 4-8h and 8-24h after 
start of feeding (9 a.m.) and blood samples were taken at each of these 
time points. Feed was presented in the morning and remained available 
throughout the 24h period. This shorter feeding test was also confounded 
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by the use of different feeds for lean and obese animals as described 
above. Blood samples were analysed for concentrations of glucose, non-
esterified fatty acids (NEFA), insulin, leptin and cortisol. The blood sample 
taken at time point 0h is a fasted morning sample, before feeding starts, 
and the sample taken at 24h is a morning plasma sample taken in the fed 
state. The 10 day feeding test was performed to more closely represent 
WKHRIIVSULQJV¶QRUPDOIHHGLQJEHKDYLRXUDVLWZDVDYHUDJHGRYHUDORQJHU
time period.  
Finally, offspring were humanely euthanased and dissected at 17 months 
and expression of genes involved in hypothalamic appetite regulation, 
insulin and leptin resistance and cortisol regulation was assessed.  
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4.3. Results 
4.3.1. Feeding test  
At 16 months of age, food intake was measured over 10 days and 
averaged to food intake per day. Food intake of NSL offspring was 
statistically lower than NSO (Figure 4.1). 
 
Figure 4.1: Food intake adjusted for body weight in adult offspring 
averaged to intake per day from measurements over a 10 day period at 16 
months of age.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=9) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=8) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=9).  
* p<0.05. Data are means and error bars represent SEM. 
For the analysis of postprandial dynamics of plasma hormones and 
metabolites, food intake was measured over a 24h period after an 
overnight fast accompanied by blood sampling. In this 24h measurement, 
food intake was lower in NAO as compared to both RAO and NSO and 
lower in NSL than NSO (Figure 4.2). 
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Figure 4.2: Offspring total food intake at 16 months of age over 24h after 
an overnight fast, adjusted for body weight.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7).  
* p<0.05. Data are means and error bars represent SEM. 
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Most food intake occurred in the first 2h after feeding with a lower food 
intake in NSL compared to NSO and a slightly higher intake in NSO as 
compared to NAO at 4 to 8h after feeding (Table 4.1). 
Table 4.1: Offspring food intake at 16 months of age over the course of 
24h after an overnight fast and adjusted for body weight.  
Food intake  
(MJ/kg) 
RAO NAO NSO NSL 
0-2h 0.17 ± 0.01 0.16 ± 0.01 0.19 ± 0.02 a 0.10 ± 0.01 b 
2-4h 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.03 ± 0.01 
4-8h 0.08 ± 0.01 0.06 ± 0.01 c 0.09 ± 0.01 d 0.07 ± 0.01 
8-24h 0.10 ± 0.01 0.06 ± 0.01 0.08 ± 0.01 0.07 ± 0.01 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, n=7) whilst others were maintained 
in a less restricted environment, inducing a lean body weight (NSL, n=7).  
Comparisons a versus b, p=0.001; c versus d, p=0.044. Data are displayed 
as means ± SEM. 
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Fasting plasma leptin was higher in NAO as compared to NSO, as described 
in Chapter 3. NSL had reduced plasma leptin concentrations throughout 
the interventions and these were significantly lower than NSO at 24h 
(Figure 4.3). Both NAO and NSO leptin concentrations were higher at 24h 
(fed) than at baseline (fasted, p<0.05). 
Figure 4.3: Plasma leptin concentrations over the course of the feeding 
test after an overnight fast. Blood samples were taken over a 24h period 
just before and after feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7).  
SIRU1$2YHUVXV162ÁSIRU162YHUVXV16/'DWDDUH
means and error bars represent SEM. 
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When expressing leptin concentrations relative to the initial, fasted 
measurement to emphasise the postprandial dynamics, NAO had a fall in 
leptin concentrations at 2h and 4h after feeding as compared to NSO and 
RAO (Figure 4.4). 
Figure 4.4: Plasma leptin concentrations relative to fasted concentration 
over the course of the feeding test after an overnight fast. Blood samples 
were taken over a 24h period after feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7).  
* p<0.05 for RAO versus NAO; # p<0.IRU1$2YHUVXV162ÁSIRU
NSO versus NSL. Data are means and error bars represent SEM. 
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Plasma glucose concentrations were lower in NSL animals throughout and 
were significantly lower compared to NSO at 4h and 8h (Figure 4.5). 
  
Figure 4.5: Plasma glucose concentrations over the course of the feeding 
test after an overnight fast. Blood samples were taken over a 24h period 
after feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=7), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7).  
ÁSIRU162YHUVXV16/FRPSDULVRQ*OXFRVHFRQFHQWUDWLRQVGLGQRW
differ between 24h and baseline. Data are means and error bars represent 
SEM. 
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On considering postprandial dynamics relative to fasted concentrations, 
plasma glucose was higher in NAO as compared to RAO at 4h after feeding 
(Figure 4.6). 
Figure 4.6: Plasma glucose concentrations relative to fasted concentration 
over the course of the feeding test after an overnight fast. Blood samples 
were taken over a 24h period after feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=7) or born to 
mothers nutrient restricted in late gestation followed by accelerated early 
postnatal growth rate (NAO, red, n=8) or born to mothers nutrient 
restricted in late gestation followed by standard early postnatal growth 
rate (NS). After weaning, a subset of NS offspring were maintained in the 
same restricted environment as RA and NA (NSO, green, n=7) whilst 
others were maintained in a less restricted environment, inducing a lean 
body weight (NSL, yellow, n=7).  
* p<0.05 for RAO versus NAO comparison. Data are means and error bars 
represent SEM. 
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Similarly to the plasma glucose concentrations, NSL insulin concentrations 
were lower than in NSO, with significant differences at 0, 4, 8 and 24h. 
NSO insulin concentrations were higher at 24h (fed) than at baseline 
(fasted, p=0.023; Figure 4.7). Since the fasted concentrations of insulin 
between groups were very close together, insulin dynamics, in contrast to 
fasted concentrations, did not show any further differences (Figure 4.8).  
  
Figure 4.7: Plasma insulin concentrations over the course of the feeding 
test after an overnight fast. Blood samples were taken over a 24h period 
after feeding the animals. 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=5).  
ÁSIRU162YHUVXV16/'DWDDUHPHDQVDQGHUURUEDUVUHSUHVHQW
SEM. 
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Figure 4.8: Plasma insulin concentrations relative to fasted concentration 
over the course of the feeding test after an overnight fast. Blood samples 
were taken over a 24h period after feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=5).  
ÁSIRU162YHUVXV16/'DWDDUHPHDQVDQGHUURUEDUVUHSUHVHQW
SEM. 
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Plasma NEFA concentrations did not differ throughout the feeding test, 
both when expressed as absolute values (Figure 4.9) and when expressed 
relative to the baseline measurement (Figure 4.10). However, NEFA 
concentrations were higher at 0h before feeding (fasted) than at 24h (fed) 
in all groups (p<0.05).  
  
Figure 4.9: Plasma NEFA concentrations over the course of the feeding test 
after an overnight fast. Blood samples were taken over a 24h period after 
feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=7), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7). Data are means and error bars represent SEM. 
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Figure 4.10: Plasma NEFA concentrations relative to fasted concentration 
over the course of the feeding test after an overnight fast. Blood samples 
were taken over a 24h period after feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=7), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7). Data are means and error bars represent SEM. 
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Cortisol concentrations were higher in NAO than in RAO throughout the 
feeding test but were only significantly different at 4h (Figure 4.11). The 
area under the curve was higher in NAO than in RAO, with RAO, 46 ± 42 
nmol/L over 24h; NAO, 347 ± 181 nmol/L over 24h; NSO, 112 ± 37; NSL, 
73 ± 22 nmol/L over 24h; RAO versus NAO, p=0.046. 
Figure 4.11: Plasma cortisol concentrations over the course of the feeding 
test after an overnight fast. Blood samples were taken over a 24h period 
after feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7).  
* p<0.05 for RAO versus NAO. Data are means and error bars represent 
SEM. 
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When expressing plasma cortisol concentrations relative to the baseline 
value the difference in cortisol dynamic was diminished (Figure 4.12). 
Figure 4.12: Plasma cortisol concentrations relative to fasted 
concentration over the course of the feeding test after an overnight fast. 
Blood samples were taken over a 24h period after feeding the animals.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=8), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=7). Data are means and error bars represent SEM. 
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4.3.2. Hypothalamic gene expression 
As described in Chapter 2, the expression of genes of interest was 
normalised with expression of housekeeping genes. The expression of 18S 
was stable within and between groups and was used as the housekeeping 
gene for normalisation throughout. Other housekeeping genes considered 
were YWHAZ and RPO, which also showed a very low variation (Table 4.2) 
but were expressed at a lower concentration (higher Ct). 
Table 4.2: Cycle threshold of housekeeping genes used. Expression of 18S 
was measured in all 3 dilutions of complementary DNA used for gene 
expression analysis. YWHAZ and RPO were only measured once. 
Measurements of 18S were correlated between dilutions: a versus b, 
R2=0.55; b versus c, R2=0.46; a versus c, R2=0.44.  
Ct RAO NAO NSO NSL 
18S (1st dil.)
 a
 13.4 ± 0.1 13.6 ± 0.2 13.3 ± 0.1 13.4 ± 0.1 
18S (2nd dil.)
 b
 11.8 ± 0.2 12.0 ± 0.2 11.8 ± 0.1 11.7 ± 0.2 
18S (3rd dil.)
 c
 11.1 ± 0.3 11.6 ± 0.1 11.3 ± 0.1 11.4 ± 0.2 
YWHAZ 18.2 ± 0.1 17.6 ± 0.2 17.8 ± 0.2 18.1 ± 0.2 
RPO 18.9 ± 0.2 18.9 ± 0.1 18.9 ± 0.2 19.2 ± 0.2 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, n=5), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RAO and NAO (NSO, n=7) whilst others were maintained 
in a less restricted environment, inducing a lean body weight (NSL, n=8). 
Data is displayed as means ± SEM.  
18S, ribosomal 18S; YWHAZ, Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein; RPO, RNA polymerase I polypeptide A. 
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4.3.2.1. Hypothalamic insulin and leptin sensitivity 
The gene expression of PTP1B was higher in NSO offspring as compared to 
NSL (Figure 4.13 A) but expression of IR, obR and SOCS3 were not 
changed between groups (Figure 4.13 B-D). 
   
 
Figure 4.13: Gene expression of hypothalamic genes normalised for 18S, 
displayed in arbitrary units.  
A) PTP1B, protein tyrosine phosphatase, non-receptor type 1; B) IR, 
insulin receptor; C) obR, leptin receptor; D) SOCS3, suppressor of cytokine 
signalling 3. 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=5), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=8).  
* p<0.05. Data are means and error bars represent SEM. 
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4.3.2.2. Hypothalamic appetite regulation 
Gene expression of both the orexigenic NPY and the anorexigenic MC3R 
were higher in NSL as compared to NSO. The abundance of messenger 
ribonucleic acid (mRNA) of both receptors of adiponectin were lower in NSL 
as compared to NSO and higher in NAO as compared to RAO (Figure 4.14 
A, B, D, E). The expression of growth hormone stimulating receptor 
(GhSR), agouti-related peptide (AgRP) and MC4R were not altered between 
groups (Figure 4.14 C, F, G). 
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Figure 4.14: Gene expression of hypothalamic genes normalised for 18S, 
displayed in arbitrary units.  
A) NPY, neuropeptide Y; B) MC3R, melanocortin 3 receptor; C) MC4R, 
melanocortin 4 receptor; D) ADIPOR1, adiponectin receptor 1; E) 
ADIPOR2, adiponectin receptor 2; F) AgRP, agouti-related protein; G) 
GhSR, growth hormone stimulating receptor (ghrelin receptor).  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=5), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=8).  
* p<0.05. Data are means and error bars represent SEM. 
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higher in NSO as compared to NSL (Figure 4.15 A-C). Expression of the 
brain-derived neurotrophic factor (BDNF) gene was not altered (Figure 
4.15 D). 
  
 
Figure 4.15: Gene expression of hypothalamic genes normalised for 18S, 
displayed in arbitrary units.  
A) mTOR, mammalian target of rapamycin; B) AMPK, adenosine mono 
phosphate-activated kinase; C) FTO, fat mass and obesity associated gene; 
D) BDNF, brain-derived neurotrophic factor. 
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=5), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=8).  
* p<0.05. Data are means and error bars represent SEM. 
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4.3.2.4. Hypothalamic control of the cortisol system 
Expression of GCR was higher in NSO than in NSL and expression of 
corticotropin releasing hormone (CRH) and arginine vasopressin (AVP) 
higher in NAO as compared to RAO (Figure 4.16).  
  
 
Figure 4.16: Gene expression of hypothalamic genes normalised for 18S, 
displayed in arbitrary units.  
A) GCR, glucocorticoid receptor; B) CRH, corticotropin releasing hormone; 
C) AVP, arginine vasopressin.  
Offspring were either born to mothers fed to requirements followed by 
accelerated early postnatal growth rate (RAO, blue, n=5), born to mothers 
nutrient restricted in late gestation followed by accelerated early postnatal 
growth rate (NAO, red, n=8) or born to mothers nutrient restricted in late 
gestation followed by standard early postnatal growth rate (NS). After 
weaning, a subset of NS offspring were maintained in the same restricted 
environment as RA and NA (NSO, green, n=7) whilst others were 
maintained in a less restricted environment, inducing a lean body weight 
(NSL, yellow, n=8).  
* p<0.05. Data are means and error bars represent SEM. 
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4.4. Discussion 
In adult offspring, maternal nutrient restriction, but not early postnatal 
growth rate, was accompanied with changes in gene expression which are 
consistent with a lack of clear upregulation of an anorexigenic response 
and insulin resistance. However, observed food intake did not differ after 
either intervention when it was averaged from a 10 day long observation of 
food intake. In a separate measurement of food intake over 24h following 
an overnight fast, food intake was lower in NAO as compared to RAO and 
NSO, plasma glucose, leptin and cortisol were higher. Both food intake and 
plasma metabolites during the 24h period show the most marked 
differences between lean and obese animals. 
The food intake as measured and averaged over 10 days is likely the more 
representative overall determination of food intake, which means that, at 
17 months of age, all animals maintained in the obesogenic environment 
had the same body weight, fat mass and food intake, regardless of their 
perinatal intervention. Dietary habits of the adult offspring have also been 
shown to be unaffected by famine during their late fetal development [234, 
449], which is consistent with the absence of an effect on adult body 
weight [229, 233]. Part of the difference between the 24h and the 10 day 
measurements of food intake may be explained by the fact that for the 
single 24h measurement all animals were subjected to an overnight fast 
before the food intake test and blood sampling. Plasma leptin, insulin and 
NEFA concentrations differed significantly between baseline and 24h, both 
measurements representing morning samples in fasted and fed state, 
respectively. This indicates that endocrine and metabolic status and, 
possibly, food intake behaviour are changed by the overnight fast. 
However, NAO offspring did not show a markedly different pattern from the 
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other groups in their metabolic response to an overnight fast which could 
have explained the lower food intake observed after overnight fasting in 
this group. As it is, there is little evidence for the difference in food intake 
to be much more than by chance. 
In addition, as animals were euthanased in the fasted state, the gene 
expression observed in the hypothalamus is representative of the fasted 
state at the beginning of the single 24h food intake measurement.  
4.4.1. Maternal nutrient restriction followed by obesity changes the 
hypothalamic appetite regulation of adult offspring and their central 
insulin and leptin sensitivity in the fasted state 
Whilst the plasma leptin concentration was higher in NAO in the fasted 
state, which would induce an anorexigenic response, genes displaying a 
higher expression in NAO as compared to RAO have been characterised 
both as anorexigenic, i.e. mTOR [203], and orexigenic, AMPK [191], but 
the effects of adiponectin receptors [22] and FTO on food intake are not 
entirely clear. A lack of clear anorexigenic response to increased plasma 
leptin concentrations may be at least partially explained by central leptin 
resistance, i.e. a combination of a decrease of leptin transport across the 
blood brain barrier and a decrease in signalling following the binding of 
leptin to its receptor [450].  
Maternal nutrient restriction in late pregnancy did not lead to a direct 
difference in hypothalamic gene expression involved in insulin and leptin 
resistance as both receptors, IR and obRb, were not changed in expression 
and whilst there was a trend to higher expression of direct inhibitors PTP1B 
and SOCS3 in NAO as compared to RAO (>1.4-fold, p=0.051 for PTP1B), 
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this did not reach statistical significance. NSL hypothalami did not show a 
change in gene expression of IR, obRb and SOCS3 but PTP1B was reduced, 
suggesting a higher hypothalamic insulin and leptin sensitivity in NSL as 
compared to NSO.  
The primary neurotransmitters involved in hypothalamic appetite 
regulation are NPY, AgRP and ɲ-melanocyte stimulating hormone (ɲ-MSH), 
which binds to receptors MC3R and MC4R. Whilst I could not measure gene 
expression of POMC, the gene coding for ɲ-MSH, due to circumstances and 
time restrictions, none of the other genes were differentially regulated 
between obese groups. However, NSL animals had substantially higher 
expression of NPY and MC3R as compared to NSO. Since NPY and MC3R 
stimulation have opposing effects with regards to appetite regulation, a 
direct effect to increase or decrease of food intake could not be 
extrapolated from these findings.  
Although food intake of NSO and NSL animals cannot be compared with 
regards to physiological changes in appetite regulation because the feed 
given differed significantly, it does give further insight into the causes of 
the lower body weight shown by the lean group, i.e. both the higher 
physical activity and a lower food intake relative to body weight 
contributed to this difference. This difference in food intake was not 
intended to be part of the interventional design as feed, i.e. grass, was 
present ad libitum. The higher food intake in obese animals may, 
therefore, be representative of the higher palatability of the high-energy 
pellets and/or the assumed (relative) central insulin and leptin resistance.  
The associated lack of responses in plasma leptin, insulin and glucose in 
these lean animals as compared to obese animals are consistent with 
170 
 
common observations of postprandial metabolic differences between 
obese, insulin-resistant and lean, insulin-sensitive individuals [451-453].  
Expression of genes downstream of insulin was potentially altered as 
hypothalamic AMPK, which is inhibited by insulin and leptin [454, 455], 
was higher in the NAO group than in RAO. AMPK is activated by 
phosphorylation in the insulin signalling cascade, so an increase in gene 
expression does not allow any conclusions on protein activity, especially 
since there is, to my knowledge, no clear data available on the regulation 
of AMPK gene expression or of the association of AMPK expression and 
activity. I, therefore, commenced an analysis of AMPK protein abundance 
in both its phosphorylated form and of total AMPK hypothalamic protein by 
Western Blotting but this was unsuccessful due to technical and time 
limitations. Whilst the higher gene expression of AMPK in the NAO group 
does not allow any direct conclusions on insulin and leptin action in these 
hypothalami, it is striking that the AMPK expression in the NSL animal was 
altered in the opposite direction, i.e. there was a lower expression in NSL 
as compared to NSO animals. Therefore, although what influences AMPK 
expression is unknown, it is tempting to see a relationship with the 
DQLPDOV¶RYHUDOOLQVXOLQVHQVLWLYLW\,QWKHK\SRWKDODPXV[456] and other 
tissues [193, 457], AMPK has been reported as an inhibitor of mTOR, so it 
is curious to see here that AMPK and mTOR expression display similar 
patterns between groups. It would, therefore, be of interest to investigate 
this further at the level of protein activation. 
Another hormone thought to activate AMPK by phosphorylation is 
adiponectin. Receptors for adiponectin are expressed on the primary 
neurons of the ARC [458]. Plasma adiponectin concentrations are 
negatively associated with body weight [91] and their association with food 
intake is not entirely resolved, with studies indicating both an increase and 
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a decrease of food intake with administration of adiponectin [22, 94]. 
3ODVPDDGLSRQHFWLQZRXOGEHH[SHFWHGWREHUHGXFHGLQµREHVH¶DQLPDOV
but as a result of its multiple active isoforms it is very challenging to 
measure and, therefore, we have no information on RIIVSULQJV¶ adiponectin 
concentrations. Since expression of adiponectin receptors 1 and 2 
(ADIPOR1/2) was lower in lean offspring, i.e. in animals with potentially 
higher plasma adiponectin concentrations, it is feasible that these 
receptors are more highly expressed in obese animals to compensate for 
lower plasma adiponectin concentrations. However, direct conclusions 
cannot be drawn without the information on plasma adiponectin 
concentrations.  
PTP1B is thought to be one of the main mechanisms mediating insulin and 
leptin resistance as it dephosphorylates the activated form of the insulin 
receptor [459] and dephosphorylates JAK2 in the leptin signalling pathway 
[460], hence attenuating the signal despite insulin or leptin binding to their 
receptors. PTP1B is thought to be upregulated both in peripheral organs 
and in the hypothalamus by inflammatory mechanisms including tumour 
necrosis factor (TNF) [461] but higher PTP1B protein levels have also been 
observed in muscle and white adipose tissue (WAT) of obese or diabetic 
subjects [462], decreasing with weight loss [463]. To my knowledge, 
PTP1B expression has not previously been explored in studies with 
manipulation of the fetal environment, but it is a likely candidate for 
mediating at least the central part of proposed insulin and leptin resistance 
in this study, following nutrient restriction in late pregnancy and 
accelerated early postnatal growth.  
Whilst it has been clearly established in humans that a polymorphism in 
the FTO gene is associated with obesity [464] and a knockout model 
results in a lean phenotype [465], the relationship of mRNA expression in 
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adipose tissue and obesity in individuals not carrying that polymorphism is 
less clear and has been reported as both a positive and a negative 
relationship [466, 467]. In rodents, general overexpression of FTO 
including the hypothalamus as a result of polymorphisms has been 
associated with hyperphagia, high body weight and fat mass [468]. Long 
term nutrient restriction leads to a decrease in hypothalamic, but not 
adipose tissue, FTO expression suggesting that FTO gene expression is 
inhibited downstream of the leptin-induced signal transducer and activator 
of transcription 3 (STAT3) pathway [469]. Acute fasting, however, does 
not change hypothalamic FTO expression [470]. The higher expression of 
FTO in NAO offspring may, therefore, be indicative of a more orexigenic 
regulation, possibly secondary to hypothalamic leptin resistance. 
The changes we can see after maternal nutrient restriction in late 
pregnancy are consistent with the reported timing of hypothalamic 
maturation with regards to the appetite regulating system. Both in humans 
and in sheep, appetite-related neuropeptides are expressed from mid-
gestation i.e. from 21 weeks in humans [275] and 81d in sheep [276, 
277], after which the number of neurons expressing these peptides 
increases, the hypothalamus differentiates further morphologically and, at 
least in the non-human primate, projections are formed in late pregnancy 
[80]. Therefore, it would seem likely that characteristics of the appetite-
regulatory parts of the hypothalamus can be influenced with long term 
consequences during this period of plasticity in mid- to late gestation. 
Besides rodent models, there are few studies which investigate the effect 
of maternal nutrient restriction during pregnancy on the young or adult 
offspring. In a previous study from our group, when applying nutrient 
restriction in sheep in mid pregnancy, offspring at one year of age had a 
lower food intake but the gene expression of main ARC neuropeptides were 
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not altered [471]. Nutrient restriction of sheep in late pregnancy did not 
lead to changes in body weight, body composition or food intake but 
markers of appetite regulation were not assessed [429]. On the other 
hand, overnourishing sheep in late pregnancy leads to a change in initial 
QHRQDWDOLQWDNHRIPRWKHU¶VPLONDQGH[SUHVVLRQRIK\SRWKDODPLF
neuropeptides but these offspring were not maintained until adulthood 
[343].  
Since food intake regulation in the brain is very complex and involves 
homeostatic circuits including the ARC and hedonic influences, both of 
which are not yet fully understood, it would be very challenging to conduct 
a study that would give a clear picture of changes in the appetite-
regulatory system. Food intake can be regulated very finely within this 
complex system, so that changes in one part of the system, i.e. 
hypothalamic gene expression in NAO offspring, might be compensated for 
in other parts of the system and hence not lead to an overt change in 
phenotype. Adult NAO offspring had both higher plasma leptin and insulin 
concentrations and, as Sebert et al. reported in our sheep study, a higher 
expression of ghrelin in the abomasum, potentially increasing both 
anorexigenic and orexigenic peripheral signalling, respectively [472]. 
Therefore, the changes in hypothalamic gene expression might result from 
these changes in offspring endocrine and metabolomic phenotype rather 
via long term programming of the hypothalamus directly. However, the 
majority of the peripheral signalling compounds that were increased in 
NAO as compared to RAO animals, i.e. leptin, insulin and glucose would 
result in anorexigenic signalling, not the partially orexigenic response 
observed. It is reasonable to assume that anorexigenic response to insulin 
and leptin may be blunted in these animals if the trend to increase in 
PTP1B reached biological significance but glucose would still have a similar 
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effect. Because plasma ghrelin concentrations are very difficult to 
determine in ruminants [473], the concentration of mRNA measured in the 
abomasum is the only indication that NAO offspring may express 
peripheral orexigenic signals.  
Finally, whilst other research suggests that accelerated early postnatal 
growth may be positively associated with adult overweight in humans 
[243], this was not demonstrated in this study, as NAO and NSO offspring 
had very similar body weight, composition, appetite regulatory gene 
expression and only differed in peripheral insulin sensitivity and plasma 
leptin concentrations.  
4.4.2. Maternal nutrient restriction and early postnatal growth rate 
influence the postprandial dynamics of plasma leptin and glucose 
As most food intake occurs during the first 2 hours after the overnight fast, 
the main postprandial response would be expected between 2 and 4 hours 
after feeding. Leptin shows a different dynamic relative to its higher fasted 
baseline measurement in NAO as compared with RAO and NSO animals, 
i.e. a drop in leptin concentrations at 2 and 4 hours after feeding. A similar 
drop in postprandial leptin was observed when comparing obese, non-
diabetic men with lean men [452]. At the same time, plasma glucose 
concentrations have a stronger postprandial peak at 4 hours after feeding 
in NAO as compared to RAO groups, again pointing to a reduced glucose 
tolerance in these animals.  
This alteration in postprandial endocrine and metabolic dynamics is part of 
the phenotype for which offspring of mothers who were nutrient restricted 
in late pregnancy appear to be programmed. That is, despite having the 
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same body weight and body composition as the other obese offspring, the 
obesity developed by NAO offspring has metabolic effects that are more 
adverse than can be seen in both RAO and NSO animals with respects to 
leptin signalling and peripheral insulin sensitivity.  
4.4.3. Maternal nutrient restriction affects cortisol-related gene 
expression in adult offspring 
Plasma cortisol concentrations were not significantly altered between 
groups in any of the fasted measurements in mothers or offspring (see 
Chapter 3) but was higher in a postprandial measurement during the food 
intake test in NAO as compared to RAO groups. Since ovine plasma cortisol 
follows a diurnal rhythm of about 10 peaks per day, starting with a peak 
about 60 minutes after initial feeding [474], the sampling frequency of our 
study was too low to distinguish between those peaks or to cover a clear 
postprandial response. Therefore, the reported plasma cortisol 
concentrations can only give a general overview of the cortisol system. 
Since crucial parts of cortisol regulation take place in the hypothalamus, I 
measured gene expression of some key genes and they showed significant 
differences. The expression of the glucocorticoid receptor (GCR) and, with 
that, probably the sensitivity of the hypothalamus to negative feedback 
with regards to AVP and CRH expression and secretion showed a trend to 
higher values (>1.4 fold, p=0.064) in NAO as compared to RAO without 
reaching statistical significance and was significantly lower in NSL as 
compared to NSO animals. Regardless of this assumed higher sensitivity to 
the negative feedback in NAO, expression of AVP and CRH were 
significantly higher in NAO as compared to RAO animals whilst neither 
were changed in NSL as compared to NSO groups. From the expression of 
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AVP and CRH alone, one would expect a higher ACTH secretion from the 
pituitary and, subsequently, higher cortisol secretion from the adrenal 
gland but this was not demonstrated in these animals. Therefore, despite a 
lack of clear phenotypic consequence, there are changes on the regulatory 
level after maternal nutrient restriction, which are not further influenced by 
early postnatal growth of the offspring. Whether this also occurs at the 
protein level of these genes should be confirmed and, if so, downstream 
consequences these changes have without increasing plasma cortisol 
should be explored.  
Whilst periconceptional nutrient restriction causes an earlier fetal increase 
in prepartum cortisol, earlier delivery [475] and changes in related 
hypothalamic gene regulation in the fetus at late gestation [476], little is 
known on long term programming of the HPA axis by late gestational 
nutrient restriction. It was reported that human intra-uterine growth 
restricted (IUGR) fetuses have higher plasma cortisol concentrations than 
normal weight fetuses [326, 477]. However, in a study of a similar 
maternal nutrient restriction of 50% from day 118 of gestation in sheep 
conducted by Burrage et al., there was no significant effect on fetal plasma 
cortisol, ACTH and glucose at 140 days gestation [294]. In both our and 
BurrDJH¶VVWXGLHVFRUWLVROFRQFHQWUDWLRQVDWWKHGLIIHUHQWDJHSRLQWVDQG
both in mothers and in offspring were consistently higher after maternal 
nutrient restriction but this did not reach statistical significance. It is 
possible that the mechanism in sheep is similar to the one in human IUGR 
but is less pronounced, so that the sample numbers in these animal 
studies are not sufficient to show a clear effect. Similarly, at 16 months of 
age, cortisol measurements in NSL offspring were consistently lower 
compared with NSO animals without reaching statistical significance. In 
humans, fasted plasma cortisol concentrations are not correlated with body 
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mass index (BMI) but some regulatory parts of the cortisol system may be 
altered in obese subjects as gene expression and protein activity of 11ß-
hydroxysteroid dehydrogenase type 1, the enzyme converting inactive 
cortisone to active cortisol, is increased in adipose tissue of obese 
individuals [478, 479]. Similarly, in sheep, obesity does not influence 
cortisol or other stress signalling molecules unless there was a stressor 
added, which induced a stronger response [480] whilst our data might 
suggest a trend to higher plasma cortisol concentration in obesity. This is 
of importance as glucocorticoids positively regulate hypothalamic 
expression of the anorexigenic neurotransmitter POMC [481] and may, 
therefore, change the perception of appetite.  
Since CRH and GCR have been shown to be susceptible to long term 
regulation of gene expression during the periconceptional period, which 
may be an effect of epigenetic programming [476, 482], it would be of 
interest to investigate the hypothalamic samples of this study with regards 
to histone acetylation and DNA methylation of these genes to see if a 
similar effect can be reached in late pregnancy. Secondarily, it would be 
interesting to measure POMC gene expression to see if it would be 
correlated to cortisol concentration or GCR expression.  
To my knowledge, alteration of hypothalamic GCR expression has, to date, 
only been observed in offspring subjected to maternal nutrient restriction 
during the periconceptional phase [476]. Although it has been reported 
that maternal nutrient restriction in early to mid pregnancy in sheep has 
an effect on RIIVSULQJV¶ pituitary and adrenal responses, this study did not 
further investigate the hypothalamic component of cortisol regulation 
[483]. So even though NAO offspring are phenotypically unremarkable as 
their plasma cortisol concentrations are similar to that of RAO, changes in 
hypothalamic gene expression can be observed in adult offspring that 
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might be adaptive to the intervention in late gestation. The change in 
offspring hypothalamic GCR, CRH and AVP expression is unlikely to be 
caused by changes in maternal (and fetal) cortisol concentrations since 
these were subtle. Edwards et al. showed a relationship of very low 
maternal plasma glucose concentrations with fetal HPA axis 
responsiveness, associated with maternal nutrient restriction in late 
pregnancy [484]. However, this difference only manifested in acute 
hypoglycaemia and alteration of plasma ACTH or cortisol during the chronic 
hypoglycemia caused by the nutrient restriction was not observed. This 
suggests that chronic hypoglycemia causes changes in the regulatory 
mechanisms which do not show in the plasma phenotype and that 
measuring plasma cortisol concentrations is not sufficient to detect all 
changes in this system.  
It would, therefore, be necessary to assess whether maternal nutrient 
restriction in late pregnancy consistently leads to the changes in gene 
expression we observed and whether these changes would lead to 
phenotypical differences in a stress situation in the adult offspring.  
Especially AVP expression would be of interest for further research because 
of its implication with hypertension [485]. AVP binds to 2 receptors, V1R, 
which increases systemic vascular resistance, and V2R in the kidneys, 
which increases blood volume, so that AVP leads to increased arterial 
pressure [486]. If the increased gene expression in NAO offspring 
translates to a higher hypothalamic and pituitary AVP protein expression 
and higher plasma AVP then this may be seen as a higher blood pressure 
in these animals. Although blood pressure was measured in the adult 
offspring in our study, these measurements were deemed unreliable as the 
animals were anaesthetised at the time. In the human studies following 
the Dutch famine cohort, an earlier onset of coronary heart disease was 
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seen in offspring of mothers affected by the famine in early pregnancy but 
no difference was seen for offspring of mothers affected in late pregnancy 
as compared to individuals unaffected by the famine [487-489]. However, 
independently of the time of famine, the individuals who developed 
coronary heart disease tended to have lower birth weight [487], but 
neither effect was accompanied by a significant change in blood pressure. 
The association of cardiovascular disease, as well as higher blood pressure, 
with low birth weight was also seen in the studies presented by Barker et 
al. [223]. This combination of the timing of famine and birth weight is 
surprising since offspring of mothers affected in late pregnancy are far 
more likely to be growth restricted and thus small at birth than offspring 
affected in early pregnancy. It has been postulated that the rapid postnatal 
growth associated with small babies is the crucial factor leading to later 
coronary heart disease [487]. Since NAO offspring were both small at birth 
and then experienced accelerated early postnatal growth they do fit the 
risk pattern of cardiovascular morbidity.  
4.4.4. General strengths and limitations of this study 
Even though the comparisons available to me in this study, i.e. RAO vs 
NAO, NAO vs NSO and NSO vs NSL, are sufficient to differentiate the 
effects of the interventions applied at each developmental period, it would 
have been desirable to include additional groups. Since maternal nutrient 
restriction in late pregnancy appears to be the most prominent influence 
on later metabolic health of the offspring, additional groups, e.g. RSO (no 
maternal intervention, standard early postnatal growth rate followed by 
obesity, to compare with NSO) and RSL (no maternal intervention, 
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standard early postnatal growth rate followed by a lean body weight, to 
compare with NSL).  
Secondly, for a better comparability between obese and lean offspring it 
should be considered whether lean animals could be fed the highly energy-
dense pellets as well as grass. This would enable better interpretation of 
feeding test and of all postprandial metabolites and hormones as described 
in this chapter. Presumably, the difference in body weight between obese 
and lean offspring would be less pronounced if the only difference in 
treatment is indeed the higher physical activity in lean animals. I would 
hypothesise that other changes between NSO and NSL would persist since 
activity is of very high importance in the regulation of insulin sensitivity 
and, possibly, leptin sensitivity. 
4.5. Conclusions 
Maternal nutrient restriction, but not additional accelerated early postnatal 
growth, leads to changes in adult offspring hypothalamic gene expression 
that are consistent with decreased insulin and leptin sensitivity (Figure 
4.17, Figure 4.18) and modification of the cortisol system. The opposite 
effects were seen if NS offspring were not subjected to obesity in 
adulthood and maintained lean. However, these changes were not 
associated with higher food intake or body weight, likely due to the highly 
complex nature of appetite regulatory circuits. Changes in gene expression 
can be partially explained by insulin and leptin resistance whilst expression 
of other genes may be under long term regulation by perinatal changes in 
epigenetic markers. Genes known to be susceptible to epigenetic 
regulation in rodents include POMC [490], BDNF [308], CRH [482], GCR 
[317, 491] and AVP [492], which would be of interest to examine more 
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closely with regards to DNA methylation and histone acetylation in this 
study to see if it matches the gene expression patterns observed. Besides 
the metabolic changes in NAO offspring discussed in Chapter 3, i.e. 
increased insulin resistance and plasma leptin concentrations, these 
animals also showed changes in postprandial dynamics of plasma leptin 
and glucose. Alteration of hypothalamic cortisol regulation was observed 
but plasma cortisol itself was unaffected. Overall, NAO animals display 
changes which are consistent with stronger adverse consequences of 
obesity, despite not being more obese in adulthood than RAO offspring. 
Figures 4.17 and 4.18 sum up the changes in NAO as compared to RAO 
offspring in hypothalamic appetite regulation both on an inter- and intra-
cellular level. 
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Figure 4.17: Overview of changes in plasma hormones and metabolites 
and hypothalamic gene expression in NAO offspring as compared to RAO 
offspring at 17 months of age. Plasma leptin, insulin and glucose were all 
shown to be higher at fasting, during the GTT or in the 24h metabolite 
measurements. Nevertheless, appetite regulatory proteins NPY, AgRP and 
BDNF were not changed in gene expression. 
Nuclei are: arcuate nucleus (ARC), ventromedial nucleus (VMN), lateral 
hypothalamus (LHA), dorsomedial nucleus (DMN), paraventricular nucleus 
(PVN).  
NPY, neuropeptide Y; AgRP, agouti-related peptide; POMC, pro-opio 
melanocortin; CART, cocaine and amphetamine related transcript; OT, 
oxytocin; CRH, corticotropin releasing hormone; BDNF, brain-derived 
neurotrophic factor; PP, pancreatic polypeptide; MCH, melanin 
concentrating hormone; ACTH, adrenocorticotropic hormone; TRH, thyroid 
releasing hormone; TSH, thyroid stimulating hormone; 5HT, serotonin; 
SNS, sympathetic nervous system. Adapted from figures in Chapter 1 and 
[95-99]. 
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Figure 4.18: Overview of changes in hypothalamic gene expression with 
focus on intracellular signalling in NAO offspring as compared to RAO at 17 
months of age. 
Plasma insulin and leptin concentrations were higher in fasted state or 
after the GTT. Signalling of insulin and leptin receptors were potentially 
LQKLELWHGE\KLJKHUH[SUHVVLRQRI62&6DQG373%DOWKRXJKWKLVGLGQ¶W
reach significance. FTO, which is thought to be inhibited in expression by 
leptin through STAT3, was increased. Primary orexigenic 
neurotransmitters NPY and AgRP are not changed in gene expression. 
Whilst AMPK and mTOR are increased in gene expression it is not clear 
what this means on a protein activity level. Overall food intake is not 
changed in these animals. 
Adenosin monophosphate-activated protein kinase; BSX, brain-specific 
homeobox transcription factor; CPT1, carnitine palmitoyl-transferase 1; 
FAS, fatty acid synthase; FOXO1, forkhead box O1; GHSR, growth-hormone 
secretagogue receptor; IR, insulin receptor; IRS, insulin receptor 
substrate; JAK, janus kinase; MAPK, MCOA, malonyl-CoA; MTOR, 
mammalian targeWRIUDSDP\FLQ1)ǉ%QXFOHDUIDFWRUǉ%13<
neuropeptide Y; OBR, leptin receptor; PDK1, pyruvate dehydrogenase 
kinase 1; PGC1ɲ, PPAR ɀ coactivator 1ɲ; PI3K, phosphoinositide-3-kinase; 
POMC, pro-opiomelanocortin; phosphoinositide-3-kinase; PPAR, 
peroxisome proliferator-activated receptor ɀ; PTP1B, protein tyrosine 
phosphatase non-receptor type 1; SHP2, protein tyrosine phosphatase 
non-receptor type 11; SOCS3, suppressor of cytokine signalling 3; SREBP1, 
sterol regulatory element-binding protein 1; STAT3, signal transducer and 
activator of transcription 3; TG, triglyceride; TNF, tumour necrosis factor; 
TSC1/2, tuberous sclerosis 1 and 2. 
This figure is based on the papers as referenced throughout the 
corresponding section of the introduction and especially reviews [182, 
184, 185, 192]. 
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5. The acute and long term 
influences of dietary choline on 
metabolic health of lactating 
mothers and their offspring 
5.1. Introduction 
As I have described in more detail in Section 1.9.2.3 of the introduction, 
most experimental work modulating choline intake during development 
concentrated on describing the role of choline during pregnancy. The 
lactation period, however, has not been extensively investigated.  
Previous studies have shown that a choline-deficient diet during pregnancy 
leads to increased gene expression of an inhibitor of cell cycle progression, 
CDKN3, of the fetal hippocampus [372, 373]. These changes had long term 
effects, as the adult offspring demonstrated altered hippocampal function 
[374], decreased memory performance [375, 376] and attention to stimuli 
[368] compared to offspring whose mothers had been fed sufficient choline 
in the form of a salt. A postnatal intervention of choline supplementation 
as intubation or subcutaneous injection of choline chloride, affected spatial 
memory, as measured in a maze test, and increased the number of 
hippocampal dendritic spines and memory performance was positively 
correlated with hippocampal capacity to release acetylcholine (Ach) [386, 
493]. In rats, the period of 16-30 days of age has been suggested as a 
developmental phase during which spatial memory can be positively 
influenced in a long term manner [386, 493] and age-related memory loss 
ameliorated by administering additional choline. Studies examining 
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postnatal choline supplementation are few and, to my knowledge, only 
examined the consequences on spatial memory in the offspring. Our study 
was, therefore, novel by looking at other outcome measures and by 
providing a model closer to the human situation, in which breastfed infants 
UHO\PDLQO\RQFKROLQHFRQWHQWRIPRWKHU¶VPLONZKLFKZRXOGPRVWOLNHO\EH
influenced by maternal choline intake [494].  
Within these studies, differences in availability and routes of uptake of 
choline as salt as opposed to phosphatidylcholine (PC) have not been taken 
into account and there are not many studies comparing choline salt with 
PC. Free choline is taken up through a low-affinity and low-specificity 
transport system by organic cation transporters (OCT), through a high-
affinity system by choline transporter 1 (CHT1) or intermediate-affinity 
systems by choline transporter-like proteins [495]. PC and SM, on the 
other hand, are taken up into tissues through transporters CD36 and 
scavenger receptor class B type 1 (SR-B1) and, possibly, through non-
specific internalisation of lipid particles, e.g. uptake of micelles into 
intestinal epithelium [496]. In fact, PC and its derivative carrying only one 
fatty acid, lyso-PC, are facilitating micelle uptake and lipoprotein secretion 
and are thus instrumental for lipid digestion [497]. As not all tissues 
display the same receptors, choline salt and PC may differ in distribution 
but this has not been well described. Upon digestion, free choline enters 
the circulation in the hydrophilic phase of plasma whilst PC and SM are 
circulating as part of lipoproteins and both pool in the liver, which has 
enzymes to carry out the CDP-choline pathway and the 
phosphatidylethanolamine methyltransferase (PEMT) pathway to produce 
PC from free choline and PE, respectively. Thus it might be hypothesized 
that metabolically these two forms of choline are unlikely to be the same. 
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Choline and its metabolites are strongly involved in cell replication and 
tissue growth as it is essential for cell survival, membrane integrity and 
signalling, protein and DNA methylation and in neuronal signalling (as 
reviewed in [365]). During the lactation period rat pups increase their body 
weight about 6 times (approximately from 8g at birth to 50g at 21d), and 
is, therefore, a period of rapid growth. Compared to humans or other 
larger mammals, rats are born relatively immature and most of the rapid 
growth occurs during rat lactation, making this period comparable to the 
third trimester of fetal development in larger mammals and humans. In 
the early postnatal period of the rat pancreas [498], the immune system 
[499] and brain [383, 384] including the appetite regulating system [500], 
continue to develop and are sensitive to environmental stimuli, which may 
result in lasting effects on organ development and function.  
Rat milk choline concentrations are about 20-fold higher than in maternal 
serum [501], which suggests that the pup has a high requirement for 
choline in early postnatal life. Although mammary glands synthesise PC 
from both the PEMT [502] and the CDP pathway [503], phosphocholine 
concentration, one of the main choline metabolites in milk, is reduced in 
rat milk after feeding choline-devoid diet for 21d [494]. This suggests that 
endogenous synthesis cannot meet the needs of the mammary gland. 
Choline is additionally transported from plasma into milk [501] and feeding 
rats a choline-devoid diet during late pregnancy and lactation led to 
depletion of choline metabolites from the liver [504], suggesting that, 
during lactation, maternal choline stores are preferentially utilised for milk 
production. 
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5.1.1. Aims and Hypotheses 
It has been previously observed, both by our group and others [397] but 
not considered in the majority of published studies [369, 379], that, at 
least during lactation period, rapid choline depletion leads to a decrease in 
food intake and body weight and, if not reversed, death.  
1) ,K\SRWKHVLVHGWKDWWKHUHLVDQDFXWHHIIHFWRQERWKWKHPRWKHUV¶
DQGRIIVSULQJV¶IRRGLQWDNHDQGWKLVLVGXHWRsingalling changes in 
appetite regulation.  
2) Due to the important structural and functional role of choline in the 
brain, I hypothesised that these early changes, affected by both the 
availability and the form of choline in the diet, are mediated 
through structural changes in the brain.  
3) These changes would be evident both in early life and extending 
into adulthood.  
4) Since choline has such a crucial role in cell membrane structure and 
growth, I hypothesised that the morphology of the small intestine, 
an organ dependent on rapid cell turnover, would be compromised 
by choline deficiency.  
As with a majority of organs, the pancreas is still developing before 
weaning in rats. Recently, it has been shown that drastically reduced 
methyl donor availability, i.e. methionine, folate and choline, in early 
postnatal life in rats alters pancreatic characteristics and improved glucose 
tolerance permanently [505]. Also, as described in the introduction, early 
postnatal growth rate may have effects on long term glucose tolerance in 
rodents. Since previous studies conducted by our group in 2009/2010 have 
shown that rat offspring whose mothers were fed a choline-devoid diet 
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weighed less at weaning, this could potentially alter, or be associated with, 
glucose tolerance, independently of the effects of choline availability.  
5) I, therefore, hypothesised that this intervention may influence 
glucose tolerance in adult offspring. 
To address these objectives and hypotheses, I fed diets differing in the 
content and form of choline to lactating rats. Brain phospholipids and brain 
fatty acid composition on PC and PE molecules were analysed to determine 
the effect of choline on brain structure, membrane fluidity and signalling. I 
measured established effects of choline deficiency, including liver fat 
accumulation [506] and estimated the concentrations of choline 
PHWDEROLWHVLQPRWKHU¶VPLONE\DQDO\VLQJWKHVXFNOLQJRIIVSULQJV¶ stomach 
content at weaning (21 days of age). Abundance of the predominant 
appetite regulatory proteins neuropeptide Y (NPY) and ɲ-melanocyte 
stimulating hormone (ɲ-MSH) was determined in the hypothalamic arcuate 
nucleus (ARC) WRILUVWJDLQLQVLJKWLQWRFKROLQH¶VUROHLQDSSHWLWHUHJXODWLRQ
Glucose tolerance was assessed in the offspring at a young adult age of 9 
weeks.  
5.2. Methods 
The design and all methods for this study are described in sections 2.10-
2.21. In short, my study was designed to assess the long term effects of 
low choline availability and the difference between choline salt and PC 
during the lactation period. As in previous studies carried out by this group 
(2009/2010), pregnant rats of 10-12 weeks of age at mating were entered 
into the experiment. After giving birth, they were fed a diet in which the 
choline content and source (form) was manipulated but all other nutrients 
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were kept the same. The diets were isocaloric and isonitrogenous and the 
micronutrients, with the exception of choline, were identical and met the 
requirements of lactating and growing rats. Two female offspring from 
each mother were weaned to a semi-purified diet containing 1g/kg choline 
in the form of free choline until 11 weeks of age. This study extended 
earlier work by the group with the added step of following some of the 
offspring fed a diet containing a standard amount of choline until young 
adult age. Since designs were very similar some of the results presented in 
this chapter were derived from the 2009/2010 studies and will be marked 
accordingly and differences between the studies discussed as necessary. 
The study was designed by myself together with Prof. Catherine Field, Dr. 
Rene Jacobs and Ms Sue Goruk. In the daily animal work I was assisted by 
Ms Nicole Coursen and staff of the animal facility. I performed and/or 
supervised the analytical studies. I have compiled, analyzed and 
interpreted the results of the experiments described in this chapter.  
5.3. Results 
5.3.1. Maternal body weight and food intake 
The food intake of mothers fed a choline-devoid diet was lower than that of 
the two choline groups at 2 weeks post partum and both D mothers (Figure 
5.1) and D offspring (Figure 5.7) had a lower body weight at postnatal day 
14 as compared to C and PC. This was more than predicted from earlier 
studies and the research team rescued these mothers by feeding the 
choline sufficient (salt) diet for the remaining five days until weaning (days 
16-21). In doing this to the study design, the study represented 
insufficient maternal dietary choline deprivation during the last part of 
lactation. After weaning, these D mothers were kept on a diet containing 
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0.1 g/kg choline added as a bitartrate salt until they were killed at week 4 
post-partum. When feeding the choline-restored diet, D mothers gained 
weight, but body weight remained significantly lower than C but not PC 
mothers 21 days after giving birth. After weaning, maternal weights 
further aligned and showed no difference in body weight at euthanisation 
as compared to C and PC mothers. At euthanasia at 4 weeks after birth, PC 
mothers showed a lower body weight compared to C mothers (Figure 5.1). 
 
Figure 5.1: Maternal weight development during intervention over 4 weeks 
postpartum. The arrow represents the time point of re-introducing choline 
into the diet of D mothers.  
PC (blue, n=4): mothers fed a diet containing 1 g choline as PC per kg diet; 
C (red, n=4): mothers fed a diet containing 1 g choline as bitartrate per kg 
diet; D (green, n=3): mothers fed a choline-devoid diet; all diets were fed 
from giving birth to euthanisation at 4 weeks postpartum except for D as 
described.  
* p<0.05 for PC versus D comparison; ÁSIRU&YHUVXV'FRPSDULVRQ
# p<0.05 for PC versus C comparison. Data are means and error bars 
represent SEM. 
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As is consistent with their weight development, D mothers showed a trend 
for a lower food intake as measured in week 2 postpartum and as 
compared to C and PC mothers (p=0.057 for both comparisons, Figure 
5.2). Food intake did not differ between C and PC mothers.  
 
Figure 5.2: Maternal food intake adjusted for body weight as measured at 
weeks 1 and 2 postpartum.  
PC (blue, n=4): mothers fed a diet containing 1 g choline as PC per kg diet; 
C (red, n=4): mothers fed a diet containing 1 g choline as bitartrate per kg 
diet; D (green, n=3): mothers fed a choline-devoid diet; all diets were fed 
from giving birth to euthanisation at 4 weeks postpartum except for D as 
described. Data are means and error bars represent SEM. 
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5.3.2. Effects on maternal organs and fat mass 
At 4 weeks postpartum mothers were euthanised and dissected. There was 
no effect on tissue weight when adjusted for maternal body weight 
between groups, nor was intestinal length different between groups (Table 
5.1). 
Table 5.1: Maternal tissue weights at 4 weeks postpartum.  
Tissue PC C D 
BAT (mg/g) 1.0 ± 0.2 0.8 ± 0.1 0.9 ± 0.1 
Gonadal fat 
(mg/g) 
11 ± 2 14 ± 1 11 ± 2 
Spleen (mg/g) 2.7 ± 0.2 2.4 ± 0.2 3.1 ± 0.2 
Liver (mg/g) 37 ± 1 41 ± 2 43 ± 4 
Intestine (cm) 140 ± 1 136 ± 3 137 ± 4 
PC: mothers fed a diet containing 1 g choline as PC per kg diet, n=4; C: 
mothers fed a diet containing 1 g choline as bitartrate per kg diet, n=4; D: 
mothers fed a choline-devoid diet, n=3; all diets were fed from giving birth 
to euthanisation at 4 weeks postpartum except for D as described. Data is 
displayed as means ± SEM. BAT, brown adipose tissue. 
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Examination of maternal small intestinal morphology demonstrated 
significant differences in length of villi in all sections (duodenum, jejunum, 
ileum), with the longest villi in PC mothers and the shortest in D mothers 
(Figure 5.3). 
 
Figure 5.3: Villus length in mothers divided by intestinal section and 
intervention groups, in samples obtained from the 2009/2010 studies.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet, n=4; 
C (red): mothers fed a diet containing 1 g choline as bitartrate per kg diet, 
n=4; D (green): mothers fed a choline-devoid diet, n=4; all diets were fed 
from giving birth to euthanisation at 4 weeks postpartum except for D as 
described.  
* p<0.05. Data are means and error bars represent SEM. 
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Maternal crypt was deeper in D mothers in the duodenum as compared to 
C and PC and shallower in the jejunum of D mothers as compared to C 
(Figure 5.4). 
 
Figure 5.4: Crypt length in mothers divided by intestinal section and 
intervention groups, in samples obtained from the 2009/2010 studies.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet, n=4; 
C (red): mothers fed a diet containing 1 g choline as bitartrate per kg diet, 
n=4; D (green): mothers fed a choline-devoid diet, n=4; all diets were fed 
from giving birth to euthanisation at 4 weeks postpartum except for D as 
described.  
* p<0.05. Data are means and error bars represent SEM. 
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5.3.3. ǯ choline intake at the end of lactation 
,QRIIVSULQJV¶VWRPDFKFontent the highest free choline concentration was 
found in C offspring and the lowest in D. PC concentration was higher in 
the PC group than in C or D. Sphingomyelin was lower in the PC group as 
compared to C and glycerophosphocholine was lower in D as compared to 
C (Figure 5.5). 
Figure 5.5: Offspring stomach content concentrations of choline chloride 
(ChoCl), phosphatidylcholine (PC), lyso-phosphatidylcholine (LPC), 
sphingomyelin (SM), phosphocholine (PCho) and glycerophosphocholine 
(GPC) in nmol/g, divided by intervention group, at 3 weeks of age, in 
samples obtained from the 2009/2010 studies.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet 
(n=8); C (red): mothers fed a diet containing 1 g choline as bitartrate per 
kg diet (n=11); D (green): mothers fed a choline-devoid diet (n=7); all 
diets were fed to mothers from giving birth to weaning at 3 weeks 
postpartum.  
* p<0.05. Data are means and error bars represent SEM. 
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Despite differences in the forms of choline there was no significant 
difference in the overall choline content of the stomach contents. Total 
phospholipid concentration was substantially higher in PC as compared to C 
and D offspring (Figure 5.6).  
 
Figure 5.6: Offspring stomach content concentrations of a sum of choline-
containing metabolites (choline chloride, lyso-PC, PC, sphingomyelin, 
phosphocholine and glycerophosphocholine) and of the sum of 
phospholipids (PC, lyso-PC, PE, lyso-PE, phosphatidylserine, 
phosphatidylinositol) in nmol/g, divided by intervention group at 3 weeks 
of age, in samples obtained from the 2009/2010 studies.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet 
(n=8); C (red): mothers fed a diet containing 1 g choline as bitartrate per 
kg diet (n=11); D (green): mothers fed a choline-devoid diet (n=7); all 
diets were fed to mothers from giving birth to weaning at 3 weeks 
postpartum.  
* p<0.05. Data are means and error bars represent SEM. 
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5.3.4. Offspring growth and food intake after weaning 
Offspring weight and length did not differ at 1 week postnatal age but D 
offspring weighed less than C offspring from 2-5 weeks of age. After 
weaning at 3 weeks the remaining two offspring per mother were weaned 
to a diet with 1 g choline as bitartrate per kg diet. D offspring restored 
their weight by 6 weeks of age. Weights did then not differ significantly 
after that up to euthanisation at 11 weeks of age (Figure 5.7). 
 
Figure 5.7: Offspring postnatal weight development.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet; C 
(red): mothers fed a diet containing 1 g choline as bitartrate per kg diet; D 
(green): mothers fed a choline-devoid diet; all diets were fed to mothers 
from giving birth to weaning at 3 weeks postpartum except for D as 
described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet. Offspring data is averaged within litters 
at 1 and 2 weeks of age (PC, 4 litters; C, 4 litters; D, 3 litters) and numbers 
are n=8 (PC) and n=7 (C and D) for 3-11 weeks of age.  
SIRU3&YHUVXV'ÁSIRU&YHUVXV'Data are means and 
error bars represent SEM. 
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D offspring had lower weight gain during suckling without reaching 
statistical significance (p=0.057 as compared to PC and C for 1-2 weeks 
and p=0.057 as compared to PC for 1-3 weeks of age, Figure 5.8).  
 
 
Figure 5.8: Weight gain of offspring between age 1 week and 2 weeks 
(left) and 3 weeks (right).  
PC (blue, 4 litters): mothers fed a diet containing 1 g choline as PC per kg 
diet; C (red, 4 litters): mothers fed a diet containing 1 g choline as 
bitartrate per kg diet; D (green, 3 litters): mothers fed a choline-devoid 
diet; all diets were fed to mothers from giving birth to weaning at 3 weeks 
postpartum except for D as described. Data is averaged within litters. Data 
are means and error bars represent SEM.  
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Whilst body weight of the offspring did not significantly differ between 
groups at weaning at 3 weeks of age, D offspring had less gonadal adipose 
tissue, but similar brown adipose tissue (BAT) mass, as compared to C and 
PC offspring (Table 5.2). 
Table 5.2: Offspring tissue weights at weaning.  
Tissue PC C D 
BAT (mg/g) 3.8 ± 0.1 4.0 ± 0.3 3.5 ± 0.5 
Gonadal fat 
(mg/g) 
1.7± 0.2 a 1.5 ± 0.2 a 0.8 ± 0.4 b 
PC: mothers fed a diet containing 1 g choline as PC per kg diet, 4 litters; C: 
mothers fed a diet containing 1 g choline as bitartrate per kg diet, 4 litters; 
D: mothers fed a choline-devoid diet, 3 litters; all diets were fed from 
giving birth to euthanisation at 3 weeks postpartum except for D as 
described.  
Comparison a vs b (groups PC versus C), p=0.022; a vs b (groups C versus 
D), p=0.048. Data are displayed as means ± SEM. 
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After weaning, offspring food intake was measured regularly and when 
adjusted for body weight, food intake was higher in D and PC as compared 
to C offspring only at 4 weeks of age (Figure 5.9). 
 
Figure 5.9: Offspring food intake adjusted for body weight after weaning.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet, n=8; 
C (red): mothers fed a diet containing 1 g choline as bitartrate per kg diet, 
n=7; D (green): mothers fed a choline-devoid diet, n=7; all diets were fed 
to mothers from giving birth to weaning at 3 weeks postpartum except for 
D as described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet.  
ÁSIRU&YHUVXV'SIRU3&YHUVXV&Data are means and 
error bars represent SEM. 
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5.3.5. Intraperitoneal glucose tolerance test (GTT) 
Over the 120 minute course of the GTT at 9 weeks of age neither glucose 
(Figure 5.10) nor insulin (Figure 5.11) concentrations nor either the area 
under the curve (AUC) or the homeostatic model assessment for insulin 
resistance (HOMA-IR,Table 5.3) differed between groups.  
 
Figure 5.10: Blood glucose concentration measured during the GTT.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet, n=8; 
C (red): mothers fed a diet containing 1 g choline as bitartrate per kg diet, 
n=6; D (green): mothers fed a choline-devoid diet, n=7; all diets were fed 
to mothers from giving birth to weaning at 3 weeks postpartum except for 
D as described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet. Data are means and error bars represent 
SEM. 
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Figure 5.11: Plasma insulin concentration measured during the GTT.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet, n=8; 
C (red): mothers fed a diet containing 1 g choline as bitartrate per kg diet, 
n=6; D (green): mothers fed a choline-devoid diet, n=7; all diets were fed 
to mothers from giving birth to weaning at 3 weeks postpartum except for 
D as described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet. Data are means and error bars represent 
SEM. 
 
Table 5.3: Characteristics of the GTT: glucose and insulin AUC and HOMA-
IR. Glucose was measured in mmol/L and insulin in ng/ml and the AUC 
determined over 120 minutes.  
Measurement PC C D 
AUC glucose 486 ± 48 416 ± 42 362 ± 39 
AUC insulin 23 ± 5 13 ± 5 22 ± 8 
HOMA-IR 1.9 ± 0.6 1.8 ± 0.3 1.5 ± 0.1 
HOMA-IR was calculated from baseline glucose and insulin measurements.  
PC: mothers fed a diet containing 1 g choline as PC per kg diet, n=8; C: 
mothers fed a diet containing 1 g choline as bitartrate per kg diet, n=6; D: 
mothers fed a choline-devoid diet, n=7; all diets were fed to mothers from 
giving birth to the end of lactation at 3 weeks postpartum except for D as 
described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet. Data is displayed as means ± SEM. 
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5.3.6. Long term effects on offspring organs and body composition 
At 11 weeks of age, offspring showed no differences in fat mass or organ 
weight. The small intestine was slightly shorter in PC as compared to C 
offspring (Table 5.4). 
Table 5.4: Offspring tissue measures at 11 weeks of age.  
Tissue PC C D 
PAT (mg/g) 22.8 ± 4 28.2 ± 2 23.7 ± 3 
BAT (mg/g) 0.9 ± 0.1 0.9 ± 0.1 1.0 ± 0.1 
Gonadal fat 
(mg/g) 
19.7 ± 2 21.9 ± 1 22.6 ± 3 
Spleen (mg/g) 2.6 ± 0.1 2.2 ± 0.1 2.6 ± 0.1 
Liver (mg/g) 32.2 ± 1 32.8 ± 1 33.3 ± 1 
Intestine (cm) 111 ± 1 a 119 ± 2 x 116 ± 1 b 
PC: mothers fed a diet containing 1 g choline as PC per kg diet, n=8; C: 
mothers fed a diet containing 1 g choline as bitartrate per kg diet, n=7; D: 
mothers fed a choline-devoid diet, n=7; all diets were fed from giving birth 
to euthanisation at 3 weeks postpartum except for D as described; after 
weaning all offspring were fed a diet containing 1 g choline as bitartrate 
per kg diet.  
Comparison a vs b, p=0.018. Data is displayed as means ± SEM. 
5.3.7. Brain phospholipids 
Maternal brain concentrations of phospholipid classes lyso-
phosphatidylethanolamine (LPE) and lyso-phosphatidylcholine (LPC) were 
lower in PC than in C. D adult offspring had significantly lower 
concentrations of PC and SM as compared to PC offspring. In weanling 
offspring, C animals had generally lower phospholipid concentrations as 
compared to PC and D, with significant differences between PC and C for 
phosphatidylinositol (PI), PE, phosphatidylserine (PS), SM and LPC and 
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significant differences between C and D for PE, LPE, PC, SM and LPC 
(Figure 5.12). 
 
 
Figure 5.12, continued on the next page. 
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Figure 5.12: Phospholipid class concentrations divided by age groups and 
intervention groups.  
Panel A, mothers;  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet, n=4; 
C (red): mothers fed a diet containing 1 g choline as bitartrate per kg diet, 
n=4; D (green): mothers fed a choline-devoid diet, n=3; all diets were fed 
to mothers from giving birth to euthanisation at 4 weeks postpartum 
except for D as described. 
Panel B, weanling offspring;  
PC (blue): offspring raised by PC mothers, 4 litters; C (red): offspring 
raised by C mothers, 4 litters; D (green): offspring raised by D mothers, 3 
litters; offspring were euthanased at 3 weeks of age.  
Panel C, adult offspring;  
PC (blue): offspring raised by PC mothers, n=7; C (red): offspring raised 
by C mothers, n=6; D (green): offspring raised by D mothers, n=4; after 
weaning all offspring were fed a diet containing 1 g choline as bitartrate 
per kg diet.  
PI, phosphatidylinositol; PE, phosphatidylethanolamine; PS, 
phosphatidylserine; LPE, lyso-phosphatidylethanolamine; PC, 
phosphatidylcholine; SM, sphingomyelin; LPC, lyso-phosphatidylcholine.  
* p<0.05. Data are means and error bars represent SEM.  
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Total phospholipid classes were not changed in mothers but were lower in 
D adult offspring as compared to C and lower in C weanling offspring as 
compared to D and PC (Table 5.5). 
Table 5.5: Total phospholipid concentrations in the brain, divided by age 
groups and intervention groups. Samples from weanlings are taken from 
offspring at 3 weeks of age, from adult offspring at 11 weeks of age and 
mother samples are taken 4 weeks postpartum.  
Phospholipids 
(nmol/g) 
PC C D 
  Mothers 556 ± 59 663 ± 10 601 ± 72 
  Weanling 545 ± 31 a 432 ± 21 b 549 ± 31 c 
  Adult offspring 556 ± 43 712 ± 95 d 222 ± 36 e 
PC: mothers fed a diet containing 1 g choline as PC per kg diet; C: mothers 
fed a diet containing 1 g choline as bitartrate per kg diet; D: mothers fed a 
choline-devoid diet; all diets were fed from giving birth to 4 weeks 
postpartum except for D as described; after weaning at 3 weeks all 
offspring were fed a diet containing 1 g choline as bitartrate per kg diet. 
Numbers (n) as in Figure 5.12. 
Comparison a vs b, p=0.017; b vs c, p=0.021; d vs e, p=0.001. Data is 
displayed as means ± SEM. 
5.3.8. Brain fatty acids attached to PC 
When comparing fatty acid classes attached to brain PC, mothers and adult 
offspring did not show any differences whilst PC weanling offspring had a 
slightly higher percentage of saturated fatty acid (FA) as compared to C 
weanlings (Table 5.6 A). Percentages of functional fatty acids arachidonic 
acid and docosahexaenoic acid (DHA) were not changed in any of the 
groups (Table 5.6 B). 
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Table 5.6: Fatty acids attached to PC in the brain as percentage of total 
fatty acids, divided by age groups and intervention groups;  
A, fatty acids as divided into main classes; B, functional fatty acids 
docosahexaenoic acid (DHA) and arachidonic acid. 
A 
FA class (%) PC C D 
SFA    
  Mothers 61 ± 0.3 60 ± 0.7 61 ± 1.2 
  Weanling 68 ± 0.9 a 65 ± 1.0 b 66 ± 0.4 x 
  Adult offspring 62 ± 0.8 63 ± 0.4 61 ± 0.5 
MUFA    
  Mothers 26 ± 2.7 27 ± 2.7 26 ± 3.7 
  Weanling 21 ± 1.2 23 ± 0.6 23 ± 0.2 
  Adult offspring 26 ± 1.3 25 ± 1.4 27 ± 0.5 
ǔ-3 PUFA    
  Mothers 2.5 ± 0.2 2.5 ± 0.1 2.6 ± 0.1 
  Weanling 1.6 ± 0.1 2.2 ± 0.3 2.0 ± 0.1 
  Adult offspring 2.2 ± 0.2 2.4 ± 0.1 2.4 ± 0.2 
ǔ-6 PUFA    
  Mothers 3.8 ± 0.1 4.2 ± 0.5 3.8 ± 0.4 
  Weanling 5.2 ± 0.2 5.9 ± 0.4 5.4 ± 0.3 
  Adult offspring 4.2 ± 0.4 4.2 ± 0.2 5.3 ± 0.7 
 
  
208 
 
B 
FA (%) PC C D 
Arachidonic acid    
  Mothers 2.8 ± 0.2 3.1 ± 0.5 2.7 ± 0.2 
  Weanling 4.4 ± 0.2 4.8 ± 0.4 4.2 ± 0.3 
  Adult offspring 3.2 ± 0.3 3.3 ± 0.1 3.9 ± 0.3 
DHA    
  Mothers 1.8 ± 0.1 1.8 ± 0.1 1.6 ± 0.1 
  Weanling 1.3 ± 0.1 1.8 ± 0.3 1.6 ± 0.1 
  Adult offspring 1.5 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet; C 
(red): mothers fed a diet containing 1 g choline as bitartrate per kg diet; D 
(green): mothers fed a choline-devoid diet; all diets were fed to mothers 
from giving birth to weaning at 3 weeks postpartum except for D as 
described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet. Numbers (n) as in Figure 5.12. 
SFA: saturated FA; MUFA: mono-unsaturated FA; ǔ-3 PUFA: omega 3 poly-
unsaturated FA; ǔ-6 PUFA: omega 6 poly-unsaturated FA. Comparison a vs 
b, p=0.043. Data is presented as means ± SEM. 
5.3.9. Brain fatty acids attached to PE 
NRQHRIWKHIDWW\DFLGFODVVHVDWWDFKHGWR3(LQPRWKHU¶VEUDLQVH[SUHVVHG
as a percentage of total fatty acids, differed between groups. However, 
DHA concentrations were lower in PC mothers as compared to D mothers. 
Weanling brain PE had a higher percentage of mono-unsaturated fatty 
acids (MUFA) attached in PC offspring as compared to D due to a difference 
in oleic acid (18:1; PC, 18 ± 1% w/w; C, 14 ± 1% w/w; D, 12 ± 2% w/w; 
PC versus D, p=0.017). C adult offspring brain PE had a significantly higher 
percentage of docosahexaenoic acid DQGRYHUDOOǔ-3 FAs attached to it as 
compared to PC (Table 5.7), whilst ɲ-linolenic acid (18:3n3; PC, 5.2 ± 
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0.6% w/w; C, 4.0 ± 0.3% w/w; D, 4.8 ± 0.2% w/w; PC versus C, 
p=0.040) was higher in PC than in C adult offspring.  
Table 5.7: Fatty acids attached to PE in the brain as percentage of total 
fatty acids, divided by age groups and intervention groups; A, fatty acids 
as divided into main classes; B, functional fatty acids docosahexaenoic 
acid (DHA) and arachidonic acid. 
A 
FA class (%) PC C D 
SFA    
  Mothers 65 ± 17 42 ± 4 38 ± 2 
  Weanling 51 ± 2 50 ± 4 48 ± 2 
  Adult offspring 44 ± 3 40 ± 3 42 ± 4 
MUFA    
  Mothers 23 ± 13 35 ± 1 31 ± 1 
  Weanling 18 ± 1 a 14 ± 1 13 ± 2 b 
  Adult offspring 31 ± 2 26 ± 1 28 ± 1 
ǔ-3 PUFA    
  Mothers 5 ± 5 13 ± 2 17 ± 1 
  Weanling 13 ± 1 17 ± 3 18 ± 1 
  Adult offspring 13 ± 2 c 18 ± 1 d 16 ± 3 
ǔ-6 PUFA    
  Mothers 7 ± 1 10 ± 3 13 ± 1 
  Weanling 17 ± 2 18 ± 1 20 ± 1 
  Adult offspring 11 ± 1 15 ± 1 14 ± 2 
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B 
FA (%) PC C D 
Arachidonic acid    
  Mothers 2.0 ± 2.0 6.3 ± 1.8 8.4 ± 0.5 
  Weanling 12 ± 1 13 ± 1 14 ± 1 
  Adult offspring 7 ± 1 9 ± 1 9 ± 2 
DHA    
  Mothers 2 ± 2 e 7 ± 3 12 ± 1 f 
  Weanling 12 ± 1 15 ± 3 16 ± 1 
  Adult offspring 7 ± 2 g 14 ± 1 h 11 ± 3 
PC: mothers fed a diet containing 1 g choline as PC per kg diet; C: mothers 
fed a diet containing 1 g choline as bitartrate per kg diet; D: mothers fed a 
choline-devoid diet; all diets were fed to mothers from giving birth to 
weaning at 3 weeks postpartum except for D as described; after weaning 
all offspring were fed a diet containing 1 g choline as bitartrate per kg 
diet. Numbers (n) as in Figure 5.12. 
SFA: saturated FA; MUFA: mono-unsaturated FA; ǔ-3 PUFA: omega 3 poly-
unsaturated FA; ǔ-6 PUFA: omega 6 poly-unsaturated FA. Comparison a vs 
b, p=0.040; c vs d, p=0.014; e vs f, p=0.022; g vs h, p=0.025. Data is 
presented as means ± SEM. 
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5.3.10. Accumulation of fat in the liver 
The concentration of total fat in maternal livers was higher in PC mothers 
as compared to C mothers. In PC weanling offspring livers had a lower fat 
content as compared with D weanling offspring in that study (Figure 5.13). 
 
 
Figure 5.13: Hepatic fat content of mothers and weanling offspring as 
assessed in the 2009/2010 study.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet, 
mothers n=8, offspring n=6; C (red): mothers fed a diet containing 1 g 
choline as bitartrate per kg diet, mothers n=8, offspring n=7; D (green): 
mothers fed a choline-devoid diet, mothers n=6, offspring n=7; all diets 
were fed to mothers from giving birth to weaning at 3 weeks postpartum.  
* p<0.05. Data are means and error bars represent SEM. 
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Choline-containing phospholipids and PE were measured in C and D but, as 
a PC diet group was not included in the 2009 study these livers were taken 
from, not PC mothers. Expressed as metabolite content for the entire liver, 
D mothers had lower stores of PC and betaine (Table 5.8). In the 2009 
study, livers of D mothers were lighter than of C mothers (8.8 ± 0.7 g and 
11.4 ± 0.4 g, respectively, p=0.005). 
Table 5.8: Estimation of choline metabolite content for the whole liver of C 
and D mothers, i.e. mg/liver, as assessed in the 2009 study.  
metabolite  
(mg) 
PC 
free 
choline 
betaine PE SM 
C 113 ± 6 a 0.4 ± 0.1 1.6 ± 0.1 c 39 ± 4 9.3 ± 0.4 
D 76 ± 7 b 0.5 ± 0.2 1.2 ± 0.1 d 38 ± 5 8.3 ± 0.5 
C: mothers fed a diet containing 1 g choline as bitartrate per kg diet, n=8; 
D: mothers fed a choline-devoid diet, n=6; all diets were fed to mothers 
from giving birth to weaning at 3 weeks postpartum.  
Comparisons a versus b, p=0.002; comparison c versus d, p=0.032. Data is 
presented as means ± SEM. 
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5.3.11. Effects on appetite regulation in the ARC: NPY and ơ-MSH 
The number of NPY-positive cells counted in the ARC and standardised for 
area was higher in PC mothers as compared to D mothers. There was no 
difference observed between any of the adult or weanling offspring groups 
(Figure 5.14). 
 
Figure 5.14: Number of NPY-positive cells counted in the ARC and 
standardised for area, divided by age groups and intervention groups.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet; C 
(red): mothers fed a diet containing 1 g choline as bitartrate per kg diet; D 
(green): mothers fed a choline-devoid diet; all diets were fed to mothers 
from giving birth to the end of lactation at 3 weeks postpartum except for 
D as described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet. Numbers (n): mothers, PC n=2, C n=4, D 
n=2; weanling offspring, PC n=7, C n=6, D n=5; adult offspring, PC n=6, C 
n=5, D n=7. 
* p<0.05. Data are means and error bars represent SEM. 
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Number of ɲ-MSH-positive cells counted in the ARC and standardised for 
area did not differ between any of the groups but was highest in D 
weanling offspring (Figure 5.15). 
 
Figure 5.15: Number of ɲ-MSH-positive cells counted in the ARC and 
standardised for area, divided by age groups and intervention groups.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet; C 
(red): mothers fed a diet containing 1 g choline as bitartrate per kg diet; D 
(green): mothers fed a choline-devoid diet; all diets were fed to mothers 
from giving birth to weaning at 3 weeks postpartum except for D as 
described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet. Numbers (n): mothers, PC n=2, C n=4, D 
n=2; weanling offspring, PC n=7, C n=6, D n=5; adult offspring, PC n=6, C 
n=5, D n=7. Data are means and error bars represent SEM. 
The ratio of NPY- to ɲ-MSH-positive cells within the ARC and standardised 
for area did not differ between any of the groups (Figure 5.16). 
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Figure 5.16: Ratio of NPY- to ɲ-MSH-positive cells counted in the ARC and 
standardised for area, divided by age groups and intervention groups.  
PC (blue): mothers fed a diet containing 1 g choline as PC per kg diet; C 
(red): mothers fed a diet containing 1 g choline as bitartrate per kg diet; D 
(green): mothers fed a choline-devoid diet; all diets were fed to mothers 
from giving birth to weaning at 3 weeks postpartum except for D as 
described; after weaning all offspring were fed a diet containing 1 g 
choline as bitartrate per kg diet. Numbers (n): mothers, PC n=2, C n=4, D 
n=2; weanling offspring, PC n=7, C n=6, D n=5; adult offspring, PC n=6, C 
n=5, D n=7. Data are means and error bars represent SEM. 
Due to the experimental difference between the 2011 and 2009/2010 
studies explained at the beginning of this result section, interpretation has 
to take into account the length of feeding a choline-devoid diet to mothers. 
For an easier overview, information about which study specific data is 
taken from is listed below (Table 5.9). 
Table 5.9: Overview of data origin.  
Results taken from  
the 2011 study  
(D, choline-devoid diet day 1-16) 
Results taken from  
the 2009/2010 studies  
(D, choline-devoid diet day 1-21) 
all growth data intestinal morphology 
all food intake data stomach content data 
all tissue weights at dissection 
maternal liver lipids and choline 
contents 
glucose tolerance test offspring liver lipids 
all brain data  
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5.4. Discussion 
5.4.1. Effects of feeding a choline-devoid diet during lactation 
'LPLQLVKLQJPRWKHU¶VFKROLQHLQWDNHGXULQJODFWDWLRQOHGWRDtrend to lower 
maternal food intake and changes in intestinal morphology (shorter villi in 
the jejunum, ileum and duodenum without a change in intestinal length) 
that may result in disturbed nutrient uptake. Consistent with reduced 
nutrient availability through either a potential decrease in intake and/or a 
reduction in nutrient absorption, offspring of mothers fed the choline-
devoid diet during early lactation grew more slowly and had a smaller 
gonadal fat pad at 3 weeks of age. Although the total choline metabolite 
concentrations in the RIIVSULQJV¶ FRQVXPSWLRQRIPRWKHU¶VPLONZHUHVLPLODU
at the end of lactation, there were differences in the form of choline due to 
diet. At this point D weanling offspring had higher liver lipid concentrations 
and showed higher concentrations of brain phospholipids. Offspring 
reached the same weight as offspring whose mothers were fed choline-
containing diets by adulthood and also showed no other differences in 
organ and fat masses, except that phospholipid concentrations were now 
much lower in the brain. This suggests that growth differences can be 
compensated for by providing sufficient choline after early lactation but 
there may be lasting effects on the lipid composition of the brain. 
5.4.1.1. Acute effects on maternal outcomes 
With regards to acute effects in D mothers as measured at 4 weeks post 
partum it must be considered what influence the re-introduction of choline 
into their diet had (1 g/kg for days 16-21 postnatal age and 0.1 g/kg from 
day 21 to euthanisation on day 28). The immediate effects on maternal 
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body weight were rapid and considerable. The effects we observed in the 
hypothalamic neurons at week 4 are, therefore, unlikely to be a direct 
effect of choline depletion as appetite regulatory signalling including 
neurotransmitter expression in neurons of the ARC is a rapidly responding 
system. Measurement of hypothalamic NPY and ɲ-MSH would therefore, at 
week 4, most likely reflect the effect of a low-choline diet rather than the 
earlier choline-devoid diet and, therefore, a milder form of depletion. D 
mothers re-gained weight quickly after choline was re-introduced into their 
diet and although food intake was not recorded during this time it is very 
likely that this weight gain was accompanied by higher food intake. 
Overfeeding has been associated with a voluntary reduction of food intake, 
associated with a slight reduction in NPY [507] and an increase in pro-opio 
melanocortin (POMC) gene expression in the ARC [508]. Rapid weight gain 
in choline-depleted D mothers could, therefore, indeed be associated with 
a decreased ratio of NPY- to POMC-positive neurons in the ARC once 
normal weight is re-established, i.e. the same weight as C and PC mothers. 
Therefore, the results of hypothalamic immunohistochemistry at 4 weeks 
post partum do not allow to draw conclusions about the effect of choline 
GHSOHWLRQRQWKHPRWKHUV¶DSSHWLWHUHJXODWRU\V\VWHP)URPWKHGDWD
shown it can be assumed that the effects of feeding a choline-devoid diet 
seen on maternal food intake is not a mere effect of palatability as food 
intake after the first week on this diet is not changed compared to C and 
PC. A lower food intake is only seen once choline depletion has been 
established. The reduced food intake during choline depletion could be a 
dysfunction in feedback mechanisms through an unknown mechanism or it 
could indeed be a direct effect of choline deficiency in the form of a lack of 
acetylcholine signalling to the muscarinic acetylcholine receptor 3 (M3R) in 
secondary neurons.  
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A knockout model of the M3R shows a lean, hypophagic phenotype [509]. 
Consistent with that, blocking M3R with the antipsychotic drug olanzapine 
increases M3R binding capacity, food intake and body weight in a dose-
dependent manner [510]. In the ARC, POMC-positive neurons also secrete 
acetylcholine and in the fasted state, i.e. when ɲ-MSH concentrations are 
low, acetylcholine has an orexigenic effect by increasing melanin-
concentrating hormone (MCH) expression in the lateral hypothalamic area 
(LHA) [511]. A lack of acetylcholine in the maternal brain could, therefore, 
affect appetite regulation directly. This is a hypothesis that would need to 
be explored further in following studies. 
In all 3 studies we conducted with a design of feeding lactating mothers a 
choline-deficient diet (2009-2011) we saw the same decrease in food 
intake of these mothers after feeding this diet for a week, although this 
change did not reach significance in the 2011 data presented above. 
However, most other studies conducting experiments with choline-devoid 
diets in adult or pregnant rodents do not report this striking change in food 
intake. The reasons for this difference are unknown and, to my knowledge, 
have not been discussed previously. 
A study conducted by Copeland et al. feeding choline-devoid diets to 
adolescent rats showed that 20% of rats lost body weight rapidly and died 
within the first 6 weeks on the choline-devoid diet. Pregnant females, 
lactating mothers and weanling offspring have increased requirements for 
choline relative (for secretion with milk and utilised in growth processes, 
respectively) to their body weight as compared to non-pregnant, non-
lactating adult rats and might, therefore, show signs of rapid choline 
depletion which might differ from physiological signs of a slower depletion. 
However, in other studies with 3 week old rats a normal weight gain 
despite feeding a choline-devoid diet for 12 weeks was reported [512], 
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suggesting that weanling animals are not necessarily more vulnerable to 
choline depletion. 
Deprivation of young male rats of zinc, another micronutrient essential for 
tissue growth [513], induced a decrease in their food intake by about 30% 
and rats stopped growing [514]. Besides a lower food intake, the growth 
rate relative to energy intake is inefficient in these animals, likely due to 
structural and catalytic effects of zinc [515, 516]. The mechanism by which 
food intake is decreased remains unclear [517]. Deficiency of other 
developmentally important micronutrients, including vitamin B6 [518], 
inhibit food intake as well whilst deficiency of most micronutrients, 
including selenium [519], vitamin D [520] and iron [521], do not result in 
changed food intake or growth rate in young rodents.  
Even though a choline-devoid diet does not show an effect on appetite 
regulation of adult animals [522, 523], a diet devoid of both choline and 
methionine, a common intervention to induce hepatic steatosis, decreases 
food intake and body weight substantially [523-525]. This effect cannot be 
due to methionine alone as reducing diet content of methionine in presence 
of folate does not substantially decrease food intake [526, 527]. The 
mechanism through which methionine-choline-deficient diet decreases food 
intake is not known but, since both are interrelated in the one-methyl 
pathway, methylation processes or homocysteine may be involved in this 
mechanism in an as of yet unexplored manner. However, a diet devoid of 
both choline and folate again has no effects on body weight [528], making 
it less likely that methyl donor availability is the mechanism involved here. 
The diet used in our study had approximately 7.3 g/kg methionine (based 
on the assumption that casein has about 3% methionine [529]) which is 
considerably higher than the 3 g/kg that is used as a control diet next to 
MCD diet (cat no. 0296044010, MP Biomedicals, Illkirch, France) and, 
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therefore, D mothers were unlikely to have a methionine-and choline-
deficient diet. 
Most studies applying a choline-devoid diet during pregnancy only subject 
mothers to a short period of this diet, typically gestational day 11-17 [368, 
377], which is shorter than the period necessary in our study to induce 
hypophagia in D mothers (2 weeks). A lack of dietary choline during this 
time frame of pregnancy resulted in long term changes in the hippocampus 
of the offspring but has not been reported to produce changes in food 
intake or weight of mother and offspring [368].  
Lactation period is a period of an even higher requirement for choline than 
pregnancy, as the main storage forms of choline in the liver have been 
shown to be decreased whilst liver triglyceride concentrations are higher in 
lactating rats as compared to pregnant or non-mated rats when all 3 
groups received the same choline concentration in their diets [504]. When 
feeding a choline-devoid diet to lactating rats, hepatic choline metabolite 
concentrations are further reduced [504]. Whilst this study did not mention 
an impact on maternal and offspring weight development or food intake, 
Liapi showed that feeding a choline-devoid diet only during pregnancy does 
not change offspring weight but if this diet is continued throughout 
lactation, offspring are 46 % smaller at weaning as compared to control 
offspring [530]. This supports our findings that there is a difference in 
response to feeding a choline-devoid diet during lactation. However, this 
finding was not further explored and maternal weight development or food 
intake were not reported in this study. 
Because PC is closely involved in lipid digestion [497] and transport [358] 
it could be reasoned that choline-deprived animals develop an aversion for 
dietary fat as a dysfunction in lipid absorption has unpleasant side effects 
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[531]. Since our maternal intervention diets were relatively high in fat, 
compared to other rodent diets, a lipid aversion could have explained the 
sudden drop in food intake of D mothers. Raubenheimer et al. showed that 
a choline-devoid diet does not have an effect on food intake of adult male 
mice both in low- and high-fat diets [522] but this is a concept that could 
be further explored in lactating animals due to their apparent vulnerability 
to the effect of choline depletion on appetite.  
'PRWKHUV¶EUDLQSKRVSKROLSLGFRQFHQWUDWLRQVDQGIDWW\DFLGSURILOHRIErain 
PC were not changed but brain PE had a higher percentage of DHA 
attached as compared to PC mothers. This may suggest a decrease in PC 
biosynthesis through the PEMT pathway as PE with long-chain poly-
unsaturated fatty acids (PUFA) attached are more likely to be converted to 
PC than PE with shorter, saturated fatty acids attached [532]. However, in 
an acute need for PC, PEMT activity is unlikely to be reduced. It is more 
likely that brain phospholipid turnover is slow, as the general lack of 
change suggests, leaving no explanation for the change in DHA 
percentage.  
Taken from the 2009/2010 studies and, therefore, without choline re-
introduction in D mothers, finding that villi are shorter suggests that 
nutrient absorption may be disturbed in these animals as villi increase the 
absorptive area of the intestine [533]. If shorter villi have an effect on 
nutrient uptake into the blood stream, e.g. lower plasma glucose 
concentrations, this could increase food intake [180] but cannot explain 
the decrease of food intake observed in these mothers. The shorter villi 
could be caused either by the lack of choline, i.e. during the rapid turnover 
of villi cells there was not sufficient choline available for cell replication, or 
it is feasible that the shorter villi are actually a result of the decreased food 
intake or a combination of both. Since nutrients from the gut lumen are 
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crucial for cell proliferation, food deprivation is associated with lower rates 
of cell replication and this process is reversible by refeeding [534, 535]. 
Furthermore, the dysfunction of lipid absorption that can be assumed to 
take place in D mothers [536] may contribute to changes in intestinal 
morphology since orlistat, a pharmacological lipase inhibitor which 
decreases lipid absorption, has the side effect of damaging the brush-
border membrane and connective tissue of villi [537]. Therefore, it is 
unclear whether the changes in intestinal morphology are directly due to 
choline depletion or are secondary to reduced food intake or disturbed lipid 
uptake and more research would be necessary to ascertain the mechanism 
behind this. Intestinal crypts are primarily made up of epithelial cell and 
stem cells, with proliferation rates regulated in reaction to normal cell 
turnover and injury [538]. If the shortened villi in the duodenum are 
indeed disadvantageous for nutrient uptake this may induce the response 
of crypt cell proliferation, which we showed to be longer in D mothers. 
However, this response was not seen in jejunum or ileum. 
5.4.1.2. Effects on maternal choline metabolism and milk production 
Mothers fed a choline-devoid diet are partially able to compensate for lack 
of dietary choline in the milk they express, as overall choline content is not 
different and milk only differs in concentration of specific choline-
containing metabolites as compared to milk from C and PC mothers. This 
lack of difference in overall choline content is not due to the re-introduction 
of choline into the diet of D mothers which occurred in the 2011 study, as 
the stomach contents collected were from 2009/2010 offspring after 
feeding a choline-devoid diet to mothers throughout the lactation period. 
0HDVXUHPHQWVIRUPRWKHU¶VPLONZHUHFDUULHGRXWLQWKHRIIVSULQJV¶ 
VWRPDFKFRQWHQWZKLFKDWGD\VRIDJHUHSUHVHQWVPRWKHU¶VPLONEXW
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may also contain an amount of the solid diet provided for mothers since rat 
offspring start consuming solid foods around 17 days postnatal age [539]. 
Our results show that offspring are primarily protected from short term 
maternal choline deficiency with regards to total choline concentrations. 
However, offspring are smaller and have less central body fat mass at 
weaning and show differences in adult brain phospholipid concentrations, 
suggesting that theUHDUHFKDQJHVLQPRWKHU¶VPLONWKDWKDYHDFXWHDQG
long term effects on the offspring. 
In lactating mothers, choline and choline-containing phospholipids secreted 
in milk are likely to be derived from both biosynthesis and storage forms in 
the liver and other tissues. Rate of biosynthesis and the extent of 
utilisation of stores may depend on dietary choline availability. In the 
2009/2010 studies livers were lighter in D as compared to C animals, likely 
due to glycogen mobilisation in response to reduced food intake to 
maintain stabile plasma glucose concentrations. When choline metabolites 
were expressed as total metabolite content per liver rather than per gram 
liver to compensate for the change in size, the amounts of PC and, to a 
smaller extent, betaine were lower in D livers. This suggests that liver-
stored PC was used in milk production in these animals. The reduction of 
PC in the liver did not lead to steatosis whilst in other studies feeding 
choline-devoid diet liver PC is not necessarily further reduced to induce 
steatosis [540]. However, hepatic steatosis has only been shown to be 
induced by feeding a choline-devoid diet in male rodents, not females, 
probably due to the higher PEMT activity in females caused by oestrogen 
[541]. This protection may persist despite depletion of liver PC stores in D 
mothers. 
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The reduction in food intake may indicate the distinctiveness of choline 
metabolism during the lactation period, which needs to be explored in 
further studies.  
5.4.1.3. Acute effects on offspring 
It is, so far, not entirely clear how feeding choline in different forms affects 
the availability and the tissue distribution of choline. It has to be assumed 
WKDW'RIIVSULQJKDGDFFHVVWRIHHGLHPRWKHU¶VPLONFRQWDLQLQJVLPilar 
overall choline concentrations as compared to C and PC but the amount of 
milk ingested and, with that, total choline intake rather than choline 
concentrations could not be assessed.  
In rodents, macronutrient restriction during lactation decreases offVSULQJV¶ 
body weight at the time point of weaning [542, 543]. This suggests that if 
rodent mothers are undernourished to a high degree during lactation, as 
was the case for D mothers after the first week of lactation in our study, 
this will indeed have direct impact on RIIVSULQJV¶ development. This effect 
may be mediated by a lower milk output or by a lower energy density of 
the milk. In humans, general malnutrition reduces milk output and fat 
content of the milk [544, 545]. If milk consumption in D offspring was 
indeed lower than in C and PC offspring then this would mean that D 
offspring ingested less choline during lactation. The lower growth rate seen 
in D suckling offspring could, therefore, be caused by a lower availability of 
nutrients, LQFOXGLQJFKROLQHVHFRQGDU\WRPRWKHU¶VORVVRIERG\ZHLJKW$Q
overall decrease in choline intake secondary to lower milk intake in D 
offspring could help explain the increase in liver lipid concentrations at 
weaning as production of very low-density lipoproteins (VLDL) may be 
impaired in these animals. However, it is not clear why brain phospholipid 
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concentrations would be higher in D as compared to C offspring if their 
overall availability of phospholipids was limited, compared to C and PC 
offspring. However, in the 2011 study we had to provide choline (as free 
choline) to the mothers during the last week of lactation as weight loss was 
very high and this may have affected the availability of choline to the 
developing brain in the offspring of D mothers. This might suggest that 
there is preferential choline deposition in the brain. Further tests may show 
whether this change is phenotypically relevant by changing behaviour of 
these animals. 
There are some experimental designs described [546] that measure 
RIIVSULQJV¶ food intake during suckling and these could be considered for 
IXWXUHVWXGLHV,WZRXOGEHRILQWHUHVWWRH[SUHVVPRWKHU¶VPLONGLUHFWO\
[547] instead of drawing conclusions about maternal metabolism from 
RIIVSULQJV¶ stomach content. To closer monitor RIIVSULQJV¶ choline 
availability throughout lactation it may, additionally, be desirable to 
euthanise one offspring per mother per week and collect their stomach 
contents. This would help determine if choline content of milk changes 
during lactation and if there is a critical period for later effects on the 
offspring. 
5.4.1.4. Long term effects on offspring 
Outcome measures in adult offspring that were significantly affected by a 
lack of choline in the maternal nutrition during lactation were not a mere 
continuation of the effects of this treatment at weaning. Early postnatal 
growth is commonly manipulated through two different study designs in 
rodents, with differing long term results. Similar to the findings of our 
study, directly restricting maternal food intake during lactation to 50% 
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showed an acute growth restriction of weanling offspring but no difference 
in body weight at an adult age of 23 weeks postnatal as compared to 
controls [542]. However, rats which were delayed in growth by being 
raised postnatally in a bigger litter than control animals, did not catch up in 
body weight after weaning [221, 548], which was associated with a lower 
food intake throughout lactation and adulthood. What exactly the 
difference between these two interventions might be is unclear. In order to 
determine whether any of the long term effects we saw in the offspring 
were indeed effects mediated by a difference in maternal choline intake or 
whether the delay in early growth was the main influencing factor it would 
be necessary to introduce a group pairfed to the D group. 
The intervention did also not show an effect on RIIVSULQJV¶ glucose 
homeostasis or appetite regulation. We had assessed brain phospholipids 
and fatty acid composition of PC and PE in these animals to gain some 
insights into structural changes, which might underlie behavioural changes 
connected to choline depletion during development. The changes in brain 
phospholipid concentrations were striking and it would be very interesting 
to see if these observations could be repeated in studies of animals with 
long term changes in spatial memory due to gestational choline depletion. 
Although phospholipid concentrations were drastically changed, fatty acids 
attached to PC and PE did not show any significant changes compared to C 
offspring. 
Cholinergic signalling has recently been implied in myelination processes in 
the brain and also in the decline of myelination with age as is associated 
ZLWK$O]KHLPHU¶VGLVHDVH[549, 550]. Specifically, inhibiting breakdown of 
acetylcholine dela\VSURJUHVVLRQRI$O]KHLPHU¶VGLVHDVH[550]. Since myelin 
is making up a major part of neuronal lipid mass, it is feasible that 
demyelination is associated with a lower phospholipid content seen in adult 
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D offspring. In order to get a better idea if this is indeed the case, brain 
acetylcholine content and neuronal degree of myelination should be 
determined in future studies. Since myelination starts just before birth and 
continues throughout lactation period until about 6 weeks of age in the rat 
[551], it would make sense that lower choline availability during early 
suckling influences myelination processes but in D offspring at weaning 
there is no indication of that as brain phospholipid concentrations are even 
higher than in C offspring. Again, a closer look at brain characteristics may 
give further ideas as to what mechanisms are involved and what 
consequences that might have for the animals¶EHKDYLRXU 
Figure 5.17 summarises findings and possible mechanisms of this 
comparison. D mothers are fed an isocaloric diet devoid of choline. 
Through an unknown mechanism mothers decrease their food intake 
drastically (although this did not reach statistical significance in this study), 
which is likely mediated through central appetite regulation, possibly 
through disturbance of acetylcholine signalling. Intestinal morphology is 
changed in these mothers with shorter villi in all 3 sections of the small 
intestine. This may be caused by decrease in choline availability or be 
secondary to the reduction in food intake. Hepatic PC stores are depleted 
EXWPRWKHU¶VPLONFKROLQHFRQFHQWUDWLRQVDUHQRWDOWHUHG+RZHYHULW is 
OLNHO\WKDWWKHYROXPHRIPRWKHU¶VPLONSURGXFHGZDVUHGXFHGLQ'
mothers, which would reduce offspring caloric and choline intake, leading 
to a reduced early postnatal growth rate. In the adult D offspring 
concentrations of phospholipids were drastically reduced, which may be 
associated with a loss of myelination and manifest in behavioural changes.  
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Figure 5.17: Overview of changes induced by feeding lactating mother a 
diet devoid of choline as compared to a standard amount of choline as 
bitartrate. Mothers have decreased food intake, intestinal villi are shorter 
and a disturbed lipid uptake can be assumed. Maternal liver PC is 
GHFUHDVHGDQGPRWKHU¶VPLONLVDVVXPHGWREHGHFUHDVHGLQYROXPH
although choline concentration itself is not changed, leading to a lower 
growth rate in offspring. In adult offspring, brains show a substantial 
decrease in phospholipid concentration, which may be associated with loss 
of myelin. 
5.4.2. Effects of feeding choline in differing forms during lactation 
Feeding mothers a different form of choline during lactation, i.e. PC as 
compared to choline chloride, had less pronounced effects than feeding a 
diet without choline but it is remarkable that there were differences 
between these mothers and offspring at all.  
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5.4.2.1. Acute effects in mothers and offspring 
PC mothers showed longer intestinal villi and a 3 fold increase in liver lipids 
compared to mothers fed the C diet but there was no difference in 
maternal and offspring weight at any time. The increase in hepatic lipids in 
PC-fed mothers was unexpected since choline depletion, not choline 
supplementation is known to induce hepatic steatosis in males. However, 
there is no indication that 60 mg fat per g liver, i.e. 6% w/w fat, 
constitutes steatosis, which has, in other rat studies, been defined as 60% 
fat in hepatocytes as determined by histology [552] and over 25% in a 
magnetic resonance measurement of hepatic lipids [524]. A small part of 
the higher hepatic lipid content in PC mothers may be explained by the 
pooling of PC in liver due to its lipophilic nature. Dietary PC rather than 
free choline is stored primarily as PC (85%) in the liver, without further 
conversion, whilst free choline is primarily stored as betaine (85%) and 
only 15% as PC [553]. It has recently been shown that injecting mice with 
PC-rich HDL leads to accumulation of PC in the liver and that 30% of the 
PC is converted to triglycerides [554]. By feeding choline as PC rather than 
salt, PC-content of chylomicrons may be increased, which subsequently 
reach the liver and induce an increase in triglycerides there, even if the 
effect may not be large. To my knowledge, this has not been described 
before as choline supplementation studies commonly use choline salts, not 
PC, as the dietary supplement. In future studies, the choline phospholipid 
concentrations of the liver of mothers and offspring would have to be 
analysed, as was already carried out for C and D mothers, and compared 
with the other groups. 
Milk of PC mothers had lower concentrations of free choline and 
sphingomyelin and a higher concentration of PC and overall phospholipids 
but no difference in overall choline concentration as compared to C and D 
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PRWKHUV&KROLQHFRQFHQWUDWLRQVLQPRWKHU¶VPLONDUHWKRXJKWWREHGHULYHG
both from plasma and, with that, liver stores and from biosynthesis [502]. 
Our finding of higher PC concentration in milk of mothers fed PC is, 
therefore, consistent with studies by Cheng et al. as described on the 
previous page [553], which showed that dietary PC is predominantly stored 
as PC in liver, as these stores may then be utilised to reach the high 
FKROLQHFRQFHQWUDWLRQVXVXDOO\IRXQGLQPRWKHU¶VPLON 
5.4.2.2. Long term effects in offspring 
Brain phospholipid concentration of PC offspring was higher at weaning by 
26% as compared to C offspring, which may reflect an acute effect of 
higher phospholipid intake and availability for brain deposition. In 
adulthood, PC offspring had a lower percentage of DHA and overall ǔ-3 FA 
but higher ɲ-linolenic acid attached to brain PE, whilst total concentration 
of PE in the brain was not changed. The changes in ǔ-3 FAs attached to PE 
may have implications for membrane fluidity and anti-inflammatory 
signalling [354]. Brain concentrations of ǔ-3 FAs and specifically DHA have 
been negatively associated with anxiety-like behaviour in rats [555]. In 
animals with high choline availability in the form of PC rather than choline, 
it could be assumed that activity of PC biosynthesis through the PEMT and 
CDP-choline pathways was reduced. Changes in PC fatty acids may indicate 
PEMT activity and the contribution of this pathway to the PC present in a 
tissue. There were only few differences in PC fatty acids in brains of this 
study and certainly not of the magnitude described by DeLong et al. [556]. 
This paper showed that PC synthesised through the CDP-choline pathway 
has predominantly medium length, saturated fatty acids attached whilst PC 
synthesised from PE has more long chain, poly-unsaturated fatty acids. 
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This suggests that feeding choline as PC or free choline did not make a 
difference in adult RIIVSULQJV¶ brain PC biosynthesis. 
In the PEMT pathway, the molecular species of PE used has PUFA attached 
[532]. As PEMT activity is reduced when PC is available [557] it would 
follow that percentage of PUFA attached to PE is preserved in animals with 
higher PC availability. However, in adult PC offspring there is a lower 
percentage of ǔ-3 FAs attached to PE, suggesting that there may be 
another, unknown mechanism underlying this change. 
In further studies, it will be of interest to test if differences in behaviour 
can be found between animals fed diets with different forms of choline. 
Small intestine of adult PC offspring was 7% shorter compared to C 
offspring. How these changes may be mediated by systemic PC availability 
is unknown.  
Feeding the PC diet instead of the C diet led to a bigger difference in many 
of the outcomes measured as compared with D animals. This suggests 
either that the bioavailability of PC is better than that of choline bitartrate 
or that differences arise from limited capacity of the conversion from free 
choline to PC and vice versa through the CTP-choline pathway. Studies on 
bioavailability are few but they show that PC leads to higher and longer 
lasting elevation of blood choline concentrations [347, 349, 553] and are, 
therefore, consistent with my results.  
Figure 5.18 summarises the findings and potential mechanisms for 
mothers fed a diet containing PC rather than free choline and their 
RIIVSULQJ0RWKHUV¶YLOOLDUHORQJHUDQGOLYHUWULJO\FHULGHFRQFHQWUDWLRQVDUH
KLJKHU0RWKHUV¶PLONFRQWDLQVKLJKHUFRQFHQWUDWLRQVRI3&DQG
phospholipids and their offspring show changes in brain composition as 
they have a higher phospholipid concentration at weaning age and a higher 
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percentage of MUFA but lower percentage of ǔ-3 PUFA attached to brain 
PE at a young adult age.  
 
Figure 5.18: Overview of changes induced by feeding lactating mother a 
diet containing choline as PC as compared to choline bitartrate. Mothers 
have higher lipid concentrations in the liver and longer intestinal villi. 
Offspring receive a diet higher in PC and phospholipids (PL) and their brain 
lipids are changed to a higher overall phospholipid concentration and 
higher percentage of MUFA and lower percentage of ǔ-3 PUFA attached to 
brain PE. 
5.4.3. General strengths and limitations of this study and future 
work 
In this study some outcomes that had the appearance of being different 
between groups did not reach statistical significance were limited by lack of 
power due to a low n-numbers. The low number of animals used was due 
to this study being a combination of 1) a follow-up study to confirm some 
results in the immune system that had come out of the 2009/2010 studies 
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and of 2) a pilot study which was to elucidate if there may be any long 
term effects of this intervention, which had not been done before. In order 
to separate the effects of delayed postnatal growth and maternal choline 
deficiency during lactation it would be advisable to add a fourth 
intervention group. Mothers of this group would receive a sufficient amount 
of choline in the diet but would be pair-fed with the D mothers of the 
cohort. Furthermore, to follow up on the most prominent difference we 
observed in adult offspring, neurological assessment in connection with the 
suspected myelin deficit should be carried out, specifically testing for 
symptoms like fatigue and changed motor function, known to be 
associated with demyelination diseases like multiple sclerosis [558]. Brain 
structure would have to be analysed accordingly. 
Since a complete lack of choline in mothers led to complications in the 
2011 study to the point where animals had to be rescued with a standard 
choline diet it would be better to have a low choline group instead in future 
studies, i.e. mothers fed a diet containing 0.1 g/kg free choline during 
lactation. This may still reduce food intake and the effect of choline 
depletion and decreased food intake could be separated by having a group 
of mothers pair-fed to this group of low choline-fed mothers. 
For comparability with human dietary intake of choline it may be desirable 
to include a group which receives a diet with the choline metabolites which 
are present in food at the highest concentrations, free choline, PC and 
glycerophosphocholine, in proportions similar to a human diet [350].  
About 10% of bacteria have PC as part of their cell wall, with PC either 
being synthesised from exogenous choline sources or from methylation 
from PE or both [559]. Ability to produce PC from PE differs between 
bacterial species and, in a human study, it was suggested that the pre-
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existing gastrointestinal bacterial composition is strongly predictive as to 
whether the subject develops fatty liver in response to choline depletion 
[560]. Gut microbiome might, therefore, explain some of the differences in 
response to choline-devoid diets reported in other studies. Similarly, since 
rats are coprophagic [561] hindgut bacteria might contribute to their 
choline intake quite substantially if they are not prevented from re-
ingesting their faeces. However, in our study and many other studies 
effects of choline depletion could clearly be seen and bacterial PC 
production cannot be considered sufficient to prevent depletion. 
5.5. Conclusions 
Our findings clearly show that early lactation is a crucial period for choline 
intake as lactating mothers react to a choline-devoid diet differently from 
those fed sufficient choline and differently from non-lactating adult animals 
as the food intake of D mothers decreased substantially. Secondly, the 
amount and form of dietary choline consumed by the mother during 
lactation period is crucial for the ofIVSULQJV¶ growth and brain development. 
This period needs to be studied more closely with regards to choline 
metabolism as the distinctiveness of this period and the mechanisms 
behind the changes we described are poorly understood. 
In lactating mothers, choline availability and form do indeed change 
intestinal morphology and liver lipid and choline metabolite concentrations 
acutely. Offspring have a slower growth pattern in early postnatal life but 
glucose tolerance is not influenced in the RIIVSULQJV¶ early adulthood whilst 
brain phospholipids, which may represent myelination, are substantially 
changed. 
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It is beyond the scope of this study to draw any definitive conclusions 
about mechanisms underlying the effects observed in this study. Further, 
carefully planned studies will give a better idea with regards to the 
mechanisms involved, as I pointed out throughout this discussion. As 
choline is involved in methyl group metabolism, a choline-devoid diet, 
especially fed during early development, could potentially change 
methylation of genes. This is a mechanism that could be examined in 
further studies, both for global DNA methylation and methylation of 
specific genes, but there is currently not sufficient information to indicate 
which genes could be mediating the changes described in this chapter. As 
for the structural characteristics of choline in membranes and structures 
like myelin, cell culture studies could be employed to gain further insights 
into the response of tissues to choline-depletion. 
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6. Conclusions 
6.1. General aims 
This thesis aimed to investigate the influence of perinatal nutritional 
interventions on the development of metabolic disease and appetite 
regulation in the adult offspring. This aim was considered in 2 different 
studies. The first investigated the influence of maternal macronutrient 
restriction in late pregnancy and the early postnatal growth rate in a sheep 
model. The second studied the influence of a diet devoid of choline, a 
vitamin with key roles in tissue growth and brain development, during the 
lactation period in a rat model. 
In the sheep study, my aims were achieved by assessing glucose 
tolerance, food intake, the metabolic and endocrine responses to feeding, 
and appetite regulation. In the rat study, the main focus was on food 
intake oIPRWKHUVDQGRIIVSULQJFRPSRVLWLRQRIPRWKHU¶VPLONDQGFKDQJHV
in tissue growth and especially brain lipid composition.  
6.2. Summary of findings 
6.2.1. Macronutrient restriction in a sheep model 
Restriction of maternal macronutrient intake in late pregnancy to 60% of 
maternal nutrient requirements caused maternal hypoglycemia and higher 
plasma non-esterified fatty acids (NEFA) concentrations and led to lower 
birth weights. Despite a higher growth rate relative to birth weight, N 
offspring (born to mothers nutrient restricted in late pregnancy) were still 
smaller than R offspring at weaning but were of similar weight by 6 months 
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of age, regardless of perinatal intervention. The insulin sensitivity of NAO 
offspring (N offspring subject to accelerated early postnatal growth and an 
obesogenic environment after weaning) was reduced compared to that of 
both RAO (R offspring with the same postnatal interventions as NAO) and 
NSO groups (N offspring subject to standard early postnatal growth and an 
obesogenic environment after weaning), supporting the concept that slow 
growth in late gestation, followed by accelerated growth in early postnatal 
life, is especially detrimental for adult glucose tolerance. Although it is 
likely that insulin resistance is programmed in one of the main organs 
involved in glucose metabolism, i.e. muscle, white adipose tissue or liver, 
preliminary research in these organs did not give further insights into the 
mechanisms behind the long term effects of perinatal interventions on 
offspring insulin resistance. 
Despite higher fasted plasma leptin, postprandial insulin (glucose tolerance 
test) and 24h glucose concentrations in NAO offspring, food intake was not 
different in these offspring compared to RAO group. Hypothalamic gene 
expression suggested central insulin and leptin resistance as there was a 
non-statistically significant trend to higher gene expression of protein 
tyrosine phosphatase, non-receptor type 1 (PTP1B). Overall gene 
expression did not indicate an anorexigenic stimulus despite the increased 
plasma leptin, insulin and glucose. Although commonly associated with 
overweight and obesity, NAO offspring showed signs of leptin and insulin 
resistance at a similar body weight and composition as RAO offspring. 
Whilst NAO glucose tolerance was affected earlier than that in NSO 
offspring, overall effects induced by maternal macronutrient restriction in 
late pregnancy did not differ significantly with respect to early postnatal 
growth rate. Contrary to my hypothesis, accelerated early postnatal growth 
following a low birth weight did not lead to greater obesity or fat mass in 
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this model. This might have been due to the use of sheep, as I am not 
aware of other sheep studies inducing increased adiposity by subjecting 
lambs to similar perinatal interventions. This may be a programming effect 
specific to humans.  
NSL offspring (N offspring subject to a standard early postnatal growth 
rate and an environment inducing a lean body weight) did not show 
peripheral or central insulin and leptin resistance, suggesting that adverse 
effects of maternal macronutrient restriction in late pregnancy do not 
manifest, at least at a young adult age, if offspring obesity is prevented.  
6.2.2. Choline intake during lactation in a rat model 
In rats, feeding lactating mothers a choline-devoid diet decreased their 
food intake by an unknown mechanism, an effect that is not seen if male 
[512, 522, 523] or female non-pregnant or pregnant rodents [528, 562, 
563] are subjected to a similar diet. This finding suggest that the demand 
for choline during lactation exceeds the ability to synthesise this nutrient. 
$OWKRXJKRIIVSULQJV¶LQWDNHRIPRWKHU¶VPLONGLGQRWGLIIHULQWRWDOFKROLQH
and phospholipid concentrations, the volume of milk available may be 
decreased secondary to the reduction in maternal food intake. Offspring of 
mothers fed a choline-devoid diet for the first 2 weeks of lactation had a 
delay in growth but ultimately attained a normal mature body weight. In 
adult offspring, brain phospholipid concentrations were substantially 
decreased, suggesting that lactation is a sensitive period with regards to 
long term effects of maternal choline intake.  
Dietary intake of choline as phosphatidylcholine (PC), rather than free 
choline, in lactating mothers increased PC and overall phospholipid 
FRQFHQWUDWLRQRIPRWKHU¶VPLON2IIVSULQJJURZWKZDVQRWDIIHFWHGEXWDW
239 
 
weaning, brain phospholipid concentrations were higher. At a young adult 
age, their brain fatty acid profile was altered, with an increase in mono-
unsaturated fatty acids and a decrease in ǔ-3 poly-unsaturated fatty acids 
attached to phosphatidylethanolamine, a prominent phospholipid in the 
brain. This may have implications for membrane fluidity and anti-
inflammatory signalling.  
6.3. Limitations of the models 
6.3.1. Sheep as a model for human development 
Sheep are a good model for human development as they both give birth to 
offspring at a similar stage of organ development as described in more 
detail in Chapter 1, with the highest increase in body weight and pancreas, 
adipose tissue and appetite regulatory pathway development occurring in 
the last third of pregnancy. Like humans, sheep predominantly give birth 
to single, twin or triplet offspring rather than large litters.  
As ruminants, sheep have a distinctly different digestive system and their 
dietary requirements clearly differ from humans. The difference in 
digestive system has been accounted for in my experiments by having 
longer fasting periods before blood samples were taken, that is before 
glucose tolerance tests and the 24 hour feeding tests were performed, with 
an overnight fast of 18h as opposed to 9-12h, which is adopted in humans. 
Despite this difference, it has previously been shown that, consistent with 
human epidemiological studies, sheep develop obesity and/or insulin 
resistance after perinatal interventions [429, 471]. 
The animals in this study were subjected to a comparatively mild nutrient 
restriction, resulting in maternal hypoglycemia without distinct endocrine 
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changes. This may, therefore, not be a directly translatable model for 
intra-uterine growth restriction (IUGR) pregnancies in which the fetus 
experiences hypoinsulinemia, which could further influence intrauterine 
growth and later insulin resistance [231, 477]. However, the phenotype 
displayed by the offspring is consistent with findings in human IUGR 
cohorts with regards to adiposity and insulin metabolism.  
6.3.2. Technical limitations during the sheep study 
Unfortunately, the offspring of mothers allocated to be fed to requirement 
or nutrient restricted did not give birth to a balanced number of male and 
female offspring but, within the groups I analysed, there was no significant 
difference in outcomes between males and females, so that the imbalance 
was not likely to skew these data and conclusions. It would have been 
desirable to have a slightly greater number of animals in each group since 
several outcomes showed a trend to be different without reaching 
statistical significance. It can only be speculated that with a more strongly 
powered study these differences would have stood out more clearly. 
Since sheep are not commonly used as an animal model besides for 
developmental research, commercial assays are not as readily available as 
they would be for human or rodent work. The genome of sheep is not 
entirely sequenced and some attempts to design primers had to use bovine 
or pig sequences and were not successful in the sheep samples. These 
included 1)ǉ%ZKLFKZRXOGKDYHEHHQGHVLUDEOHWRPHDVXUHLQDGLSRVH
tissue as a general marker of inflammation. Similarly, there are only few 
antibodies tested for measurement of sheep protein and, in the limited 
time frame I had to conduct the sheep and rodent studies in Nottingham 
and Edmonton respectively, it was not possible to spend more time 
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optimising Western blotting or immunohistochemistry, even though it 
would have been desirable to confirm gene expression findings on a 
protein level.  
6.3.3. Rats as a model for human development 
Rodents are a valuable model for human development as long as 
developmental differences are taken into account. As I was assessing the 
effects of early postnatal diet on development of brain and insulin 
resistance in rats, this may be used as a model for late pregnancy in 
humans as these organs develop in those periods in rats and humans, 
respectively. 
This study is well-designed with regards to the distribution of sexes in the 
offspring examined. From a litter of 11 offspring per mother, one male and 
one female were selected for dissection at 3 weeks of age but no outcome 
differences could be detected between sexes except for gonadal fat mass, 
which is larger in males. For the extension of the study after weaning, two 
female offspring were selected per mother to reduce effect variance 
between animals due to sex differences. Oestrogen is known to increase 
messenger ribonucleic acid (mRNA) expression of 
phosphatidylethanolamine methyltransferase (PEMT) [564], therefore 
promoting choline biosynthesis from ethanolamine and potentially 
protecting females from choline deprivation as compared to males. If this 
study was to be repeated with male offspring, it is feasible that the 
outcomes seen after feeding mothers a choline-devoid diet would be 
stronger because males may be less able to compensate for choline 
depletion. However, at the time point of intervention there should not be a 
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significant sex difference as oestrogen concentrations and, with that, PEMT 
activity does not change before puberty [565]. 
6.3.4. Technical limitations during the rat study 
For reasons to do with the timing of my work in Edmonton in relation to 
when the studies could be performed I had to combine data from several 
studies for the chapter included in this thesis. This is not ideal and in future 
studies all measurements would have to be repeated in a more consistent 
manner. However, for the purpose of my thesis comparing effects between 
groups within the studies was thought to be valid as effects on maternal 
decrease in food intake and weight loss relative to initial weight were 
comparable between studies. 
6.4. Future work 
6.4.1. Future directions for macronutrient restriction in sheep 
As discussed in Chapter 2, the groups I investigated for my thesis were 
only half of the groups included in the original sheep study. I selected the 
groups I used based on hypotheses involving glucose tolerance and 
appetite regulation of the offspring. Future studies with a similar design 
could include fewer groups to more specifically investigate metabolic health 
and this would enable a larger number of animals in each group. For this, it 
would be desirable to have direct control groups for each of the nutrient 
restricted groups, i.e. RSO and RSL (i.e. a standard early postnatal growth 
rate with and without induction of obesity after weaning) additional to 
RAO. However, using the RAO group in the study discussed here as the 
only group not subjected to maternal nutrient restriction is legitimate since 
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the NAO, NSO and NSL groups could be compared to each other to 
differentiate the effects of the time periods affected by interventions. 
6HFRQGDULO\LWLVPRVWUHSUHVHQWDWLYHRIWRGD\¶VDIIOXHQWVRFLHWLHVWRKDYH
offspring subjected to accelerated early postnatal growth and an 
obesogenic post-weaning environment as a control group.  
Another tissue of interest to investigate would have been the pancreas, 
specifically the state of pancreatic ß-cells in the adult offspring, to further 
determine the cause and the likely continuation of insulin resistance with 
age in the maternally nutrient restricted animals. ß-cells have to be 
isolated immediately at post mortem and as glucose tolerance was not a 
crucial point of the original research question this was not done in this 
study. Additionally, it would be of interest whether the main contributor to 
impaired glucose metabolism is the liver, muscle or subcutaneous/visceral 
fat mass. This could be determined with gene expression analysis of insulin 
receptor substrates [566], PTP1B [462] and genes of lipogenesis, 
glycogenesis and gluconeogenesis. With regards to the changes seen in the 
hypothalamic cortisol regulatory system, further tests could be carried out, 
assessing markers of cardiovascular health and/or subjecting the offspring 
to a specific stress and recording the endocrine response to it. 
Several of the hypothalamic genes with altered expression could be 
assessed for protein abundance and, especially if epigenetic modifications 
have been shown before for these genes, they could be analysed for DNA 
methylation and histone acetylation to assess the role of epigenetic 
changes in the long term mediation of metabolic health outcomes. At 
present this is difficult in sheep as the genome is not fully known and 
antibodies are not readily available.  
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6.4.2. Future directions for choline interventions during lactation in 
rats 
As the long term choline study was performed as a pilot study, further 
studies may benefit by increasing the choline concentration of the D diet 
slightly, i.e. increasing it from 0 g/kg to 0.1 g/kg to avoid the drastic 
weight loss seen in D mothers. The effects of choline depletion and the 
weight loss secondary to it can be distinguished by adding a pair-fed 
group, i.e. a fourth group that is fed the same amount of diet with a 
standard choline concentration as D mothers are consuming.  
It may also be of interest to have another group consuming a diet with all 
forms of choline at proportions similar to the human diet with a suboptimal 
total concentration of e.g. 0.5 g choline per kg diet, to closer represent 
human choline consumption.  
With regards to the changes seen in the brain of offspring, which may lead 
to behavioural changes, further tests could be carried out for these 
animals, not only testing spatial memory as previously, but also tests 
investigating other behaviours such as anxiety. I discussed in Chapter 5 
that the reduction in brain phospholipids of adult D offspring may be 
associated with a decrease in myelination. To assess this further, brain 
histology would have to be carried out. 
6.5. Final remarks 
The perinatal periods have been shown to be sensitive periods for long 
term development of offspring in the studies of my PhD, both in a 
restriction of overall macronutrient intake and in a restriction of a specific 
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micronutrient with a central role in brain development and tissue growth, 
choline. A crucial part of the effects seen may be mediated through 
changes in growth rates, i.e. slower growth in late pregnancy followed by 
accelerated growth in early postnatal life in the sheep study, and slower 
growth in early postnatal life in the rat study. 
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Appendix A: Paper abstract 
Endocrinology 152: 2816Ȃ2826, 2011 
Maternal Nutrient Restriction During Late Gestation and Early Postnatal 
Growth in Sheep Differentially Reset the Control of Energy Metabolism in 
the Gastric Mucosa 
Sebert SP, Dellschaft NS, Chan LLY, Street H, Henry M, Francois C, Sharma 
V, Fainberg HP, Patel N, Roda J, Keisler D, Budge H, and Symonds ME. 
Early Life Nutrition Research Unit (S.P.S., N.S.D., L.L.Y.C., H.S., M.H., 
C.F., V.S., H.P.F., N.P., J.R., H.B., M.E.S.), Academic Child Health, Division 
of Human Development and Nottingham Respiratory Medicine Biomedical 
Research Unit, School of Clinical Sciences, University Hospital, Nottingham 
NG7 2UH, United Kingdom; and Department of Animal Sciences (D.K.), 
University of Missouri, Columbia, Missouri 65201 USA. 
Fetal growth restriction followed by accelerated postnatal growth 
contributes to impaired metabolic function in adulthood. The extent to 
which these outcomes may be mediated centrally within the hypothalamus, 
as opposed to in the periphery within the digestive tract, remains 
unknown. In a sheep model, we achieved intrauterine growth restriction 
experimentally by maternal nutrient restriction (R) that involved a 40% 
reduction in food intake through late gestation. R offspring were then 
either reared singly to accelerate postnatal growth (RA) or as twins and 
compared with controls also reared singly. From weaning, all offspring 
were maintained indoors until adulthood. A reduced litter size accelerated 
postnatal growth for only the first month of lactation. Independently from 
postnatal weight gain and later fat mass, R animals developed insulin 
resistance as adults. However, restricted accelerated offspring compared 
with both the control accelerated and restricted restricted offspring ate less 
and had higher fasting plasma leptin as adults, an adaptation which was 
accompanied by changes in energy sensing and cell proliferation within the 
abomasum. Additionally, although fetal restriction down-regulated gene 
expression of mammalian target of rapamycin and carnitine 
palmitoyltransferase 1-dependent pathways in the abomasum, RA offspring 
compensated for this by exhibiting greater activity of AMP-activated 
kinase-dependent pathways. This study demonstrates a role for perinatal 
nutrition in the peripheral control of food intake and in energy sensing in 
the gastric mucosal and emphasizes the importance of diet in early life in 
regulating energy metabolism during adulthood.  
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Appendix B: Conference 
abstracts 
Canadian Nutrition Society, Vancouver, BC, 
Canada (poster presentation by Erin Lewis) 
Maternal choline intake during suckling alters immune development in the 
offspring. 
Lewis ED, Dellschaft N, Goruk S, Curtis JM, Jacobs R, Field CJ (2012). 
Agricultural, Food and Nutritional Sciences, University of Alberta, Alberta, 
Canada, T6G 2R3. 
Choline is an essential nutrient for the normal function of all cells; however 
few studies have explored its role during immune system development. 
The most abundant forms of choline in the diet and breast milk are free 
choline and phosphatidylcholine (PC) which differ in their metabolism and 
may have different metabolic roles in the body. The objective of this 
research was to determine the essentiality of choline and the effect of 
feeding different metabolites of choline to dams on immune development 
in offspring. After giving birth, Sprague-Dawley dams were fed 1 of 3 high 
fat, isocaloric diets differing only in amount and form of choline; 0 g/kg 
choline (D, n=7), 1.0 g/kg free choline (FC, n=15) or 1.2 g/kg PC (PC, 
n=12). At 3 weeks, 2-3 of the suckled pups from each dam were killed and 
splenocytes isolated to measure the type of cells present (via flow 
cytometry) and the ability of cells to produce cytokines (by ELISA) ex vivo 
DIWHUVWLPXODWLRQ7RWDOFKROLQHFRQWHQWRIWKHGDP¶VPLONSXSV¶VWRPDFK
content) did not differ significantly among groups, but the PC group had a 
higher PC content (p<0.05). Final body weight was lower in the D pups 
compared to PC and FC pups (p<0.05). The D group had a higher % of 
CD8+CD28+ T cells compared to choline groups and a higher % of NK cells 
(CD3+CD161+) compared to FC group (p<0.05), but the cytokine 
response after stimulation did not differ from FC. Cells from PC pups 
produced more (133%) IL-6 than the FC pups (p<0.05) when stimulated 
with ConA. Compared to FC, the PC splenocytes had a higher proportion 
(43%) of regulatory T cells (CD4+CD25+) and activated cytotoxic T cells 
(CD8+CD71) (p<0.05). The response to lipopolysaccharide (bacterial 
antigen) did not differ among groups. However, a higher proportion of 
IgM+ cells were found in PC group compared to FC group and a higher 
proportion of IgA+ cells compared to both FC and D groups (p<0.05). 
These findings suggest that the amount and form of choline in the 
maternal diet during suckling influences immune development in offspring. 
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World Congress on Developmental Origins of 
Health and Disease (DOHaD), Portland, OR, USA 
(poster presentation) 
Dietary Choline Intake During Lactation Impacts the Growth of Offspring. 
Dellschaft N, Jacobs R, Goruk S, Coursen N, Curtis J, Field C (2011). 
Agricultural, Food and Nutritional Sciences, University of Alberta, Alberta, 
Canada, T6G 2R3. 
Aims: Although it has been established that choline is an important 
nutrient during pregnancy, the essentiality of choline (or the dietary forms 
of choline) in the maternal diet during the suckling period has not been 
established and is the purpose of the current study. 
Methods: Sprague-Dawley dams (n=4/group) were fed a high-fat, 
isocaloric diet from delivery until the end of the suckling period (21d), 
containing phosphatidylcholine (PC), choline (C) or neither (D). Similar to 
our earlier studies, D mothers gain less weight during lactation. At 21d, 
stomach contents were collected (n=2/dam) and analysed by LC-MS for 
choline metabolites. 2 female pups per dam were weaned to a high-fat diet 
(20% w/w) containing 1g/kg choline as free choline and body weight and 
food intake were measured regularly until 11 wks of age. 
Results: In RIIVSULQJV¶ stomach content there was a lower concentration of 
free choline in D (0.3±0.1mg/g) compared to C (6.1±1.0) and a higher PC 
concentration in the PC group (66±13mg/g) compared to D (35±13) and C 
(24±3), p<0.05, suggesting that endogenous synthesis of PC is reduced in 
D mothers. Length and body weight for D pups was significantly lower than 
that of PC and C at 4 wks (weight: PC, 90±1; C, 89±2; D, 66±2g; p<0.05) 
and 5 wks of age (PC, 137±5; C, 135±4; D, 116±3g; p<0.05) but did not 
differ at 7 wks. This catch up growth was likely due to a higher food intake 
adjusted for body weight (wk 4, PC, 140±2; C, 120±5; D, 166±13 mg 
diet/g body weight*d; for PC vs. C, C vs. D p<0.01) by the D pups. At 9 
wks of age, an intraperitoneal glucose tolerance test (IPGTT) was 
performed but insulin and glucose response (area under the curve) did not 
differ significantly among groups. 
Conclusions: Our findings suggest that a source of choline is required in 
the maternal diet during suckling to provide choline for maternal milk and 
to induce normal growth in the offspring. The effects of maternal choline 
deficiency on pup body weight remained for several weeks, despite feeding 
a choline sufficient diet. Rapid catch-up growth occurred by 7-8 wks of age 
but glucose tolerance at 9 wks was not significantly affected. Currently, 
studies are underway in these animals to determine the effects of early 
choline deprivation on immune function and appetite regulatory pathways 
in the hypothalamus later in life. (Funded by ALMA, Alberta Egg Producers 
and NSERC.) 
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Experimental Biology, Washington, DC, USA 
(poster presentation) 
Choline Intake During Lactation Alters Maternal and Infant Growth and the 
Ex Vivo Response of Splenocytes to Lipopolysaccharide (LPS).  
Dellschaft N, Goruk S, Curtis J, Jacobs R, Field C (2011). Agricultural, Food 
and Nutritional Sciences, University of Alberta, Alberta, Canada, T6G 2R3. 
To determine if choline is required in the diet during lactation, immediately 
after birth, the pups from 26 Sprague-Dawley dams were randomized to 
the dams and the dams fed one of 3 high fat (20% w/w) diets differing 
only in the amount and form of choline: a diet with the recommended 1g 
choline as bitartrate/kg diet (C, n=11) or phosphatidylcholine (PC, n=8), 
or a choline-devoid diet (D, n=7) Dams and pups were sacrificed at 21 d 
and splenocytes isolated from dams and stimulated in vitro with LPS. All 
results were compared to the choline salt diet, C. Dams and pups weighed 
less (P<0.05) when fed D. Spleens from D had a higher % of antigen 
presenting cells (IgM+, OX62+OX6+, CD68+11+) but cells produced less 
,)1ǄDIWHU/36'DPVEXWQRWSXSVZHLJKHGPRUHDQGKDGD
higher gonadal and perirenal fat mass (P<0.05) when fed PC. Spleens from 
PC had a higher % activated macrophages (CD284+) and Th2 (CD71+), 
and total and activated B (CD80+28+, IgG+) cells and a lower % T reg 
cells (CD25+Fox+) (P<0.05). PC cells produced more (P<0.05) IL-6 
(188%) with LPS. These results suggest 1) that choline is needed in the 
maternal diet during lactation to ensure maternal and infant growth and to 
support the immune response to LPS and 2) that providing choline as PC 
instead of a salt may further promote maternal growth, alter the activation 
state of immune cells and the ability to produce IL-6 with LPS. (Supported 
by Alberta Innovates Biosolutions and NSERC)  
Women, Child, Health Research Institute 
(WCHRI) Annual research day, Edmonton, AB, 
Canada (poster presentation by Peter Iglinski)  
Dietary Choline Influences the Distribution of Immune Cells in the Spleens 
of Dams during Lactation.  
Iglinski P, Dellschaft N, Goruk S, Jacobs R, Curtis J, Field C (2010). 
Agricultural, Food and Nutritional Sciences, University of Alberta, Alberta, 
Canada, T6G 2R3. 
It is established that choline is required during pregnancy for fetal neural 
development. The objective of this summer project was to determine 
whether dietary choline is necessary for the maternal immune system 
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during lactation and to investigate whether supplementing different forms 
of choline affects immune function differently. 
64 Sprague-Dawley pregnant females were fed standard rodent chow. 
Within 24h of delivery they were randomized to one of 6 nutritionally 
complete diets that differed only in the amount and form of choline. 
Choline bitartrate (CB) and lecithin (phosphatidylcholine (PC)) were used in 
the diets (added in a g/kg diet basis) as a source of choline. The diets were 
ZERO (0 g choline), CB (1g), 2xCB (2g), 4xCB (4g), PC (1g), and 2xPC 
(2g). After 21d the dams and pXSVZHUHZHLJKHGDQGNLOOHGDQGWKHGDPV¶
spleens collected and splenocytes isolated. Cells were treated with 
monoclonal antibodies and the mononuclear cell population gated and 
analyzed by flow cytometry. Groups were compared using ANOVA and 
differences bHWZHHQJURXSV3ZHUHLGHQWLILHGE\D'XQFDQ¶V
multiple range test. 
Final body weight was lower in dams and pups fed the ZERO diet compared 
to CB (P<0.05). Additionally, the proportion of T cells (total CD3+, CD4+, 
CD8+) and the activated T cells (CD28+, CD27+) were significantly lower 
in dams fed the ZERO diet (P<0.05). Feeding 4xCB, but not 2xCB resulted 
in significantly lower body weights of both dams and pups compared to the 
1xCB. Dams and pups fed the PC diet compared to the CB diet had higher 
body weights and a higher proportion of activated CD4+ cells (CD71+) and 
antigen presenting cells (CD80+) (P<0.05). 
These preliminary findings suggest that choline is required for the maternal 
immune system during lactation, that there may be a detrimental effect of 
supplementing high amounts of free choline and that providing choline in 
the form of PC as compared to salt results in differences in maternal and 
pup body weight and in immune phenotypes. Further research will assess 
whether these phenotype differences affect characteristics of immune 
function in both the offspring and mother. 
International Conference on Developmental 
Origins of Health and Disease: Metabolic 
Programming, Munich, Germany (oral 
presentation) 
The Influences of Nutrient Restriction in Late Pregnancy and Accelerated 
Postnatal Growth on the Insulin and Leptin Systems and Hypothalamic 
Gene Expression Following Obesity in the Sheep.  
Dellschaft N, Sebert S, Gardner D, Keisler D1, Symonds M, Budge H 
(2010). Early Life Nutrition Research Unit, Academic Child Health, School 
of Clinical Sciences, University of Nottingham, Nottingham, UK; 1 
Department of Animal Sciences, University of Missouri, Columbia, Missouri 
65201 USA. 
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Objectives: Prenatal caloric restriction followed by accelerated postnatal 
growth influences later risk for metabolic diseases associated with obesity, 
raising the question as to whether long term programming of hypothalamic 
appetite control may be modulated by perinatal growth. 
Methods: Pregnant twin-bearing sheep were either fed to requirements (R; 
n=8) or nutrient restricted to 60% of this amount (N; n=15) from 110 
days up to term (~147 days). Twin offspring were reared to promote either 
accelerated (A) (RA, n=8; NA n=8) or standard (S) (NS, n=7) early 
postnatal growth. After weaning, offspring were then kept in a low activity 
environment until 17 months of age when insulin response to a GTT was 
assessed and entire hypothalami dissected for gene expression analysis by 
real-time PCR.  
Results: Adult offspring body weight and composition were similar. Plasma 
leptin and insulin responsiveness were higher in N compared to R offspring. 
Whilst gene expression of hormone receptors i.e. insulin, leptin and ghrelin 
were unaffected, genes involved in insulin and leptin signalling (PTP1B), 
energy sensing (mTOR, AMPK, FTO), blood pressure regulation (AVP) and 
the glucocorticoid system (GCR) were overexpressed in N compared to R 
offspring.  
Conclusions: Although maternal diet did not alter adult body weight or 
composition, long term systemic changes in leptin and insulin regulation 
were induced by fetal growth restriction. These adaptations were further 
associated with differential responses in the gene expression profiles within 
the hypothalamus, suggesting programmed alterations in energy sensing 
pathways.  
International Conference on Developmental 
Origins of Health and Disease: Metabolic 
Programming, Munich, Germany (oral 
presentation by Sylvain Sebert) 
Maternal nutrient restriction and early accelerated postnatal growth 
programs liquid chromatography±electrospray±high-resolution mass 
spectrometry (LC-ESI-HRMS) metabolomic profiles in the blood.  
Alexandre-Gouabau M1, Moyon T1, Antignac J2, Dellschaft N3, Budge H3, 
Symonds M3, Sebert S3 (2010). 1 INRA, UMR Physiologie des Adaptations 
Nutritionnelles, Rue de la Géraudière, BP 71627, 44316 Nantes, Cedex 3, 
France; 2 /DERUDWRLUHG¶(WXGHGHV5pVLGXVHW&RQWDPLQDQWVGDQVOHV
Aliments (LABERCA), Ecole Nationale Vétérinaire (ENVN), USC INRA 2013, 
Nantes, France; 3 Early Nutrition Research Unit, University of Nottingham, 
Nottingham, UK. 
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Background: Consistent evidences suggest that alterations in energy 
metabolism perinatally programmed risks for metabolic diseases. 
Nonetheless, the alterations that induce and maintain the program are yet 
unrevealed. Metabolomic modelling can be critical upon that matter. 
Design: Twin-bearing sheep were allocated to either fed a control (C, n=9) 
or a restricted diet (R, 60% of C, n=16) during late gestation (110 days to 
term ~ 145 days). Mothers delivered twins bred either in environment that 
favored accelerate (A) or restricted (R) postnatal growth (CA; n=9, RA, 
n=7, RR, n=7). Weaned offspring were raised indoor up to 17 months of 
age. At 130 days of gestation in mothers and 17 months in the offspring, 
fasted blood samples were collected and assessed by liquid 
chromatography±electrospray±high-resolution mass spectrometry (LC-ESI-
HRMS).  
Results: The term R offspring was 10% lighter than C (P<0.001). RA 
offspring grew faster than both the RR and CA (P<0.01). 2629 variables 
were analysed by partial least-square-discriminant analysis (PLS-DA) 
demonstrated a dichotomy between the maternal environments 
(predictability (Q2= 40%) a difference further exacerbated when 
comparing a selection of 171 metabolites (Q2= 51%),17 months after 
birth, metabolic profiling allowed the identification of the 3 groups of 
offspring by O (orthogonal)-PLS-DA analysis (Q=51 %, P= 2.310-5).  
&RQFOXVLRQ7KLVQRYHO³RPLF´DSSURDFKGHPRQVWUDWHGORQJWHUP
programming effects induced by perinatally. We are now moving towards a 
second phase: the identification of the metabolic classes involved in these 
models. They may help the discrimination of programmed metabolic 
pathways. 
Neonatal Society scientific meeting, London, UK 
(oral presentation) 
The Influence of Maternal Nutrient Restriction in Late Pregnancy and 
Accelerated Postnatal Growth on Plasma Insulin and Leptin and 
Hypothalamic Gene Expression Following Obesity in the Sheep.  
Dellschaft N, Sebert S, Keisler D1, Symonds ME, Budge H (2010). Early Life 
Nutrition Research Unit, Academic Child Health, School of Clinical Sciences, 
University of Nottingham, Nottingham, UK; 1 Department of Animal 
Sciences, University of Missouri, Columbia, Missouri 65201, USA. 
Background: Prenatal caloric restriction, followed by accelerated postnatal 
growth, influences later risk for metabolic diseases associated with obesity. 
This may be associated with a resetting of hypothalamic appetite control 
and insulin sensitivity. 
Aim: The aim of this study was to differentiate between the long term 
effects of nutrient restriction in late pregnancy and those of accelerated 
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early postnatal growth followed by obesity. Outcomes measured were 
plasma leptin, insulin sensitivity and hypothalamic regulation of energy 
balance and blood pressure regulation. 
Methods: Pregnant twin-bearing sheep were either fed to requirements (R; 
n=8) or nutrient restricted to 60% of this amount (N; n=15) from 110 
days up to term (~147 days). Twin offspring were either reared by their 
mother as singletons to promote accelerated early postnatal growth (A) 
(RA, n=8; NA n=9) or both offspring were reared together by their mother 
to promote standard early postnatal growth (S) (NS, n=7). After weaning, 
offspring were then kept in a low activity environment until 17 months of 
age when insulin response to a glucose challenge was assessed and entire 
hypothalami dissected for gene expression analysis by quantitative real-
time PCR. Appropriate institutional Animal Ethics Committee approval was 
obtained. 
Results: Although birth weight was reduced in N offspring, adult offspring 
body weight and composition were similar between groups. Plasma leptin 
and insulin responsiveness were higher in N compared to R offspring. 
Whilst gene expression of hormone receptors i.e. insulin, leptin and ghrelin 
were unaffected, genes involved in insulin and leptin signalling (protein 
tyrosine phosphatase, non-receptor type 1), energy sensing (mammalian 
target of rapamycin, adenosine monophosphate kinase, fat mass and 
obesity associated), blood pressure regulation (arginine vasopressin) and 
the glucocorticoid system (glucocorticoid receptor) were overexpressed in 
N compared to R offspring. None of these effects were significantly 
influenced by changes in postnatal growth. 
Conclusion: Although maternal diet did not alter adult body weight or 
composition, long term systemic changes in leptin and insulin regulation 
were induced by fetal growth restriction. These adaptations were further 
associated with differential responses in the gene expression profiles within 
the hypothalamus, suggesting programmed alterations in energy sensing 
pathways. 
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Appendix C: Suppliers  
Contacts used in Nottingham 
AbD serotec     Oxford, UK 
Anglia Scientific    Cambridge, UK 
Applied Biosystems    Foster City, CA, USA 
Bio-tek Instruments Inc   Potton, UK 
Bioron      Ludwigshafen, Germany 
Fisher Scientific    Loughborough, UK  
Fujifilm     Tokyo, Japan 
Hamamatsu     Welwyn Garden City, UK 
IBM      Portsmouth, UK 
Leica      Milton-Keynes, UK 
Linton Instrumentation   Diss, UK 
Manor Farm Feeds    Oakham, UK 
Mercodia     Uppsala, Sweden 
Packard Inc     Downers Grove, Australia 
Perkin Elmer     Waltham, MA, USA 
Premier Biosoft    Palo Alto, CA, USA 
Qiagen     Hilden, Germany 
Randox Laboratories    Crumlin, UK 
Siemens     Camberley, UK 
Sigma-Aldrich     Gillingham, UK 
Techne     Burlington, NJ, USA 
Thermo Scientific    Wilmington, DE, USA 
VWR      Radnor, PA, USA 
Wako      Neuss, Germany 
Contacts used in Nantes 
Interchim     Montluçon, France 
Pall      Port Washington, NY 
Sigma Aldrich     St Quentin-Fallavier, France 
Solvent Documentation Synthesis  Peypin, France 
Thermo Fisher Scientific   Bremen, Germany 
Umetrics Inc     Umeå, Sweden 
Contacts used in Edmonton 
AB Sciex     Concord, ON, Canada 
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Agilent Technologies    Santa Clara, CA, USA 
Alpco      Salem, NH, USA 
Analtech Inc     Newark, DE, USA 
BD      Franklin Lakes, NJ, USA 
Charles River Laboratories   Montreal, QC, Canada 
Fisher      Pittsburgh, PA, USA 
Gold Top     Edmonton, AB, Canada 
Harlan Teklad     Madison, WI, USA  
Invitrogen     Burlington, ON, Canada 
Leica      Nussloch, Germany 
Lipid Nutrition    Channahon, IL, USA 
Merck      Darmstadt, Germany 
Millipore     Billerica, MA, USA 
MP Biomedicals    Solon, OH, USA 
North American Mogul Products  Chagrin Falls, OH, USA 
PMI Nutrition International   Brentwood, MO, USA 
Richardson Oilseed Ltd   Let bridge, AB, Canada 
Roche      Laval, QC, Canada 
Safeway     Calgary, AB, Canada 
Sigma      St. Louis, MO, USA 
Thermo Fisher Scientific   Edmonton, AB, Canada 
Thermo Scientific    Nepean, UN, Canada 
USB Corp     Cleveland, OH, USA 
Varian Inc     Mississauga, ON, Canada 
VWR International    Edmonton, AB, Canada 
Zeiss Ltd     Toronto, ON, Canada 
 
